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Abstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder resulting in language and social
communication impairments, restricted interests, and repetitive behaviors. Previous research has focused on
the cause, onset, and early years of the disorder, leaving the life course trajectory unknown. For females in
particular, who comprise approximately 20% of individuals with ASD, a dearth of knowledge surrounding
adolescence and puberty may pose challenges as the social, cognitive, and developmental growth inherent to
puberty overlaps the social, developmental, and behavioral impairments of ASD. Few studies have addressed
puberty in females with ASD and have reported mixed findings regarding its onset and presentation. In this
study, puberty is represented by menses. The purpose of this mixed-methods study was to explore the onset,
symptoms, and experience menses in females with ASD compared to Neurotypical peers through self- and
parent-report on web-based questionnaires and semi-structured interviews with ASD parent-participant
dyads. Analysis revealed a significant effect of ASD diagnosis in the participant or a sibling of the participant
on age at menarche (AAM), with ASD females from multiplex families (families with two or more children
diagnosed with ASD) reporting significantly earlier AAM (11.01 � 1.10 years) than Neurotypical females
with no family history of ASD (12.86 � 0.94 years; p < 0.05). Females with ASD were less likely to report pre-
menstrual symptoms than Neurotypical females, yet reported dysmenorrheal, physical, behavioral, and
emotional menstrual symptoms at similar rates. Females with ASD who reported menstrual symptoms
indicated experiencing greater burden of behavioral and emotional symptoms than Neurotypical females.
Parents were accurate reporters of their daughters’ AAM, but not menstrual symptom presentation.
Interviews with ASD parent-participant dyads revealed six themes: preparations for puberty, the physical
experience of menses, speed bumps on the road through puberty, managing the everyday, looking to the
future, and reflective advice. Together, these findings highlight the complex presentation of puberty in females
with ASD, underscoring the need for disorder-specific education, healthcare, and interventions that promote
the well-being of young women throughout adolescence and adulthood.
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ABSTRACT 
FACING PUBERTY: EXPLORING THE ONSET, SYMPTOMS AND EXPERIENCE 
OF MENSES IN FEMALES WITH AUTISM SPECTRUM DISORDER 
Whitney Eriksen 
Jennifer Pinto-Martin 
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder resulting in 
language and social communication impairments, restricted interests, and repetitive 
behaviors. Previous research has focused on the cause, onset, and early years of the 
disorder, leaving the life course trajectory unknown. For females in particular, who 
comprise approximately 20% of individuals with ASD, a dearth of knowledge 
surrounding adolescence and puberty may pose challenges as the social, cognitive, and 
developmental growth inherent to puberty overlaps the social, developmental, and 
behavioral impairments of ASD. Few studies have addressed puberty in females with 
ASD and have reported mixed findings regarding its onset and presentation. In this study, 
puberty is represented by menses. The purpose of this mixed-methods study was to 
explore the onset, symptoms, and experience menses in females with ASD compared to 
Neurotypical peers through self- and parent-report on web-based questionnaires and 
semi-structured interviews with ASD parent-participant dyads. Analysis revealed a 
significant effect of ASD diagnosis in the participant or a sibling of the participant on age 
at menarche (AAM), with ASD females from multiplex families (families with two or 
more children diagnosed with ASD) reporting significantly earlier AAM (11.01 ± 1.10 
years) than Neurotypical females with no family history of ASD (12.86 ± 0.94 years; p < 
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0.05). Females with ASD were less likely to report pre-menstrual symptoms than 
Neurotypical females, yet reported dysmenorrheal, physical, behavioral, and emotional 
menstrual symptoms at similar rates. Females with ASD who reported menstrual 
symptoms indicated experiencing greater burden of behavioral and emotional symptoms 
than Neurotypical females. Parents were accurate reporters of their daughters’ AAM, but 
not menstrual symptom presentation. Interviews with ASD parent-participant dyads 
revealed six themes: preparations for puberty, the physical experience of menses, speed 
bumps on the road through puberty, managing the everyday, looking to the future, and 
reflective advice. Together, these findings highlight the complex presentation of puberty 
in females with ASD, underscoring the need for disorder-specific education, healthcare, 
and interventions that promote the well-being of young women throughout adolescence 
and adulthood.  
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Introduction 
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Overview of the Study 
 Autism Spectrum Disorder (ASD), a neurodevelopmental disorder characterized 
by (1) impairments in social interaction and communication, and (2) restricted, repetitive 
patterns of behavior or interests, has seen a dramatic rise in prevalence in the United 
States over the past 25 years, with a near three fold increase from 2000 to 2010 alone 
(1:166 in 2000 to 1:68 in 2010; American Psychiatric Association, 2013; Christensen, 
2016). Whether resulting from improved diagnostic tools and practices (Guevara et al., 
2013; King & Bearman, 2009), increased awareness, or an increase in the rates of 
developmental disorders (Isaksen, Diseth, Schjolberg, & Skjeldal, 2013), ASD has 
become commonplace in the United States (Baxter et al., 2014; Bhat, Acharya, Adeli, 
Bairy, & Adeli, 2014; Buescher, Cidav, Knapp, & Mandell, 2014). As of 2016, ASD is 
believed to impact the lives of one in 42 males and one in 189 females in the United 
States (Christensen, 2016), making this developmental disorder more common than all 
childhood cancers combined (Siegel et al., 2014). Despite the dramatic increase in 
prevalence, the significant costs associated with care for individuals with ASD across the 
lifespan (Buescher et al., 2014; Lavelle et al., 2014; Peacock, Amendah, Ouyang, & 
Grosse, 2012), and the impact of a diagnosis of ASD on quality of life, safety and 
mortality (Billstedt, Gillberg, & Gillberg, 2005; Brenner et al., 2013; Jain et al., 2014; L. 
C. Lee, Harrington, Chang, & Connors, 2008), research on ASD remains focused 
primarily on young children and on unveiling the cause or causes of ASD (Interagency 
Autism Coordinating Committee (IACC), 2014; Perkins & Berkman, 2012). While a 
laudable goal, it does not directly address the scores of individuals living beyond the age 
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of diagnosis with ASD into adolescence and adulthood, and the realities and difficulties 
of life they face on a daily basis. Similarly, research to date has typically drawn on white 
males as participants (Krahn & Fenton, 2012), overlooking the experiences of ASD for 
those falling outside of this group. Females with ASD in particular have been largely 
ignored from research (Kirkovski, Enticott, & Fitzgerald, 2013; Lai et al., 2013; Shefcyk, 
2015; Werling & Geschwind, 2013), leaving their trajectory across the lifespan a relative 
mystery (Cridland, Jones, Caputi, & Magee, 2014; Halladay et al., 2015; Shefcyk, 2015). 
 Puberty marks the transition from childhood to adulthood. Physically, the body 
develops into its adult frame and function; cognitively, the mind gains skills in abstract 
thinking and executive control; and socially, the individual’s relationships shift towards 
friendships and romantic relationships. For children with ASD puberty poses unique 
challenges: the social, cognitive and developmental growth inherent to puberty overlays 
the social, developmental and behavioral impairments of ASD, resulting in an experience 
that may be as singular and challenging as the diagnosis of ASD itself. Females with 
ASD face additional difficulties with the onset of menses, or menstrual cycle, requiring 
access to safe and accurate age-, gender-, and disorder-specific education and healthcare. 
Currently, few studies have addressed issues surrounding puberty in this growing 
population (Burke, Kalpakjian, Smith, & Quint, 2010; Hamilton, Marshal, & Murray, 
2011; Hergüner & Hergüner, 2016; Ingudomnukul, Baron-Cohen, Wheelwright, & 
Knickmeyer, 2007; Knickmeyer, Wheelwright, Hoekstra, & Baron-Cohen, 2006; Pohl, 
Cassidy, Auyeung, & Baron-Cohen, 2014; Whitehouse, Maybery, Hickey, & Sloboda, 
2011). Those that have addressed this transition suggest that females with ASD 
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experience menarche, the first menstrual period, at times incongruent to their peers 
(Burke et al., 2010; Hamilton et al., 2011; Knickmeyer et al., 2006; Whitehouse et al., 
2011), demonstrate elevated rates of both precocious puberty and primary amenorrhea 
(Burke et al., 2010; Ingudomnukul et al., 2007; Knickmeyer et al., 2006; Pohl et al., 
2014), and experience significantly more symptoms surrounding menses (Burke et al., 
2010; Ingudomnukul et al., 2007; D. O. Lee, 2004; Pohl et al., 2014). Additionally, 
several studies have observed elevated rates of disorders related to menstruation, such as 
polycystic ovarian syndrome, in females with ASD and mothers of children with ASD 
(Ingudomnukul et al., 2007; Pohl et al., 2014). 
Puberty isn’t a singular event; it is a daily experience, a steady series of steps 
towards adulthood. As all who have gone through this transition period know, it is a 
process of getting re-acquainted with one’s developing body and ever changing 
hormones, navigating a dynamic and challenging social environment, developing new 
cognitive skills, and being in many ways simultaneously a child and an adult. While this 
natural life event may pose its challenges in the most well adjusted Neurotypical child, 
those with a diagnosis of ASD may experience additional and significant behavioral, 
physical and mental health issues that are currently not known nor well understood.   
Significance 
This study has sought to build on previous research regarding the onset and 
symptoms of menses in females with ASD, to inform the individuals, as well as their 
families and parents, about the possible course or courses this aspect of puberty may take. 
Understanding the onset, typical presentation and problems surrounding puberty for this 
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growing population is critical for their current and future health. For females, menses is a 
central tenant of puberty, denoting reproductive capacity and marking the beginning of 
womanhood in many cultures (Beausang & Razor, 2000; Rembeck, Möller, & 
Gunnarsson, 2006). Age at menarche is a known predictor of significant health concerns, 
such as breast cancer (Collaborative Group on Hormonal Factors in Breast Cancer, 2012; 
Petridou et al., 1996; Stoll, Vatten, & Kvinnsland, 1994), and depression (Joinson, Heron, 
Lewis, Croudace, & Araya, 2011; Kaltiala-Heino, Kosunen, & Rimpela, 2003; Stice, 
Presnell, & Bearman, 2001), while atypical or severe menstrual symptoms have been 
linked to conditions ranging from anemia (Bevan et al., 2001) to polycystic ovarian 
syndrome (da Silva Bouzas, Cader, Leao, Kuschnir, & Braga, 2014). Though menses 
may present a challenge in its’ own right, it may be complicated by the symptoms of 
ASD: mastering the management of menses may be difficult due to the individual’s 
emotional and behavioral challenges and the severity of ASD; menstrual symptoms may 
interact with symptoms of ASD to exacerbate either or both. Additionally, menses may 
bring increased anxiety, resistance to changes in the body, and difficulties in finding 
appropriate and acceptable hygiene products. 
This study has further sought to identify areas for future research surrounding 
puberty in females with ASD. Understanding the manifestation of menses in this 
population is key to promoting a smooth transition through adolescence, setting the stage 
for developing healthy body image, and promoting mental and physical health through 
this phase of life and beyond. The results of this study have implications in the 
development of appropriate and timely education, healthcare, and supports for females 
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with ASD, their families and practitioners that serve them. Further, the results of this 
study have implications for the health of females with ASD by identifying gynecologic 
risk factors, notably early menarche, that are known to be associated with health 
conditions across the lifespan.  
Specific Aims 
The goal of this explanatory sequential mixed method study (QUAN + qual) was 
to explore the onset and symptom presentation of puberty, represented by menses, in 
females with ASD compared to their Neurotypical (NT) peers, and to understand the 
impact of menses on females and their families in years following menarche. The 
complex interface of these two phenomena (ASD and menses) required a similarly 
multifaceted approach: the explanatory sequential design was ideal as it allowed 
purposeful exploration to reach a deep and thorough understanding of the phenomena that 
would be impossible through a single approach alone. This study consisted of two phases: 
Phase 1: Quantitative, combined self- and parent-report on web-based questionnaires to 
assess onset and presentation of menstrual symptoms and factors known to influence 
menarche and menses (e.g., exercise, BMI, race/ethnicity) from a sample of ASD and NT 
populations in the United States; and Phase 2: Qualitative, employed semi-structured 
interviews with parent-participant dyads selected through purposive sampling using data 
collected in Phase 1 to achieve a heterogeneous group for age, age at menarche, ASD 
diagnosis, and race/ethnicity. This study is the first to simultaneously address the 
presentation, experience and meaning of menses for females with ASD compared to their 
NT peers.  
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Specific Aims:  
1. Describe the onset and symptoms of menses in females with ASD compared to 
Neurotypical peers, with specific attention to: (1) age at menarche, (2) length and 
regularity of cycle, and (3) number and severity of menstrual symptoms, while 
controlling for factors known to associated with menarche and menses. 
2. Characterize the differences between self-report and parental-report of age at 
menarche and menstrual symptoms for females with ASD and Neurotypical peers.  
3. Explore the experience of menses for females with ASD and their families 
through semi-structured interviews. 
Background 
Autism Spectrum Disorders 
It has been well established that individuals with ASD exhibit significant variety 
in the hallmark symptoms of the disorder (American Psychiatric Association, 2013). 
Mirroring the heterogeneity of symptoms, the community itself encompasses both males 
and females of all ages, from all racial, ethnical and socio-economic groups and countries 
across the globe (Christensen, 2016). The cause of ASD is thought to be a combination of 
genetic and environmental factors, impacting brain development in utero (Bhat et al., 
2014), and there is currently no known cure for the disorder. As an inherently pervasive, 
lifelong disorder, individuals with ASD experience the core symptoms throughout their 
lives, though many show improvement with targeted intervention (Bhat et al., 2014). 
Despite the current trends of research on ASD focusing primarily on identifying causes of 
the disorder, improving diagnostic tools to decrease age at diagnosis, expression of 
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symptoms in early life, and pharmacologic and non-pharmacologic treatments of the 
disorder (Daniels, 2012; Interagency Autism Coordinating Committee (IACC), 2014), 
there is a growing body of knowledge focusing on the life course trajectory of those with 
ASD (Billstedt et al., 2005; Gray et al., 2014; Perkins & Berkman, 2012; Seltzer et al., 
2003).  
As children with ASD age, challenges posed by their diagnosis are supplemented 
with the common challenges of growing up (Fong, Wilgosh, & Sobsey, 1993; Seltzer et 
al., 2003). Community resources, such as the ‘Tool Kits’ offered through Autism Speaks, 
a non-profit advocacy organization for ASD, present information and guidance for 
families of children on spectrum insofar as information is available. However, for 
adolescents and adults this is truly lacking. In the Transition Tool Kit offered through 
Autism Speaks, Peter Gerhardt notes that “little is known about the interaction of ASD 
and aging […]. Concerns related to the long term health and wellness of adults with ASD 
should be at the forefront of any discussion of appropriate services” (Autism Speaks, 
2011). In practice however, issues surrounding physical maturation and sexuality in 
adolescence and adulthood often take second place to mental health concerns presented 
by ASD.  
Due to the multifaceted effects of puberty, impacting both physical and mental 
health, it is an area of potential concern for the ASD population. Literature to date 
suggests that the majority of individuals with ASD experience steady improvements in 
the core symptoms of ASD with targeted intervention, though impairments do persist into 
adulthood. A recent review of the literature on life-course trajectory of ASD symptoms 
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and impairments associated with the disorder observed significant variability in published 
findings across and within studies (Magiati, Tay, & Howlin, 2014). For the majority of 
individuals with ASD, cognitive functioning and intellectual ability remain stable over 
time (Magiati et al., 2014), with a minority of individuals showing significant decreases 
beginning at puberty (Howlin, Savage, Moss, Tempier, & Rutter, 2014; Sigman & 
McGovern, 2005). Similarly, language and communication skills generally improve as 
the individual ages, though levels remained below their NT peers and poor functional 
language skills were reported in adolescence and adulthood (Magiati et al., 2014; Seltzer 
et al., 2003). Behavioral symptoms, such as restricted interests, repetitive behaviors, and 
resistance to change, decreased as individuals aged, though individuals with severe 
Autism or Intellectual Disability (ID) showed fewer improvements, and occasionally saw 
increases in these behaviors (Magiati et al., 2014; Seltzer et al., 2003). Especially salient 
to this study, the onset of co-morbid disorders and psychiatric conditions at puberty in 
individuals with ASD, such as anxiety, depression and epilepsy, has been well 
documented (Davis III et al., 2011; Gillberg, 1984; Gillberg & Steffenburg, 1987; 
Magiati et al., 2014). Concerns voiced by parents and clinicians were diverse and 
encompass behavioral (aggression, tantrums), social and communicative (inappropriate or 
inadequate social skills), educational (choosing integrated versus specialized services) 
and concerns about independence (residential, vocational; Seltzer et al., 2003). Puberty 
and adolescence, while presenting an opportunity for growth and improvement, also 
represent a high-risk period for these individuals (Gillberg, 1984; Seltzer et al., 2003). 
Puberty and Menses in Neurotypical Females  
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Puberty, rather than a single life event, is the process of reaching physical and 
reproductive maturity. In females, the process begins with activation of the 
hypothalamic-pituitary-gonadal (HPG) axis, triggering a cascade of hormones that result 
in maturation of the reproductive system (gonadarche) and emergence of secondary 
sexual characteristics, including breast development (thelarche), axillary and pubic hair 
growth (pubarche), and finally onset of the menstrual cycle (menarche). While menarche 
itself is a rather late marker of puberty, occurring two to three years after thelarche 
(Cabrera, Bright, Frane, Blethen, & Lee, 2014; Y. Lee & Styne, 2013), it is frequently 
used as a proxy for pubertal timing due to issues in determining a “true” and clear onset 
of puberty and the challenges in accurately reporting thelarche (Coleman & Coleman, 
2002). Menarche is a distinct event, more easily observed and is noted for accuracy in 
self-report, even up to 30 years later (Cooper et al., 2006; Koo & Rohan, 1997; Must et 
al., 2002). There has been a well-documented decrease in age at menarche over the past 
300 years in Western Cultures (Adams Hillard, 2008; Wyshak & Frisch, 1982), from 17-
18 years in the 18th century (Y. Lee & Styne, 2013) to 12 to 13 years in the 20th century 
(Cabrera et al., 2014; Chumlea et al., 2003). The decreasing trend in AAM from the 18th 
to the 21st century is believed to be the result of improved nutrition, health and socio-
economic status, and is associated with these variables (Lehmann, Scheffler, & 
Hermanussen, 2010). In the United States, the mean AAM for non-Hispanic White 
females is 12.77 years, compared to 12.17 years for non-Hispanic Black females 
(Cabrera, Bright, Frane, Blethen & Lee, 2014). AAM has been associated with a number 
of variables, such as mother’s AAM, body mass index (BMI), genetic factors, race and 
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ethnicity, stress, physical activity and nutrition (Adams Hillard, 2008; Berkey, Gardner, 
Frazier, & Colditz, 2000; Braithwaite et al., 2009; Davis III et al., 2011; Karapanou & 
Papadimitriou, 2010).  
Many terms have been used in the literature to describe variation in the age at 
menarche, including early menarche, late menarche, delayed puberty, precocious puberty 
and primary amenorrhea. While some of these terms overlap, some have clinically 
distinct meanings that are critical to understanding the phenomenon of menses. Early 
menses and early puberty, for example, have been used interchangeably with definitions 
suggesting age at onset ranging anywhere from 9 to 12 years. Here the term early 
menarche is used and is defined as AAM equal to or less than 11 years. Similarly, late 
menarche and late puberty are often used in similar context; late menarche is favored 
here, defined as AAM equal to or greater than 14 years of age. Precocious puberty in 
females is clinically defined as the onset of breast and pubic hair development prior to 
eight years of age. Central precocious puberty occurs when the hypothalamus is 
prematurely activated to release gonadotropin-releasing hormone; other causes include 
tumors of the ovary or genetic conditions, such as McCune-Albright syndrome (Ball, 
Bindler, & Cowen, 2011). Primary amenorrhea, the absence of menarche and 
development of secondary sexual characteristics by 14 years of age or absence of 
menarche by 16 years of age in the presence of development of secondary sex 
characteristics, may be caused by structural abnormalities in the reproductive system, 
chromosomal and genetic abnormalities, polycystic ovarian syndrome, or may have no 
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underlying pathology (Ball et al., 2011). Please refer to Table 1 for a detailed list of 
variables associated with early and late menarche.   
Table 1. Risk Factors for Early and Late Menarche 
Early Menarche 
Early AAM in mother Maternal tobacco use during pregnancy 
Extreme maternal weight gain (<10;>40 
lbs.) during pregnancy 
Small size at birth (SMGA, IUGR) 
Maternal preeclampsia Increased BMI through childhood 
Large waist circumference Bottle feeding during infancy 
Exposure to low levels of lead Absent father in early childhood (>5 
years) 
Adverse events in childhood  
Late Menarche 
Late AAM in mother (in normal BMI 
daughter) 
Heavy maternal tobacco use (>20 
cigarettes/day) during pregnancy 
Exposure to high levels of lead Nutritional deficiency 
Excessive physical activity Low BMI 
 
Age at menarche has been shown to be significantly associated with many health 
concerns across the lifespan. Early menarche is associated with increased BMI, insulin 
resistance and glucose intolerance (Feng et al., 2008; Remsberg et al., 2005), as well as 
increased risk of cardiovascular disease, coronary heart disease, all-cause mortality and 
cancer mortality (Lakshman et al., 2009; Petridou et al., 1996). Early age at menarche is 
further associated with adolescent depression and social anxiety (Blumenthal, Leen-
Feldner, Trainor, Babson, & Bunaciu, 2009; Kaltiala-Heino et al., 2003). Late menarche 
is associated with increased risk of osteoporosis and bone fracture, possibly due to 
decreases in lifetime exposure to estrogen, particularly during peak bone acquisition 
periods (Chevalley, Bonjour, Ferrari, & Rizzoli, 2009; Ho & Kung, 2005). In cases of 
precocious puberty and primary amenorrhea, an underlying etiology should be sought and 
consideration given to interventions due to the effects of low estrogen on bone and 
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cardiac health (Chevalley et al., 2009; Feng et al., 2008; Gerdhem & Obrant, 2004; 
Grover, 2011; Ho & Kung, 2005; Remsberg et al., 2005). Table 2 details the health 
implications of which early and late menarche constitute risk factors.  
Table 2. Health and Behavioral Implications of Early and Late Menarche.  
Early Menarche 
Increased BMI and abdominal type 
obesity 
Insulin resistance and glucose 
intolerance 
Increased cardiovascular risk and 
coronary heart disease 
Fertility impairment 
Increased risk for breast cancer Increased all-cause and cancer 
mortality 
Early sexual debut, increased risk of 
STI 
Increased risk for substance abuse and 
dependence 
Increased risk for internalizing and 
externalizing problems, disruptive 
behavior disorders 
Increased risk for adolescent 
depression 
 
Increased risk of eating disorders, 
social anxiety 
Late Menarche 
Osteoporosis Increased risk of fractures 
 
 In the year following menarche, the menstrual cycle becomes more regular, 
occurring at intervals of 20-45 days, with most cycles becoming ovulatory by the end of 
the first menstrual year (Hickey & Balen, 2003). By the end of the third menstrual year, 
60-80% of females have cycles that mirror adult patterns, with cycle length lasting 21-34 
days and period length between 3 and 7 days (Deligeoroglou & Tsimaris, 2010; Flug, 
Largo, & Prader, 1984; Hickey & Balen, 2003). When menarche occurs before 12 years 
of age, nearly all menstrual cycles are ovulatory by the fifth menstrual year; however, in 
females with later onset, all cycles may not be ovulatory for eight to twelve years (Hickey 
& Balen, 2003; Vihko & Apter, 1984). An individual’s cycle length and menstrual 
symptoms are typically established by the sixth menstrual year (Deligeoroglou & 
Tsimaris, 2010). 
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 Menstrual symptoms are those associated with the hormonal fluctuation of the 
HPG axis in relation to the menstrual cycle; they may be physical, behavioral, or 
emotional, and vary in onset or severity across the cycle and menstrual years. Depending 
on the timing, grouping and severity of symptoms, they may be classified as a menstrual 
disorder, which include: dysmenorrhea, pelvic pain occurring with the onset of menstrual 
flow and lasting 2-3 days; premenstrual syndrome (PMS; A.D.A.M Medical 
Encyclopedia, 2012), physical, behavioral and emotion symptoms occurring during the 
luteal phase and decreasing following onset of menses; and premenstrual dysphoric 
disorder (PMDD; American Psychiatric Association, 2013), the most severe form of PMS 
with greater intensity and duration of symptoms, such that they significantly interfere 
with the individuals functional ability. Table 3 provides a list of physical, behavioral, and 
emotional symptoms associated with the menstrual cycle.  
Table 3. Symptoms of the Menstrual Cycle  
Physical 
Acne Breast tenderness or pain 
Bloating Cramps 
Constipation Diarrhea 
Dizziness Headache 
Nausea  Vomiting 
Behavioral 
Changes in sleep patterns Changes in appetite 
Decreased interest Difficulties concentrating 
Social withdrawal 
Emotional 
Anxiety Changes in mood or mood 
swings 
Depression Irritability or anger 
Tearfulness 
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Dysmenorrhea occurs in 20-90% of women of reproductive age (Davis & 
Westhoff, 2001). While not as prevalent as dysmenorrhea, PMS and PMDD also occur in 
a significant portion of females in the United States, with PMS occurring in 20-40% 
(Clayton, 2008; Tschudin, Bertea, & Zemp, 2010) and PMDD in 2-9% of females 
(Clayton, 2008; Tschudin et al., 2010). Menstrual symptoms and disorders have 
significant impacts on a woman’s physical, mental and emotional health. PMS and 
PMDD are not exacerbations of other psychiatric illnesses, such as anxiety, depression or 
personality disorder, though those who do have these pathologies may experience 
cyclical changes in related symptoms (Clayton, 2008). Menstrual symptoms have been 
shown to significantly decrease quality of life, functional ability, and impair participation 
in activities of daily life, and are associated with increased utilization of health care 
resources, decreased productivity, and lost work days (Clayton, 2008). Dysmenorrhea is 
the most common cause of activity restriction and school or work absence in adolescents 
and young adults. Among women in the United States, 30% report menstrual symptoms 
interfering with their home life, 17% with social life, and 14% reported interference with 
work (Hylan, Sundell, & Judge, 1999). Further, women who report menstrual symptoms 
are 2.5 times more likely to report feelings of depression and anxiety, 2.4 times more 
likely to report insomnia, three times more likely to show excessive sleepiness, and 2.5 
times more likely to report recurring pain in the previous 12 months (Strine, Chapman, & 
Ahluwalia, 2005). In adolescents, menstrual problems can lead to impaired physical and 
psychosocial functioning (Nur Azurah, Sanci, Moore, & Grover, 2013). 
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Menorrhagia, heavy menstrual periods equating to the loss of 80 mL or more of 
blood per period or four or more fully soaked pads per day at any point of the menstrual 
flow, is a common condition of menses and presents in approximately 30% of women 
(O'Flynn & Britten, 2000). While menorrhagia may be due to an underlying pathology, 
such as clotting disorder like von Willebrand’s, half of women who complain of 
menorrhagia have idiopathic etiology. Aside from risks of iron deficiency anemia related 
to blood loss (Peuranpaa, Heliovaara-Peippo, Fraser, Paavonen, & Hurskainen, 2014), 
women who complain of menorrhagia also report impaired quality of life during menses 
(Gokyildiz, Aslan, Beji, & Mecdi, 2013; Karlsson, Marions, & Edlund, 2014), 
specifically related to limitations in physical activities and social and leisure activities 
(Lukes, Baker, Eder, & Adomako, 2012). 
Puberty and Menses in Females with a Neurodevelopmental Disability 
Individuals with developmental disabilities have demonstrated differences 
regarding the onset of puberty; those with neurodevelopmental disorders, such as 
Cerebral Palsy, Down’s Syndrome, or Spina Bifida, are up to 20 times more likely to 
demonstrate early pubertal development (Siddiqi, Van Dyke, Donohoue, & McBrien, 
1999). While precocious puberty occurs in approximately one in 10,000 Neurotypical 
females, the rates increase dramatically in the Spina Bifida population, nearly one in five 
females (Elias & Sadeghi-Nejad, 1994). Conversely, individuals with Cerebral Palsy 
experience menarche significantly later than Neurotypical peers (Worley et al., 2002). In 
females with ASD, the reported mean age at menarche has ranged from 11.7 to 13.8 years 
of age, and is inconsistently reported as different from Neurotypical peers and peers with 
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other developmental disabilities (Burke et al., 2010; Hamilton et al., 2011; Ingudomnukul 
et al., 2007; Knickmeyer et al., 2006; Pohl et al., 2014; Whitehouse et al., 2011). Cases of 
primary amenorrhea have been noted in the population (Ingudomnukul et al., 2007; 
Knickmeyer et al., 2006; Pohl et al., 2014), with one study finding significantly elevated 
rate of late menarche in females with ASD (7.4%; compared to 0.5% in the Neurotypical 
population; Ingudomnukul et al., 2007). Instances of precocious puberty have also been 
observed (Burke et al., 2010; Ingudomnukul et al., 2007; Pohl et al., 2014), with rates as 
high as 3.1% in females with ASD, compared to 0.5% in the NT population (Pohl et al., 
2014). Interestingly, none have yet to detail the trajectory or clinical treatment of these 
individuals.  
Symptoms surrounding menstruation appear to be experienced at higher rates in 
females with ASD compared to NT peers. Females with ASD have been reported as 
experiencing irregular cycles, dysmenorrhea, heavy flow and menorrhagia, severe acne, 
mood and behavioral changes, and hirsutism at greater rates than those without a 
developmental disorder (Burke et al., 2010; Ingudomnukul et al., 2007; Pohl et al., 2014). 
Mothers of females with ASD have shared that menses can be difficult for their daughters 
to manage: irregular cycles complicate management of menses, such as carrying or 
changing hygiene products; an unexpected cycle leads to increased behavioral problems; 
and painful periods interfere with the ability to participate in or perform daily activities, 
such as school or therapy. While menses undoubtedly interferes with daily activities in 
Neurotypical females, the added challenges accompanying a diagnosis of ASD may leave 
these individuals and families unable or ill equipped to cope. While the symptoms of 
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menses are beginning to be documented, the effects of menses on daily life and 
functioning with ASD are, to this point, poorly described and understood.  
Table 4. Review of Published Literature on Menses in Females with ASD 
* indicates significant finding, light grey square indicates variable not reported by study  
Article N AAM 
 
EOP or 
PP 
DP or 
PA 
Menstrual 
Symptoms 
Pre-
menstrual 
Symptoms 
PCOS Hirsutism 
Knickmeyer 
et al 2006 
ASD: 38 
Controls: 
38 
ASD: 13.3 
Controls: 
12.58 
 PA: 3*     
Ingudomnu-
kul et al 2007 
ASD: 54                
Mothers: 
74       
Controls: 
183 
 EOP: 3 
PP: 0 
DP: 7* Irregular 
Cycle: 31* 
Painful 
periods: 24* 
Menorrhagia: 
20 
PMS: 14                
Severe Acne: 
15* 
ASD: 6*                
Mothers: 
5 
Hirsutism: 
16* 
Burke et al 
2010 
ASD: 14                         
DS: 13                                 
CP: 17 
ASD: 12             
DS: 11.85        
CP:12.92 
PP: 1  Irregular 
Bleeding: 2   
Menorrhagia: 
2 
Mood 
changes: 5 
  
Whitehouse 
et al 2011 
HT: 70 
TT: 216 
LT: 47 
HT: 13.07    
TT: 12.72         
LT: 12.66 
      
Hamilton et 
al 2011 
Autism: 
40                       
AS: 47                               
PDD: 37 
Autism: 
11.7 
AS:12.3         
PDD:12.1 
  >1 symptom: 
116 
>1 symptom: 
102 
  
Pohl et al 
2014 
ASD: 415                             
Controls: 
415 
 PP: 13*                                
EOP: 
34 
DP 4               
PA: 28 
Irregular
cycle: 192*        
Painful 
periods: 163* 
  Hirsutism: 
76 
Herguner et 
al. 2016 
HT: 25 
LT: 411 
HT: 13.8 
LT: 13.3 
      
EOP = Early Onset Puberty; PP = Precocious Puberty; DP = Delayed Puberty; PA = Primary Amenorrhea; 
PCOS = Polycystic ovarian syndrome; DS = Down’s Syndrome; CP = Cerebral Palsy; HT = High Autism-
like traits; TT = Typical Autism-like traits; LT = Low Autism-like traits 
 
The overall gynecologic health of females with disabilities, notably 
developmental disabilities, is grossly understudied and reports that these women do not 
receive regular gynecologic care are not uncommon (Burke et al., 2010; Shah, Norlin, 
Logsdon, & Samson-Fang, 2005). The literature to date cannot distinctly state whether 
females with ASD experience menarche and menstruation differently than Neurotypical 
peers. Even without conclusive evidence, caregivers and providers of females with ASD 
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should recognize the importance of understanding the needs of females with ASD in 
relation to puberty.  
Gaps in the Literature 
 Despite puberty being an area of significant growth and change, relatively little is 
currently known about the trajectory for females with ASD through adolescence. Studies 
have suggested that females with ASD may begin puberty, as represented by menarche, 
earlier or later than their Neurotypical peers and may experience significantly more 
menstrual symptoms. To date, few studies have considered factors known to be 
associated with age at menarche or menstrual symptoms, addressed access to and use of 
interventions for treating significant menstrual symptoms, spoken on the interaction 
between menstrual symptoms and symptoms of ASD, or given voice to these individuals 
themselves to understand the experience of puberty as a female with ASD (Burke et al., 
2010; Ingudomnukul et al., 2007; Knickmeyer et al., 2006; Pohl et al., 2014; Whitehouse 
et al., 2011). This study sought to remediate those gaps.  
Conceptual Underpinnings 
 As a mixed methods study, this research combines two distinct philosophies to 
investigate the phenomenon of puberty in females with ASD: a post-positivist stance in 
the Quantitative Phase, and a constructivist stance in the Qualitative Phase. While these 
two philosophies may initially appear at odds with each other, previous research has 
demonstrated the applicability and utility of joining top-down and bottom-up approaches 
to achieve a rich, deep understanding of the phenomenon of interest. Consistent with the 
 
 
20 
 
explanatory sequential design, the data from each phase was analyzed separately and 
mixed at the level of the conclusion. 
Table 5. Conceptual Underpinnings for the Facing Puberty Study 
Philosophy 
Phase 1: Post-positivist Phase 2: Constructivist 
Theoretical Lens 
Bronfenbrenner’s Bioecological Model 
Methodological Approach 
Mixed Methods 
Methods of Data Collection 
Phase 1: Web-Based 
Questionnaires 
Phase 2: Semi-Structured 
Interviews with AS Dyads 
 
The processes underlying both ASD and puberty involve multilayered interactions 
between one’s genes and one’s environment. Seeking to understand the overlap of these 
two phenomena therefore requires a conceptual framework that stresses the interactions 
between an individual and their environment. This study was approached through the lens 
of Bronfenbrenner’s Bioecological Model. Bronfenbrenner’s Bioecological Theory of 
Development has previously been applied to ASD research, particularly those interfacing 
with natural physiological phenomena (Souders et al., 2009). The Bioecological Model 
states that human development is influenced by the individual’s environment; proximal 
processes between the individual and their environment determine developmental 
outcomes from conception (Bronfenbrenner, 1979). Individuals are not conceived of as 
passive receptors of their environment, but rather active members within a number of 
environments: the microsystem, comprised of the family and peers; the mesosystem, with 
such settings as the classroom; the exosystem, comprised of the community and medical 
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institutions; the macrosystem, with the political philosophy, cultural customs and values, 
and social conditions; and the chronosystem, denoting time and the experienced 
sociohistorical conditions and live events. As proximal processes guide developmental 
outcomes: poor processes lead to unfulfilled outcomes, while rich processes lead to 
positive, fulfilled outcomes (Bronfenbrenner, 1979). Given that both ASD and AAM 
believed to be caused by a combination of genetic and environmental factors (Dvornyk & 
Waqar-ul-Haq, 2012; Elks et al., 2010; Gajdos, Henderson, Hirschhorn, & Palmert, 2010; 
Geschwind, 2011; Karapanou & Papadimitriou, 2010; Miles, 2011; Persico & Napolioni, 
2013), this model fits both ASD as a disorder and the course of puberty exceptionally 
well. If the female with ASD is held at the center of this model, variables from the 
individual herself, her micro-, meso-, exo- and macro-system influence her trajectory 
through and her experience of puberty. To best understand the proximal processes 
between the individual and her environment that inform her experience of puberty, we 
may consider variables located within each system that have been known or hypothesized 
to influence the course or experience of puberty. For example, variables from the 
individual herself, such as her age or BMI; from the micro- and meso-systems, the 
support of her family and peers, or education received on menstruation from a school 
program or a healthcare provider; from the exo- and macro-system, the attitudes of her 
culture and society towards menstruation and physical development in individuals with 
disabilities; and lastly, from the chrono-system, the effects of time in regulating cycles. 
These layers constantly inform and modulate one another: while a female with ASD may 
be more likely to have an increased BMI due to food preferences and decreased levels of 
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activity (individual factors), thus putting her at increased risk for early menarche; the 
neighborhood where she cannot go out and play due to safety concerns or which lacks 
affordable, healthy food options (micro- and meso-system factors) inform these very 
same individual factors and end variables. From this perspective, the relationship and 
interactions between multiple systems highlight the multitude of factors that can 
influence the onset and symptoms of puberty, as well as the behaviors of ASD.  
Figure 1. Bronfenbrenner’s Bioecological Model. 
 
 
Review of Methods 
Research Design 
As stated above, the study employed an explanatory sequential mixed-methods 
design, combining cross-sectional data from web-based questionnaires with semi-
structured dyad interviews, to garner a detailed picture of the onset, symptoms and 
experience of menses in females with ASD. Consistent with the explanatory sequential 
design, the study occurred in distinct phases, an initial Quantitative Phase followed 
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sequentially by a Qualitative Phase, and was ideal for this study as it (1) allowed 
qualitative interviews to build on quantitative findings and help explain surprising or 
unexpected results, and (2) it supported purposive sampling in the Qualitative Phase. As 
little was known about menses in this unique population at the outset of this study, these 
methods were selected in order to simultaneously characterize the presentation of menses 
in broad sample of the population through quantitative methods, while allowing an in-
depth exploration of the meaning and process of puberty and menses in these individuals 
through qualitative interviews.  
Phase 1. The Quantitative Phase, which targeted Aims 1 and 2, used a cross-
sectional, four-group design (AS participant, AS parent, NT participant, NT parent). 
Individuals completed web-based questionnaires assessing age at menarche, menstrual 
history, and menstrual symptoms of the daughter participant (i.e., self-report and parent-
report), as well as provided data on known and theoretical variables associated with 
menstrual history and symptoms; specifically, ASD diagnosis, level of exercise, nutrition, 
BMI, presence of anxiety, use of medication, and socio-demographic variables.  
Phase 2. The Qualitative Phase of the study, which spoke to Aim 3, consisted of 
semi-structured interviews with parent-participant dyads (described in more detail in Data 
Collection, Phase 2). Participants were drawn from the AS group of the Quantitative 
Phase of the study, using purposive sampling with criteria identified by Phase 1 in order 
to obtain a heterogeneous sample on (1) age, (2) age at menarche, (3) ASD diagnosis and 
(4) race/ethnicity. Interviews followed a semi-structured format, with prompts developed 
following preliminary analysis of the quantitative data and discussions with the study 
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team to further explore the family’s experience and perception of puberty for their 
daughter (Interview Guide for Parents and Daughters in Appendices I and J). 
Participants 
In this study, the ‘participant’ identifies the daughter participant according to the 
criteria below, and the ‘parent’ identifies the parent participant. Parents were those with 
legal rights and responsibilities to the participant that contributed significant time and 
energy to promoting the well-being of the participant and was most commonly the 
biological mother of the participant. 
Participants were females under the age of 18 years who had experienced their 
first menstrual cycle and had at least one cycle within the six months prior to 
participating. This was to ensure that participants could accurately recall age at menarche 
and menstrual symptoms, and were not pregnant. Individuals with reading 
comprehension below the fourth-grade level in English, as well as those with intellectual 
disability (ID; IQ ≤ 70) were excluded, as questionnaires required the ability to read, 
understand, interpret and respond to potentially nuanced and dynamic questions. Further, 
individuals with other diagnosed developmental conditions, such as Down’s Syndrome, 
or psychiatric conditions, such as Bipolar Disorder, were ineligible to participate, so as to 
capture effects occurring in the ASD population that are not attributable to other potential 
etiologies (see Table 6 for complete inclusion and exclusion criteria).   
Using convenience sampling, females with ASD and their parents were recruited 
from autismMatch, an online research recruitment site for ASD research based at the 
Center for Autism Research at the Children’s Hospital of Philadelphia, the Interactive 
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Autism Network (IAN), an online community for ASD research through a partnership of 
Kennedy Krieger Institute and the Simons Foundation in Baltimore, MD, and the 
Asperger & Autism Alliance for Greater Philadelphia (ASCEND) and Greater 
Philadelphia Autism Society (ASA-Philly) list-servs. NT females and parents were 
simultaneously recruited from autismMatch and IAN, as well as using University of 
Pennsylvania School of Nursing list-servs. Recruitment began in August 2015 and 
continued through May 2016.  
Table 6. Inclusion and Exclusion Criteria for The Facing Puberty Study 
 Autism Spectrum Disorder (AS) Group Neurotypical (NT) Group 
 
 
Inclusion 
Criteria 
• Participant: Female, under 18 years of 
age, post-menarche, with at least one 
menstrual cycle in the previous six 
months. Diagnosis of ASD, Autism, 
Asperger’s, or Pervasive 
Developmental Disorder-Not 
Otherwise Specified (PDD-NOS) 
• Parent: Legal guardian and caretaker 
of the participant.  
• Participant and Parent: Minimum 
fourth grade reading level.  
• Participant: Female, under 18 years 
of age, post-menarche, with at least 
one menstrual cycle in the previous 
six months. 
• Parent: Legal guardian and caretaker 
of the participant. 
• Participant and Parent: Minimum 
fourth grade reading level. 
 
 
Exclusion 
Criteria 
• Amenorrhea due to natural or medical 
means, or currently pregnant.  
• Diagnosis of: 
• Intellectual Disability (IQ < 70). 
• Developmental Disability: 
Cerebral Palsy, Down’s 
Syndrome or Spina Bifida. 
• Psychiatric conditions: Bipolar 
Disorder, Schizophrenia. 
• Epilepsy. 
• Genetic Syndrome. 
• Amenorrhea due to natural or medical 
means, or currently pregnant. 
• Diagnosis of: 
• Intellectual Disability (IQ < 70). 
• Developmental Disability: ASD, 
Cerebral Palsy, Down’s 
Syndrome or Spina Bifida. 
• Psychiatric conditions: Bipolar 
Disorder, Schizophrenia. 
• Epilepsy. 
• Genetic Syndrome.  
 
Two hundred and forty seven individuals consented to participate in the study (AS 
= 121, NT = 126); of these, 194 individuals progressed from consent to participation (AS 
= 88, NT = 106). The most common reason for individuals to not progress from consent 
 
 
26 
 
to participation was lack of consent or assent from both parent and participant (AS = 20, 
NT = 17; i.e., parent consented, but assent was never received from participant). Towards 
the end of the open recruitment period, individuals who did not appear to meet criteria 
attempted to consent and participate in the study (AS = 13, NT = 3). These participants 
were barred entry from the study on the grounds of potential falsified information. For 
example, while answers given to the screening questionnaire were correct to 
automatically move to the consent/assent section, suspicious information was reported in 
the consent or assent section (e.g., different last names, male first names for daughters, or 
suspicious email addresses, without clarifications given), geolocations were blocked or 
identical to other participants, or IP addresses were identical to other participants. Some 
of these ‘false participants’ did complete the study; their data has been dropped from 
analysis (AS = 8, NT = 0). Further, despite some participants and parents did not 
complete the questionnaires (AS = 8, NT = 6), resulting in their corresponding partner 
being dropped from analysis. See Figure B for participant inclusion chart.   
Phase 1. One hundred and seventy two participants and parents completed the 
web-based questionnaires (ASD = 35, ASP = 37; NTD = 48; NTP = 52); however, only 
completed pairs were included for analysis in order to meet both Aim 1 and Aim 2 needs. 
Our final sample consisted of 68 individuals in the AS group (34 parent-participant pairs) 
and 96 individuals in the NT group (48 parent-participant pairs). This sample did fall 
short of the goal of 50 pairs per group, resulting in Aim 1 analysis falling just shy of 
reaching 80% power (see Analysis). As is common with Autism research, the majority of 
our sample were non-Hispanic White, spoke English as their primary language, from 
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well-educated, high SES households, and the mother participated with the daughter (see 
Table 7 for Parent and Participant Demographics). While this does limit the 
generalizability of the findings, the homogeneity of both samples was a study strength 
considering factors that influence age at menarche, specifically race and ethnicity. For 
more detail, see Manuscripts 1 and 2.  
Figure 2. Participant Inclusion Flow Chart 
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Phase 2. Ten parent-participant dyads were selected from the 34 dyads in the AS 
group to be heterogeneous on age, AAM, ASD diagnosis, and race/ethnicity. Participants 
in this phase of the study were between 14 and 17 years of age and predominately Non-
Hispanic White (n = 7, Asian n = 1, Native American n = 2). The participants were 
diverse on AAM (Early (<10 years) n = 2, Early-Average (11-12 years) n = 3, Late-
Average (13-14 years) n = 3, Late (> 14 years) n = 2) and Autism diagnoses (Autism n = 
2, PDD-NOS n = 2, Asperger’s Syndrome n = 4, ASD = 2). For more detail, see 
Manuscript 3.  
Table 7. Demographics for Parents and Participants 
 NTD  
(n = 48) 
NTP 
(n = 48) 
ASD  
(n = 34) 
ASP 
(n = 34) 
Age 
(years) 
14.59 ± 
1.94 years 
43.01 ± 
5.87 years 
14.45 ± 
1.88 years 
45.17 ± 
6.03 years 
Race 
White 
Other / Two + 
 
33 
15 
 
39 
9 
 
30 
4 
 
30 
4 
Ethnicity 
Hispanic 
Non-Hispanic 
Other 
 
7 
33 
8 
 
4 
40 
3 
 
2 
29 
3 
 
1 
33 
0 
BMI 21.92 ± 
4.73 
27.55 ± 
5.80 
23.13 ± 
4.55 
29.60 ± 
9.83 
Psychotropic Medication 
Use 
17% 
8/48 
--- 35% 
12/34 
--- 
Language 
English 
Spanish 
Other 
 
46 
1 
1 
 
44 
3 
1 
 
34 
0 
0 
 
34 
0 
0 
Parent Education 
HS/GED - College 
Associate’s 
Bachelor’s 
Master’s 
Professional/Doctoral 
 
12 
6 
13  
12 
4  
 
6 
6 
12 
6 
4  
Income 
Less than $20,000 
$20-60,000 
$60-100,000 
$100-150,000 
More than $150,000 
Prefer not to say 
 
1 
8 
21 
10 
7 
1 
 
3 
6 
11 
3 
6 
5 
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Procedure 
We received approval from the University of Pennsylvania Institutional Review 
Board July 27th, 2015. The study was shared with AutismMatch beginning August 2015 
and remained available to potential participants through May 2016. Similarly, the study 
was shared monthly through ASCEND and ASA Philly list-servs beginning October 
2015 through May 2016. Following several months of low recruitment, the study team 
reached out to IAN and actively recruited with their team from March through May 2016.  
Once at the study website, participants completed a brief five-question screening 
questionnaire to ensure eligibility before moving forward to online consent/assent and 
enrollment. Eligible participants were enrolled in the study after electronically signing the 
informed consent or assent form. Parent participants consented to their own participation 
as well as their daughters, and all daughter participants assented to their participation.  
Data Collection and Measurement 
Phase 1. The web-based component of the study was conducted primarily through 
Qualtrics, following transition from REDCap in January 2016. The decision to move 
from REDCap to Qualtrics was driven by the challenges of design in REDCap and 
participants citing frustration in flow and navigation. Qualtrics allows a more intuitive, 
user-friendly design and is mobile-friendly, allowing participants to complete Phase 1 
from their mobile devices. Participants could complete the study at the time of their 
choosing, with the recommendation that they complete the questionnaires in a quiet 
location where they feel comfortable disclosing potentially sensitive information. As 
females with ASD represent a narrow target population that would be difficult to recruit 
 
 
30 
 
to a site-based study, the study team felt using an internet-based survey method would 
not only help to reach the sample size goals, but also ensure that individuals with diverse 
backgrounds were able to participate. While there is the potential for socio-economic bias 
in conducting Internet based research, for this study the opportunities and benefits 
outweigh this potential negative, as a site-based study would increase burden on the 
participants. Further, participants may be more comfortable participating in this research 
in the setting of their choosing, such as at home, as openly discussing puberty and 
menstruation continues to hold some social stigma and may have caused the participants 
to feel some embarrassment if asked to discuss the topic with the researcher. Participation 
through a computer or electronic device (iPad, tablet, etc.) may be preferred by AS 
participants compared to in-person or paper and pencil survey completion, which may 
improve validity of our findings. 
 Demographics. All participants began with a demographic questionnaire 
assessing age, gender, race and ethnicity, height and weight for BMI calculation, primary 
language, and grade in school. Parents were additionally asked relationship to the 
daughter participant, level of education, household income, marital status, and daughters’ 
ASD diagnosis, age at diagnosis, and use of prescription and non-prescription 
medications. See appendices C and D for daughter and parent versions. 
 Menstrual Symptoms. Onset of menses and menstrual symptoms were measured 
using a modified version of the Parker-Sneddon Menstrual Disorders of Teenagers 
(MDOT) Questionnaire (Parker, Sneddon & Arbon, 2010). The MDOT assessed the 
timing and symptoms of menses through seven structured sections, with the first section 
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querying date of birth, age at menarche, and height and weight. Section 2 addressed the 
presentation of a ‘typical’ menstrual cycle, including length of cycle, number of days 
bleeding, flow characteristics, and regularity of the cycle. Section 3 assessed frequency of 
menstrual symptoms over the past 12 months; section 4 measured the impact of 
menstrual cycles on daily activities. Section 5 asked participants to respond to statements 
about their menstrual cycle, section 6 assessed allergies and intolerances, and section 7 
reviewed personal and family history of menstrual disorders. Modifications to the 
original questionnaire included: adapting terms that are not commonly used in the United 
States to those that the population will be familiar with, replacing medications (Question 
#14) with those commonly used in the United States, limiting recall to 6 months from the 
original 12 months, removing questions (in Section 3 and 5) relating to sexuality and 
sexual practices, expanding Section 3 to include more emotional and behavioral 
menstrual symptoms, and expanding Section 7 to include menstrual symptoms and 
syndromes previously associated with ASD. The MDOT has not been validated, but has 
been used to explore and describe menstrual symptoms in adolescents worldwide. See 
appendix E.  
 Nutrition. The Dietary Screening Questionnaire (DSQ) was used to assess overall 
nutrition level of the participant, and was completed only by the parent. Developed for 
the National Health & Nutrition Examination Survey (NHANES) by the National Cancer 
Institute in 2009, this 26-item screener captures the frequency of consumption of major 
food groups – fruits, vegetables, dairy, added sugars, whole grains and fibers, and meats 
– in the past month. While it is considerably shorter than the traditional Food Frequency 
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Questionnaire used to assess nutrition and therefore sacrifices some accuracy, the DSQ 
has demonstrated reliability and validity, with responses correlating well with the longer 
Food Frequency Questionnaire (Thompson et al., 2005). See appendix F.  
 Physical Activity. The Physical Activity Questionnaire –Adolescent (PAQ-A) was 
used to assess physical activity of the participant and was only completed by the parent. 
The PAQ-A is a nine-item questionnaire, adapted for parent-report, for adolescents 14 to 
19 years old. A score of 1 indicates low physical activity, while a score of 5 indicates 
high physical activity. The questionnaire has consistently high validity and moderate 
reliability (Crocker, Bailey, Faulkner, Kowalski, & McGrath, 1997; Kowalski, Crocker, 
& Faulkner, 1997; Kowalski, Crocker, & Kowalski, 1997). See appendix G. 
 Anxiety Symptoms. The Screen for Child Anxiety Related Disorders (SCARED), 
Parent and Child versions, were used to assess anxiety in the participant. The SCARED is 
a 41-item questionnaire designed to assess for anxiety symptoms in children ages eight to 
18 years, yielding a comprehensive score for Anxiety Disorder, as well as sub-scale 
scores on Panic Disorder, Generalized Anxiety Disorder, Separation Anxiety, Social 
Anxiety Disorder, and Significant School Avoidance. The SCARED has been used 
extensively in assessing symptoms of anxiety in youth with ASD, and has been shown to 
be reliable and have internal consistency (Total score α = 0.90, Subscale scores α = 0.78-
0.87; Birmaher, Brent, Chiappetta, Bridge, Monga & Baugher, 1999). See appendix H.  
Phase 2. Interviews were conducted by the author with participants following 
completion of Phase 1 for the AS parent-participant pairs. As most individuals were not 
located in the greater Philadelphia Metropolitan Area, the majority of interviews occurred 
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by phone with both interviewer and interviewees in quiet, private locations (n = 8); one 
interview was in-person and one interview was conducted over Skype.  
Interview guides (see Appendices I and J), consisting of questions and probes to 
stimulate discussion and conversation, were developed with the research team following 
a preliminary analysis of the Quantitative Phase for AS group, using findings from the 
questionnaires to generate areas for further inquiry. Interviews were recorded using the 
Olympus 142665 DM-620 SLV Voice Recorder, with the Olympus TP-8 Telephone 
adaptor for phone interviews; field notes were recorded during interviews and are 
included with transcripts. In an effort to meet participants’ needs, interviews were offered 
to either parent or participant first, with participants being allowed to gain familiarity of 
the interview process by listening to the parent’s interview. Additionally, parents were 
allowed to support their child through the interview if needed. Interviews with parents 
typically lasted 30-40 minutes and interviews with participants approximately 15-20 
minutes.  
Data Management 
Qualtrics was used as a central resource for data collection, with management and 
data cleaning in Excel for Phase 1 of this study. Qualtrics is a web application developed 
with HIPAA-Security guidelines with features such as data encryption and is 
recommended by the Office of Human Research to University of Pennsylvania 
researchers. It provides an intuitive interface for data entry, geolocation and IP tracking, 
and automated export procedures for smooth data downloads to common statistical 
packages. Data from Part 1 was downloaded to Excel for data cleaning and coding, then 
 
 
34 
 
analyzed using Stata on a private drive on a password-protected computer in a locked 
room at the University of Pennsylvania, School of Nursing. All participants were 
assigned a coded identification number in Excel and data was de-identified from any and 
all personally identifying information. Only research personnel had access to the data in 
Qualtrics, Excel or Stata; the author was responsible for managing and maintaining the 
quantitative database. 
All interviews were digitally recorded using the Olympus 142665 DM-620 SLV 
Voice Recorder, with the Olympus TP-8 Telephone adaptor for phone interviews. 
Recordings were downloaded to a password-protected computer for back up and ease of 
transcription. The author transcribed recordings from the recording verbatim into 
Microsoft Word documents. Transcripts were de-identified from any names or personally 
identifying information (such as addresses or dates of birth), checked for accuracy and 
entered into NVivo 11, the software package used for qualitative analysis (QSR 
International Pty Ltd, 2012). An NVivo database was developed in order to store data, 
develop a coding schema, code content, and track emerging themes. The author 
developed the coding structure and a codebook in conjunction with her expert committee, 
with codes developed a posteriori from open coding selected transcripts of both parents 
and participants. All documents and data were stored on password-protected computers; 
original recordings and field notes were de-identified and subsequently secured at the 
University in a locked cabinet in a locked room compliant with IRB protocols. 
Analysis 
 Analysis began with a descriptive comparison of demographic variables between 
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AS and NT groups, according to participant report, using StataIC 14 (StataCorp, 2015). 
Stata was used for all quantitative analyses, whereas NVivo was used for qualitative data. 
In explanatory sequential mixed-methods research, quantitative and qualitative data are 
analyzed separately, providing a straightforward, clear delineation that lends itself to a 
three-paper dissertation structure, with results connected in the final stage of the study for 
discussion.  
Aim 1. The primary goal of this study was to describe the onset and symptoms of 
menses in females with ASD compared to their NT peers. To meet this aim, we 
calculated the individual’s age at menarche as reported on the MDOT ([date at menarche 
– date of birth]/365.25 = age at menarche in years) from both the participant and the 
parent. Participant AAM is reported for Aim 1, with parent report of AAM in Aim 2; the 
mean, median, standard deviations, interquartile ranges were computed for both the AS 
and NT groups. While we sought to reach sample sizes of 50 per group, which was 
sufficient to achieve 80% power, our recruitment fell short of this goal. However, a post 
hoc power calculation for the one-way ANOVA comparison of AAM by group in 
Manuscript 1 revealed that on the basis of the means and between-group comparison 
effect size observed in the study (d = 0.37), the n = 79 achieved 77% power, just shy of 
the recommended 80% (Alpha = 0.05). Given the limitations faced by the researcher, the 
power was deemed sufficient for this study.  
Reported length of cycle from both participant and parent were reported with 
descriptive statistics, including mean and standard deviation for both the AS and NT 
groups. For regularity, the raw n of participants who report a regular or irregular cycle, as 
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well as the percent of the AS and NT groups was reported (i.e., 60% of NT participants 
report a regular cycle). For number and severity of symptoms, Count and Summary 
scores were calculated for pre-menstrual, dysmenorrhea physical, emotional and 
behavioral menstrual symptoms (as show in Appendix B). For Count variables, mean, 
standard deviation and ranges for both AS and NT groups are reported where appropriate. 
For Summary variables, which represent the ‘burden’ of symptoms, an average of the 
symptoms experienced of the total symptoms within the category, with 0 indicating No 
Symptoms, 0.01-0.33 indicating Low Symptom Burden, 0.34-0.66 indicating Moderate 
Symptom Burden, and 0.67-1.00 indicating High Symptom Burden. The top six most 
frequently reported menstrual symptoms, with means and standard deviations reported, 
were also reported. Lifestyle Interference Scores are reported, for Activities and for 
Symptoms, by mean and standard deviation by group. Lastly from the MDOT, 
frequencies and percentages of participants’ knowledge of and familial history of 
gynecologic disorder were reported by group.   
Aim 2. Characterize the differences in self-report and parent-report of onset of 
menarche and menstrual symptoms between females with ASD and their Neurotypical 
peers.  
 To address this aim, the mean and standard deviations for the variables noted in 
Aim 1 for the parents and participants in both the AS and NT groups separately. Through 
these analyses, a sense of how perceptions and reporting of menses varied between 
participants and their parents was sought. Variables were compared using matched t-tests 
to assess differences between parent and participant reports.  
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Aim 3. Explore the experience of menses for females with ASD, Neurotypical 
females, and their primary parent through semi-structured interviews.  
Interviews from participants and parents were analyzed using a qualitative 
descriptive approach of thematic analysis. Interviews were transcribed verbatim from the 
primary recording device, with all field notes taken by the research included at the end of 
each corresponding interview. Analysis was conducted according to the steps outlined by 
Creswell and Clark for explanatory sequential mixed-methods studies. Following 
preparation of the qualitative data, the researcher read through all of the transcribed 
interviews and field notes, marking notes to guide development of the qualitative 
codebook and subsequent analysis in the margins. The codebook used for analysis was 
developed from this initial exploration, as well as from notable findings from Phase 1 of 
the study, and served as a mechanism to organize data, ensuring agreement across coders, 
and served to inform development of themes. Once codes were identified and set, the 
transcripts and notes were coded, and codes organized by thematic categories. Thematic 
categories were interpreted in Manuscript 3. Qualitative validity was ensured through 
triangulation of data and expert review.  
Finally, qualitative data was merged with quantitative data from Manuscript 1 and 
2 for a connected mixed methods analysis in Chapter 5 (Creswell & Plano Clark, 2011). 
As noted by Creswell and Clark (2011), inferences that are drawn from each phase of the 
study inform the merged analysis and generation of meta-inferences that are drawn at the 
conclusion of the study. Because in explanatory sequential designs qualitative data may 
provide a more detailed understanding of the question at hand, these meta-inferences 
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drawn from both components of the study unify and clarify the study as a whole 
(Creswell & Plano Clark, 2011). Validity was assured by the quality and rigor of the 
study design, by fidelity to procedures, and by interpretive rigor (Creswell & Plano Clark, 
2011; Teddlie & Tashakkori, 2009). 
Limitations and Assumptions 
 There are several limitations to this study. First, the use of web-based 
questionnaires used for Phase 1 of this study may have led to sampling bias and 
nonresponse. While some individuals may have been excluded from this study due to 
lack of Internet access, we believe this number to be negligible within the population of 
interest. To mitigate nonresponse and missing data (from participants skipping 
questions), pop-up reminders appeared at the end of each section if a question is missed. 
This allowed participants to return to any unanswered question if it was accidentally 
omitted, but not force participants to respond to any question they do not wish to answer. 
No questions forced a response from participants.  
Research has shown that web-based methods of data collection yield comparable 
results to traditional mail-in pencil and paper questionnaires (Fitzpatrick & Montgomery, 
2004; Fleming & Bowden, 2009; Greenlaw & Brown-Welty, 2009; Hewson, Yule, 
Laurent, & Vogel, 2003; Leece et al., 2004). Additionally, the use of web-based data 
collection allows the researcher to reach a larger population for sampling, reduce study 
cost and participant burden, and streamline collection and analysis of results (Cook, 
Heath, & Thompson, 2000; Dillman & Bowker, 2001; Glasgow et al., 2007; Hewson et 
al., 2003). Given the social impairments of ASD, it is believed that participants may be 
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more comfortable answering personal questions through the computer interface, 
compared to pencil and paper methods with a researcher nearby. The study inclusion and 
exclusion criteria were strict and prohibited participation of individuals with cognitive 
impairment or intellectual disability. While rates of ID in females with ASD are relatively 
high (approximated 40% in the United States; Christensen, 2016) thus lowering the 
generalizability of this study to females with ASD as a group, the results from Aim 2 
serve to guide future studies on the inclusion of individuals with cognitive impairment 
and ID, for which parent-report may be the only feasible mechanism of data collection.  
As originally planned, the research team discussed opening the study to parents 
participating alone in January of 2016. While half the target sample size had not been 
reached at this point, the research team decided not to open the study to parents 
participating alone in order to meet Aim 2. No difficulties were anticipated for participant 
engagement with the web-based component of the study, though a novel platform and 
novel questionnaires were used. The MDOT has not yet been analyzed for reliability and 
validity in this or any population. However, the MDOT offers the most comprehensive 
assessment of menstrual symptoms and impact on daily functioning identified by the PI, 
making it well suited to generate a detailed quantitative description of the presentation of 
menses in females with ASD. As puberty and menses in ASD have received little 
attention in the literature to date, it was deemed acceptable to use a non-validated 
measure given the depth of the questionnaire and the quality of data it yielded.  
Human Subjects Considerations 
Study Approval 
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 This study sought and received IRB approval from the University of 
Pennsylvania. No study procedures were initiated until approval was received on July 
27th, 2015.  
Informed Consent and Assent 
While anonymous survey research is typically exempt from review and consent, 
this study involved vulnerable populations identified by the NIH (women, children), as 
well as individuals with disability, and collected personally identifying information for 
AS participants and parents to be contacted for Phase 2 of the study. As participants were 
below the age of consent (18 years), we required consent from the ‘parent’ (parent or 
legal guardian) and assent from the ‘participant’ in the form of electronic signatures. 
Records of consent and assent were stored separately from questionnaire data and not 
associated with the data beyond the study ID number. Records linking participant to their 
study ID were destroyed at the conclusion of the study.  
Inclusion of Women, Minorities and Children 
Women comprised the vast majority of study participants, as parent participants 
were predominately mothers. Half of the participants in this study were under the age of 
18, as stipulated by inclusion criteria for the participant groups. Recruitment of 
participants did not discriminate based on an individual’s race, though, as anticipated, 
fewer minorities participated in this research, possibly due to diagnostic differences in 
ASD (Mandell et al., 2009).  
Privacy and Confidentiality 
Some personal identifying information (e-mail addresses and phone numbers) 
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were collected in this study to allow for selected participants from Phase 1 to be 
contacted for Phase 2. Contact and personally identifying information were removed 
following study completion. Every parent and participant was assigned a coded subject 
number that connected with the data collected, but was not able to be traced back to an 
individual participant. Data was stored in accordance with University of Pennsylvania 
policies. Individuals and organizations that had access to this data include the researcher 
and authorized members of the Office for Human Research Protections at the University 
of Pennsylvania. The results of this study will be discussed and shown at meetings, and 
published in journals. Private identity will not be included in any dissemination of 
findings.  
Potential Risks and Protection against Risks 
This study posed minimal risk to participants and their parents. While some 
questions addressed sensitive, personal information that could potentially have made 
participants feel uncomfortable, there were no questions specifically related to topics of 
sexuality, sexual behaviors, or abuse. As there was some concern that individuals, both 
participants and parents, may have experienced some psychological distress as the result 
of discussing puberty and menses during Phase 2 interviews, a Psychiatric-Mental Health 
Nurse Practitioner with experience working with individuals with ASD and their families 
was available should any issues arise that participants wished to discuss further. One 
parent reported a history of abuse in her daughter, but did not wish to follow up with the 
NP.  
 Participants were reminded that they did not have to answer all questions and 
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were allowed to cease participation in the study at any time without repercussion. 
However, given that the content of the study may have spark discussions or thoughts 
related to concepts of womanhood, including menstruation and sexuality, resources 
appropriate to both the ASD and NT population were provided to participants at the 
conclusion of the study, should they have further questions or interest in the topics 
covered in this study. For females with ASD, this includes the Adolescent section of 
AutismSpeaks.org and their Transitions Tool Kit; for NT females, this includes the Office 
of Adolescent Health of the U.S. Department of Health & Human Services.  
Potential Benefits 
This study sought to improve our understanding of puberty, specifically menses, 
in females with ASD. The knowledge gained from this study will help to direct future 
research and help clinicians and parents of females with ASD to open a dialogue on 
menses in this population.  
Ethics of Participant Payment 
  Participants selected a $10 e-gift card of their choice from a list of 25 businesses 
(i.e., Amazon, Starbucks, Panera) in compensation for the completion of Phase 1 
questionnaires. As Phase 2 included a significant increase in burden in time, effort, and 
potentially travel, both parents and participants were compensated for their participation 
at the rate of $25 per individual, also in the form of an e-gift card of their choice, in 
accordance with the Wage Payment Model put forth by Dickert and Grady (Dickert & 
Grady, 1999). According to this model, participation in research requires little skill, but is 
burdensome in terms of time and effort and may include some risk. As such, all 
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participants were reimbursed at the same level, based on calculations of study demands 
and equivalent labor hourly wages. For Phase 2 interviews, participants engaged in 30 to 
60 minute interviews with the researcher; as this was demanding in terms of time and 
energy, and potentially challenging topics were addressed, compensation at the rate of 
$25 per individual was appropriate.  
Importance of Knowledge Generated 
 As noted previously, limited research exists on the course of puberty in females 
with ASD and none had addressed this critical life point from a qualitative standpoint. 
The published literatures has suggested this population may be at increased risk for both 
precocious puberty and primary amenorrhea, and the presentation of menses may be 
more severe than in Neurotypical peers (Burke et al., 2010; Hamilton et al., 2011; 
Hergüner & Hergüner, 2016; Ingudomnukul et al., 2007; Knickmeyer et al., 2006; Pohl et 
al., 2014; Whitehouse et al., 2011). The overall goal of this study was to address the 
identified gaps in the literature and to improve the understanding of the course that 
puberty may take in this population, as well as the unique experience of puberty for ASD 
in females.  
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Key Terms 
Precocious puberty: Onset of menses before the 8th birthday.  
Primary amenorrhea: Absence of menses by the 16th birthday. 
Early menarche: Menarche less than or equal to 11 years of age. 
Late menarche: Menarche greater than or equal to 14 years of age. 
Regular menstrual cycles: Cycle length of 22-35 days with consistent length of time 
between periods. 
Irregular menstrual cycles: Cycle length less than 22 or more than 35 days, or with 
inconsistent length of time between periods. 
Menses: The time of menstruation.  
Amenorrhea: Absence of a menstrual period for 90 days or longer, not due to pregnancy.  
Dysmenorrhea: Pain during menstruation.  
Menorrhagia (heavy menstrual loss): Use of 4 or more fully soaked pads a day for any 
duration during the menstrual periods. 
Hypomenorrhea (light menstrual bleeding): Less than 1 fully soaked pad or use of panty 
liner being sufficient for protection. 
Premenstrual Syndrome (PMS): A grouping of symptoms with onset in the second half of 
the menstrual cycle (14+ days from the first day of the last period) that are relieved 
within 1-2 days after onset of menses. Symptoms include: acne; swollen or tender 
breasts; fatigue; difficulties sleeping; changes in appetite; indigestion, bloating, 
constipation or diarrhea; cramps; headache or backache; joint or muscle pain; anxiety or 
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depression; mood swings, irritability or tension; difficulties concentrating or with 
memory.  
Premenstrual Dysphoric Disorder (PMDD): A syndrome of depression symptoms 
brought on by monthly hormonal fluctuation. Severe and debilitating condition, PMDD 
comprises of five or more of the following symptoms, including one mood-related 
symptom: fatigue; feelings of hopelessness or sadness, possible suicidal thoughts; little to 
no interest in usual activities or relationships; feelings of tension, anxiety, or panic 
attacks; changes in appetite, food cravings or binge eating; mood swings with periods of 
crying; difficulties sleeping; irritability or anger; bloating, breast tenderness, headaches, 
joint or muscle pain; difficulties concentrating. Symptoms begin in the week prior to 
menses and typically improve within 1-2 days after the onset of menses.  
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MANUSCRIPT 1.  
Onset and Presentation of Menses in Females with Autism Spectrum Disorder Compared 
to Neurotypical Peers 
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Abstract 
 This cross-sectional descriptive study investigated the differences in age at menarche 
(AAM) and menstrual presentation between females diagnosed with Autism Spectrum 
Disorder (ASD) and Neurotypical controls using web-based self-report on the Menstrual 
Disorders of Teenagers Questionnaire (MDOT). Females with ASD from multiplex 
families reported significantly earlier AAM (n = 8, M = 11.01, SD = 1.10), compared to 
females from simplex families (with ASD: n = 24, M = 12.42, SD = 1.38; Neurotypical 
with an ASD sibling: n = 34, M = 12.18, SD = 1.34), and Neurotypical controls with no 
family history of ASD (n = 12, M = 12.86, SD = 0.94). No differences were observed in 
characteristics of the menstrual cycle or menstrual symptoms across groups.  
Keywords: Autism Spectrum Disorder, Females, Menarche, Menstruation, Menstrual 
Symptoms 
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Introduction 
Puberty marks the transition from childhood to adulthood and is a period of 
physical, cognitive and social growth. For children with Autism Spectrum Disorder 
(ASD), a neurodevelopmental disorder characterized by impairments in social 
communication and interaction, as well as restricted, repetitive patterns of behavior or 
interests (Christensen, 2016), puberty may pose unique challenges as the social, cognitive 
and developmental growth fundamental to puberty interacts with the social, 
developmental and behavioral impairments of ASD. Females with ASD may face 
additional difficulties with the onset of menses, or menstrual cycle. Menarche, the first 
menstrual cycle, and menses are central components of puberty and womanhood in 
Western cultures (Beausang & Razor, 2000; Rembeck et al., 2006). Further, they have 
been significantly associated with serious health concerns across the lifespan. Early age 
at menarche has been associated with increased risk for breast cancer (Collaborative 
Group on Hormonal Factors in Breast Cancer, 2012; Petridou et al., 1996; Stoll et al., 
1994), cardiovascular diseases (Feng et al., 2008; Lakshman et al., 2009), increased BMI 
and abdominal type obesity (Freedman et al., 2003; Okasha, McCarron, Smith, & 
McEwen, 2001), insulin resistance and type 2 diabetes (He et al., 2010; Remsberg et al., 
2005), as well as adolescent depression and anxiety (Joinson et al., 2011; Kaltiala-Heino 
et al., 2003; Mendle, Turkheimer, & Emery, 2007; Stice et al., 2001), substance abuse 
and dependence (Stice et al., 2001), earlier sexual debut (Andersson-Ellström, Forssman, 
& Milsom, 1996; Kaltiala-Heino et al., 2003), resulting in earlier exposure to and 
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increased risk for sexual transmitted infections (Coker et al., 1994; Kaestle, Halpern, 
Miller, & Ford, 2005).  
Broadly, the gynecologic health of women with physical and cognitive disabilities 
has been overlooked and understudied (Burke et al., 2010). To date, only seven studies 
have addressed the onset of menses, symptoms of the menstrual cycle or syndromes 
related to women’s health among females with Autism Spectrum Disorder. These studies 
have reported mixed findings for age at menarche (AAM; Burke et al., 2010; Hamilton et 
al., 2011; Knickmeyer et al., 2006; Whitehouse et al., 2011), elevated rates of precocious 
puberty (Pohl et al., 2014), and elevated rates of both early onset menarche and primary 
amenorrhea (Ingudomnukul et al., 2007; Knickmeyer et al., 2006). In addition to atypical 
onset, these studies elucidate a pattern of increased menstrual symptoms and syndromes 
associated with the menstrual cycle, including dysmenorrhea, irregular menstrual cycles, 
menorrhagia, hirsutism, premenstrual syndrome or premenstrual dysphoric disorder, and 
polycystic ovarian syndrome (Ingudomnukul et al., 2007; Pohl et al., 2014). However, 
these studies have limited generalizability due to small sample sizes (Burke et al., 2010; 
Knickmeyer et al., 2006), the use of Neurotypical participants grouped by scoring on 
autism questionnaires as a proxy population for those with ASD (Hergüner & Hergüner, 
2016; Whitehouse et al., 2011), lack of Neurotypical control groups (Burke et al., 2010; 
Hamilton et al., 2011), and lack of control for other variables known to be associated with 
AAM (Burke et al., 2010; Hamilton et al., 2011; Knickmeyer et al., 2006). Furthermore, 
they lack common terminology and definitions, resulting in a literature base that is 
conflicting and limited.  
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Beyond representing a critical predictor of health concerns across the lifespan, 
onset and symptoms of the menses may be particularly difficult for females with ASD to 
cope with and manage. Not knowing when to expect her period may complicate planning 
and management, the arrival of a period unexpectedly may lead to increased behavioral 
problems when her anticipated schedule changes, painful periods may interfere with her 
ability to participate in or perform activities of daily life, and heavy flows may be 
difficult to manage in such a way that does not interfere with her daily schedule, nor runs 
the risk of insufficient protection and resulting embarrassment or social ostracism. While 
menses may interfere with daily activities in Neurotypical females, the increased burden 
of planning and adjusting to menses may be challenging for females with ASD and their 
families. The unpredictability of menarche and menses, particularly in the early 
menstrual years, may pose unique challenges to those with ASD. The need for sameness, 
routine and a measure of control that is a hallmark of the disorder is unlikely to interact 
well with a time marked by irregularity (ACOG Committee on Adolescent Health Care, 
2006; Adams Hillard, 2008) and increasing symptom burden (Adams Hillard, 2008; 
Clayton, 2008; Hickey & Balen, 2003). Further, sensory differences that are often 
associated with ASD (Leekam, Nieto, Libby, Wing, & Gould, 2007; Rogers, Hepburn, & 
Wehner, 2003) may interfere with the selection and use of appropriate hygiene products 
and clothing, notably bras, for their developing bodies. The interference and severity of 
these issues during the teenage years in females with ASD have ramifications beyond 
their menstrual health and must be addressed to fully support and care for these 
individuals.  
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While the onset and symptoms of menses are beginning to be documented, the 
effects of menses on daily life and functioning with ASD have yet to be described. The 
aim of this paper is to not only examine the onset, characteristics and symptoms of 
menses for females with Autism Spectrum Disorder, but to clarify the impact of menses 
on activities of daily life, compared to Neurotypically developing peers.  
Methods 
Facing Puberty Study Procedure 
This study reports the findings from the daughters participating in the cross-
sectional, descriptive Quantitative Phase of the Facing Puberty Study, an explanatory 
sequential mixed-methods study addressing the onset, presentation and experience of 
menses for females with Autism Spectrum Disorder compared to Neurotypical peers 
through web-based questionnaires and semi-structured dyad interviews with parents and 
daughters. From August 2015 through May 2016, families with and without a diagnosis 
of an Autism Spectrum Disorder (including diagnoses of Autistic Disorder, Asperger’s 
Syndrome, or Pervasive Developmental Disorder-Not Otherwise Specified) were 
recruited predominately through two autism research registries: autismMatch located at 
the Center for Autism Research at the Children’s Hospital of Philadelphia in 
Philadelphia, PA and the Interactive Autism Network (IAN), a partnership of Kennedy 
Krieger Institute and the Simons Foundation, in Baltimore, MD. Eligible participants 
were females with and without a diagnosis of an ASD (1) under the age of 18 years, (2) 
had begun menstruating, (3) with at least one menses in the six months prior to 
participating, and one of their parents, creating a parent-participant dyad. Due to known 
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and potential influences on age at menarche, daughters could have no co-morbid 
diagnoses of Intellectual Disability, Cerebral Palsy, Down’s Syndrome, Spina Bifida, 
Bipolar Disorder, Schizophrenia, Epilepsy or known genetic syndrome. Proficiency in 
reading English, noted by a fourth-grade reading level, was necessary for both parent and 
daughter to understand and answer the web-based questionnaires. The study website was 
supported by Qualtrics. Qualtrics offers an intuitive, user-friendly design for online 
research, which meets the strict security standards required by Human Subjects Research 
while allowing individuals to access and participate in research through their technology 
of choice. A five-question screener at the home page of the study ensured participants 
reported meeting the above criteria before moving to the consent or assent section. 
Parental consent and child assent were obtained from each parent-participant dyad.  
Once both parent and daughter participants had consented, participants were 
emailed individualized links to the password-protected study website. All participation 
for the Quantitative Phase of the Facing Puberty Study was online through the study 
website. There, all participants were asked to complete a demographic questionnaire, a 
modified version of the Parker-Sneddon Menstrual Disorders of Teenagers Questionnaire 
(MDOT; Parker, Sneddon, & Arbon, 2010) and the Screen for Child Anxiety Related 
Disorders Questionnaire (SCARED; Birmaher et al., 1997; Birmaher et al., 1999). 
Parents were additionally asked to complete the Physical Activity Questionnaire for 
Adolescents (PAQ-A; Kowalski et al., 1997; Kowalski et al., 1997) on their daughter’s 
activity habits. Questionnaires took approximately 20 minutes to complete for daughters 
and 30 minutes for parents. Upon completion of the Questionnaires, participants were 
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invited to select a $10 e-gift card for their participation. For the majority of participants, 
engagement with the study ended with completion of the questionnaires; ten parent-
participant dyads with Autism Spectrum Disorder were selected for semi-structured 
interviews that explored themes identified by a preliminary exploration of finding from 
the questionnaires and are discussed in Manuscript 3. Approval to conduct this study was 
obtained from The Institutional Review Board at the University of Pennsylvania.  
Areas of Exploration  
Age at Menarche. Month and year at menarche was reported retrospectively in 
Section 1 of the MDOT. Participant’s age at menarche was calculated using their date of 
birth and midpoint of the reported month and year that menses began (e.g., [Menarche 
(1/15/16) – DOB (10/8/00)]/365.25 = 15.3 years at menarche). Participants were further 
described as having Early Menarche if the reported age at menarche was less than or 
equal to 11 years and Late Menarche if the reported age at menarche was greater than or 
equal to 14 years; these ages are commonly used for reporting early and late menarche 
(Freedman et al., 2003; Gaudineau et al., 2010; Ho & Kung, 2005; Johansson & Ritzen, 
2005; Varraso, Siroux, Maccario, Pin, & Kauffmann, 2005). Less than 10% of females in 
the United States begin menstruating before age 11 and more than 90% have begun by 
age 14 (Chumlea et al., 2003).  
Covariates. Key variables that have previously been shown to be associated with 
age at menarche were collected in the participant and parent demographic questionnaires, 
including parent and daughter participants race and ethnicity, height and weight for BMI 
calculation for the daughter, as well as family’s income (eight-point scale of increasing 
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amounts), parental education (five-point scale from High School/Some College to 
Professional/Doctoral Degree), mother’s age at menarche, maternal age at pregnancy, 
abnormal maternal weight gain during pregnancy (Yes for < 10 lbs. or > 40 lbs., No for 
10-40 lbs.), presence of preeclampsia during pregnancy (Yes or No), as well as 
participant’s level of activity from the PAQ-A. As a high proportion of NT participants 
had a sibling with a diagnosis of an ASD (74%), this was also included as a covariate 
(Yes or No). Recruitment strategies primarily through autism research databases noted 
above likely led to this ‘atypical’ control group.  
Characteristics and Symptoms of the Menstrual Cycle. Characteristics and 
symptoms of the menstrual cycle were collected in Sections 2 and 3 of the MDOT. Cycle 
length, defined as the first day of one period to the first day of the next (typically 20 to 45 
days in adolescent females; Adams Hillard, 2008), and period length, defined as the 
number of menstrual days (typically 3-7 days; Adams Hillard, 2008), as well as regularity 
of cycle and presence of clots were assessed. Participants reported their level of pain 
related to their menstrual cycle on a scale from 0 to 10, with scores of 1-3 indicating 
‘Mild’ pain, 4-7 ‘Moderate’ pain, and 8-10 ‘Severe’ pain, as well as use of over-the-
counter (OTC) pain medication and its’ effectiveness. In Section 3, participants reported 
presence of symptoms by ‘No or Never’, ‘Just before a period’, ‘At the time of my 
period’, ‘Any time of the month’, ‘All the time’ or ‘Sometimes’. Count and summary 
scores for Pre-Menstrual Symptoms, Physical Menstrual Symptoms, Behavioral 
Menstrual Symptoms, Emotional Menstrual Symptoms and Dysmenorrhea were created 
from responses to symptoms experienced in relation to the participant’s monthly cycle in 
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Section 3 (see Table 1). Count scores reflect the total number of symptoms reported by 
the participant at the appropriate time (i.e., ‘Just before a period’ for Pre-Menstrual 
Symptoms and ‘At the time of my period’ for menstrual symptoms), while Summary 
scores reflect the symptom burden, an average of the symptoms experienced of the total 
symptoms within the category, with 0 indicating No Symptoms, 0.01-0.33 indicating 
Low Symptom Burden, 0.34-0.66 indicating Moderate Symptom Burden, and 0.67-1.00 
indicating High Symptom Burden. For example, if a participant reported no symptoms of 
dysmenorrhea at the time of her period her Dysmenorrhea Count would be ‘0’ and her 
Dysmenorrhea Summary Score would be ‘No Symptoms’; conversely, if she experienced 
four of the seven symptoms included in the Dysmenorrhea category, her Count would be 
4 and her Summary Score would be ‘Moderate Symptom Burden’. The top six symptoms 
reported by participants were explored: (1) pelvic pain: cramping at the time of a period, 
(2) changes in mood at the time of a period, (3) changes in mood just before a period, (4) 
bloating at the time of a period, and a tie for (5) with feeling irritable at the time of a 
period and (6) changes in appetite at the time of a period. 
Table 1. Menstrual Symptoms by Category 
Pre-Menstrual Symptoms 
Nausea Bloating 
Constipation Diarrhea 
Headaches Indigestion 
Breast Tenderness Acne 
Changes in sleep Changes in appetite 
Lower back pain Feeling down or depressed 
Difficulties concentrating Irritability 
Anxiety related to the period Changes in mood 
Tearfulness 
Physical Menstrual Symptoms 
Nausea Vomiting 
Bloating Diarrhea 
Constipation Indigestion 
Pelvic pain Lower back pain 
Aching outside the vagina or down the 
legs 
Thrush 
Headache Dizziness 
Breast pain or tenderness Acne 
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Behavioral Menstrual Symptoms 
Changes in sleep Changes in Appetite 
Feeling withdrawn or decreased social 
interest 
Difficulties concentrating 
Emotional Menstrual Symptoms 
Feeling down or depressed Irritability 
Anxiety related to the period Changes in mood 
Tearfulness or feeling weepy 
Dysmenorrhea Symptoms 
Aching – outside the vagina Aching – down the legs 
Pelvic pain: aching Pelvic pain: cramping 
Pelvic pain: stabbing Pelvic pain: other 
Lower back pain 
 
Impact on Lifestyle. From Section 2, questions assessing the frequency, duration 
and reasoning for missing school due to a menstrual cycle were used to understand 
impact on the participant’s lifestyle. Additionally, section 4 of the MDOT assessed 
impact of menses on various activities of daily life and the impact of specific symptoms 
on activities of daily life, on a scale from 0 to 10, as well as whether interference 
occurred with some, most or all periods. Interference is reported by activity and 
symptom.  
Knowledge and Family History. The final section of the MDOT briefly assesses 
knowledge and family history of the participant for several common gynecologic 
disorders, including polycystic ovarian syndrome (PCOS), endometriosis, pelvic 
inflammatory disease, fibrocystic breasts and dysmenorrhea.  
Statistical Analysis 
 Analyses were conducted using StataIC v14.1 (StataCorp, 2015). Age at 
menarche was tested for univariate normality. Statistical analysis used to compare 
participant groups on the variables noted above. Categorical data were assessed using 
chi-square analysis, continuous data with one-way ANOVA with post-hoc Bonferroni 
adjustment where appropriate. Finally, one multiple regression model was analyzed to 
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understand the role of predictor variables noted in Areas of Exploration: Covariates on 
AAM. For all tests, a p-value of < 0.05 was considered significant and a p-value of 0.05-
0.10 was considered moderately significant.  
Results 
Participants 
Of the 380 individuals who accessed the study, 247 met criteria for the study 
determined by a five-question screener, and consented or assented to participate. Fifty-
three of these consented individuals lacked consent or assent from their corresponding 
parent or daughter to complete the dyad, and were excluded from participation. Of the 
194 individuals who were emailed an individualized link to the study, 180 accessed and 
completed the questionnaires. Sixteen of these were removed from analysis due to lack of 
dyad data (e.g., the parent completed the study, while their daughter did not), incomplete 
questionnaires (e.g., lacking answers to at least one full questionnaire), or suspected 
falsified data (e.g., reporting a date of birth that would exclude the daughter participant 
from the study). This resulted in 164 individual completed questionnaires, reflecting 82 
complete parent-participant dyads; 34 dyads in the Autism Spectrum (AS) group, and 48 
dyads in the Neurotypical (NT) control group. Participants came from families with no 
history of ASD, simplex families, in which one individual has a diagnosis of ASD, and 
multiplex families, in which multiple individuals have a diagnosis of ASD. Here, 
multiplex families are defined as the daughter participant and a sibling reporting 
diagnoses of ASD. Again, this analysis addresses only the daughters participating in the 
study; hereafter solely referred to as the “participant”.  
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Table 2 summarizes the demographic characteristics of the study participants. 
There were no significant differences between groups in terms of age, ethnicity, BMI, or 
grade in school. Participants in the NT group were more likely to report being 
‘Other/Two or more’ races (31%) and were significantly more likely to have a sibling 
with a diagnosis of an ASD (74%) compared to the AS group (12%, 25%, respectively; 
χ2(1) = 4.24, p = 0.04; χ2 = 18.78, p = 0.00). As the NT group represents an ‘atypical’ 
control group, given the high proportion of those with siblings diagnosed with an ASD, 
the decision was made to analyze variables by the following groupings: NT with no 
family history of an ASD (NT, n = 12), those from simplex families, NT with an ASD 
sibling (NT:AS for ‘Autistic Sibling’, n = 35) and AS with no ASD sibling (AS, n = 24), 
and multiplex families of AS with ASD sibling (AS:AS, n = 8). Sample size varies by 
analysis due to some missing data, and is noted for each analysis. 
Table 2. Participant Demographics 
 NT 
(n = 48) 
AS 
(n = 34) 
Significance 
Age  
M ± SD 
Range 
 
14.59 ± 1.94 years 
10.24 – 17.87 
 
14.45 ± 1.89 years 
11.25 – 17.85 
 
NS 
Race 
White 
Other / Two or more 
 
33 
15 
 
30 
4 
 
χ2(1) = 4.24 
  p = 0.04 
Ethnicity 
Non-Hispanic/Latina 
Hispanic/Latina 
Other 
 
7 
33 
8 
 
2 
29 
3 
 
NS 
BMI 21.92 ± 4.73 23.27 ± 4.55 NS 
Psychotropic Medication 
Use 
17% 
8/48 
35% 
12/34 
χ2(1) = 3.74 
  p = 0.05 
Grade 
Kindergarten-4th 
5th-8th 
9th-12th 
College 
Home Schooled 
 
1 
24 
22 
1 
0 
 
0 
18 
14 
0 
2 
 
 
NS 
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ASD Diagnosis 
Autism 
PDD-NOS 
Asperger’s  
ASD  
----  
12 
6 
10 
7 
---- 
ASD Sibling 74% 
35/47 
25%  
8/32 
χ2 = 18.78 
  p = 0.00 
 
Age at Menarche  
Age at menarche was normally distributed (M = 12.25 ± 1.33, Range 9.52 -15.12; 
Skewness/Kurtosis test for Normality χ2 = 0.85, p = 0.65). A one-way ANOVA revealed 
a significant effect of group on AAM (F(3,73) = 3.62, p = 0.02). Figure 2 illustrates that 
females from multiplex families (AS:AS) reported significantly earlier AAM (M = 11.01, 
SD = 1.10, Range = 9.51 – 13.00 years) compared to females from simplex families 
(NT:AS: M = 12.18, SD = 1.34, R: 9.94 - 15. 12 years; AS: M = 12.42, SD = 1.38, Range 
= 9.6 – 15.04 years) and those with no family history of ASD (NT: M = 12.86, SD = 
0.94, Range = 11.9 - 15.07 years). The effects size for this comparison was moderate 
(partial eta2 = 0.13) and Bonferroni post-hoc tests revealed a significant difference in 
AAM between NT and AS:AS groups (p = 0.01), a nearly significant difference in AAM 
between AS and AS:AS groups (p = 0.05), no significant different between AS:AS and 
NT:AS groups (p = 0.13), or between AS to NT:AS, AS to NT, and NT to NT:AS groups 
(p = 1.00, p = 1.00, p = 0.70). Of note, a study by Hamilton and colleagues (2011) 
reported AAM varying significantly across the previous ASD diagnostic categories. We 
found a similar trend with participants diagnosed with Autism experiencing AAM earliest 
(11.32 years) followed by Asperger’s (12.30 years), PDD-NOS (12.59 years) and ASD 
(12.92 years); however, this trend was only moderately significant (p = 0.09).  
A Chi-square test revealed that the percentage of participants who experienced 
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early menarche did differ significantly by group (χ2(3) = 12.48, p = 0.01) with no 
participants in the NT group experiencing early menarche, 18% in the NT:AS group, 
17% in the AS group and 63% in the AS:AS group (Table 3). Those experiencing late 
menarche did not differ significantly by group (χ2(3) = 1.25, p = 0.74), though a reversal 
from the early menarche trend across groups can be seen with 8% having a late menarche 
in the NT group, 9% in the NT:AS group, 13% in the AS group and none in the AS:AS 
group. Taken together, these results suggest that females with ASD from multiplex 
families may be at increased risk for early AAM compared to those from simplex 
families and those with no family history of ASD. 
Figure 1. Age at Menarche By Group.  
 
*The thick line indicates the median, the box represents the interquartile range, the 
whiskers indicate the range. 
 
Table 3. Participants Reporting Early and Late Menarche  
 
 NT 
(n = 12) 
NT:AS 
(n = 35) 
AS 
(n = 24) 
AS:AS 
(n = 8) 
Significance 
Early 
Menarche 
0% 
0/12 
18% 
6/34 
17% 
4/23 
63% 
5/8 
χ2(3) = 12.48   
 p = 0.01 
Late 
Menarche 
8% 
1/12 
9% 
3/34 
13.0% 
3/23 
0% 
0/8 
χ2(3) = 1.25    
p = 0.74 
 
8 
10 
12 
14 
16 
NT NT:AS AS AS:AS 
Reported Age at Menarche in Years by 
Group  
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Age at Menarche: Regression with Covariates  
 To control for factors known to be associated with AAM, pairwise correlations of 
AAM and covariates were conducted; Table 4 shows that of the variables collected, 
parent education and sibling with ASD were significant predictors of early AAM. These 
variables, along with the critical theoretical variables of group (AS v NT), race (White v 
Other), ethnicity (Non-Hispanic v Hispanic v Other), maternal AAM, and daughter’s 
BMI, were included in a multiple regression model to understand the impact of an ASD 
diagnosis in the family on AAM. The total model accounted for 30.83% of the variance 
in AAM and was found to be significant (F(11, 54) = 2.19, p = 0.03). A diagnosis of an 
ASD in either the participant or a sibling significantly predicted younger AAM in the 
study participants (β = -0.38, p > 0.01; β = -0.39, p > 0.01, respectively), whereas 
mother’s AAM and daughter’s BMI showed moderate significance in predicting older 
AAM (β = 0.23, p > 0.06; β = 0.23, p > 0.06, respectively); the remaining variables were 
non-significant.  
Table 4. Correlation Matrix of Covariates 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
AAM 1.00             
Group -0.10 1.00            
Race 0.01 -0.23* 1.00           
Ethnicity -0.11 0.01 0.03 1.00          
BMI 0.07 0.14 -0.003 0.09 1.00         
ASD Sibling -0.23* -0.49* -0.02 -0.00 0.03 1.00        
Mother AAM 0.08 0.20 -0.03 0.05 -0.13 0.01 1.00       
Mother AAP -0.11 0.20 0.13 0.18 0.04 -0.27* -0.01 1.00      
Pregnancy 
Weight Gain 
0.11 -0.06 0.01 0.04 0.14 0.06 -0.12 -0.02 1.00     
Preeclampsia 0.11 0.01 -0.06 -0.19 0.36* 0.01 -0.21 -0.14 0.05 1.00    
Parent 
Education 
0.25* 0.01 0.28 -0.03 -0.15 -0.17 0.07 0.44 0.14 -0.28* 1.00   
Premature 
Birth 
-0.07 0.07 -0.07 -0.09 0.02 0.15 -0.11 0.05 0.02 0.28* 0.01 1.00  
Income -0.04 0.003 -0.01 -0.06 -0.18 -0.18 0.20 0.42* 0.04 -0.23* 0.46** 0.04 1.00 
• p < .05; ** p < .01 
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Characteristics of the Menstrual Cycle 
There were no significant differences in cycle length between groups, with the 
vast majority of cycles lasting 20 to 40 days; one AS participant reported a cycle length 
of 60 days. Period length lasted between three and nine days for all participants (F(3,74) 
= 2.10, p = 0.11), with post-hoc analyses revealing moderately shorter period length for 
AS:AS (M = 5.38, SD = 1.51 days) compared to AS (M = 7.20, SD = 1.71 days; p = 
0.10). No difference between groups was observed in the number of participants 
reporting having regular periods (NT = 83%, NT:AS = 80%, AS = 78%, AS:AS = 
100%). Heaviness of menstruation was also moderately significant, with AS:AS 
participants reporting moderately significant heavier flow than NT participants. No 
difference was observed between groups in presence of clots in menstrual flow, though a 
full three quarters of AS:AS participants reported clots compared to half or less across the 
other groups.  
Nearly 90% of participants reported some level of pain with menstruation, with 
most of those reporting Mild to Moderate pain (87%); participants reporting ‘Severe’ 
pain were represented evenly across all groups (NT = 2, NT:AS = 4, AS = 2, AS:AS = 1). 
Groups reported no significant differences in pain related to the menstrual cycle (F(3,74 
= 0.94, p = 0.43) or use of OTC pain medication (χ2(3) = 5.62, p = 0.47); however, 
effectiveness of pain medication was strongly significant (F(3,43) = 4.66, p = 0.01), with 
AS:AS reporting medication being the most effective at relieving pain symptoms (M = 
9.5, SD = 0.84) compared to AS (M = 5.46, SD = 3.26; p = 0.01) and NT:AS (M = 7.45, 
SD = 1.84; p = 0.34) and NT (M = 7.0, SD = 2.0; p = 0.38) groups. AS to NT:AS was 
 
 
63 
 
also moderately different for medication effectiveness (p = 0.10). Of the participants 
reporting use of OTC pain medication for menstrual pain, 8% reported use of Naproxen, 
70% Ibuprofen, and 22% Other pain medication. There were no differences in choice of 
pain medication across groups (χ2(9) = 10.58, p = 0.31). Hormonal birth control (HBC) 
use was seen only in the NT:AS (11%) and AS (12%) groups. Participants reporting HBC 
use to regulate their period (75%), to cause their periods to happen less frequently (25%), 
to decrease their menstrual symptoms (13%), and for ‘Other’ reasons (25%).  
Symptoms of the Menstrual Cycle 
80% of NT participants reported at least one premenstrual symptom compared to 
54% of NT:AS, 58% of AS and 38% of AS:AS participants (χ2(3) = 4.75, p = 0.19). 75% 
of NT participants reported at least one symptom of dysmenorrhea, compared to 51% 
NT:AS 67% of AS and 75% of AS:AS (χ2(3) = 3.32, p = 0.35). 93% of NT participants 
reported experiencing at least one physical menstrual symptom, compared to 63% of 
NT:AS, 63% of AS and 88% of AS:AS (χ2(3) =5.30, p = 0.15). For behavioral menstrual 
symptoms, 50% of NT participants reported experiencing at least one symptom, 43% of 
NT:AS, 42% of AS and 50% of AS:AS (χ2(3) = 0.36, p = 0.95). For emotional menstrual 
symptoms, 50% of NT participants reported experience at least one symptom, compared 
to 49% of NT:AS, 46% of AS and 63% of AS:AS (χ2(3) = 0.68, p = 0.88). No differences 
were observed between groups for premenstrual symptoms for both Count and Summary 
scores (F(3,74) = 0.30, p = 0.82; χ2(9) = 17.66, p = 0.570). A nearly significant difference 
was found between groups for Physical Menstrual Symptoms on the Count score (F(3,74) 
= 2.61, p = 0.06), with post-hoc Bonferroni tests showing the AS:AS group reporting 
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significantly more symptoms than their AS counterparts (p = 0.05) and moderately more 
than their NT:AS peers (p = 0.10). Significant differences were not found for the Count 
and Summary scores for Behavioral Menstrual Symptoms (F(3,74) = 1.23, p = 0.30; χ2(9) 
= 12.14, p = 0.21), Emotional Menstrual Symptoms (F(3,74) = 1.95, p = 0.13; ; χ2(9) = 
10.17, p = 0.34), or Dysmenorrhea Symptoms (F(3,74) = 1.19, p = 0.32; χ2(9) = 9.48, p = 
0.39). Results of Summary Scores are depicted in Figures 3. The top five most reported 
symptoms were pelvic pain: cramping at the time of a period (N = 44), change in mood at 
the time of a period (N = 28), change in mood just before a period (N = 27), bloating at 
the time of a period (N = 24), and a tie between irritability at the time of a period and 
change in appetite at the time of a period (N = 23). No differences were observed across 
groups for these symptoms (Table 5). 
Figure 2. Burden of Menstrual Symptoms by Group 
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Table 5. Top Menstrual Symptoms by Group. 
 NT NT:AS AS AS:AS Significance 
Pelvic Pain: 
Cramping 
67% 
8/12 
40% 
14/35 
54% 
13/24 
75% 
6/8 
χ2(3) = 4.79 
 p = 0.19 
Change in 
Mood: 
During 
30% 
3/10 
40% 
14/35 
25% 
6/24 
50% 
4/8 
χ2(3) = 2.34  
p = 0.51 
Change in 
Mood: 
Before 
50% 
5/10 
26% 
9/35 
33% 
8/24 
38% 
3/8 
χ2(3) = 2.23 
 p = 0.53 
Bloating 33% 
4/12 
34% 
11/35 
17% 
4/24 
38% 
3/8 
χ2(3) = 2.27 
 p = 0.52 
Irritability 40% 
4/10 
29% 
10/35 
13% 
3/24 
50% 
4/8 
χ2(3) = 5.57 
 p = 0.13 
Change in 
Appetite 
23% 
5/12 
25% 
9/35 
21% 
5/24 
38% 
3/8 
χ2(3) = 2.18 
 p = 0.15 
 
Lifestyle Interference 
There were significant differences in the frequency of missing school due to the 
0% 
20% 
40% 
60% 
80% 
100% 
?NT ? 
NT:AS 
 
 AS 
? AS:AS 
Behavioral Menstrual 
Symptoms 
Significant 
Burden 
Moderate 
Burden 
Low 
Burden 
No 
Symptoms 0% 
20% 
40% 
60% 
80% 
100% 
?NT ? 
NT:AS 
 
 AS 
? AS:AS 
Emotional Menstrual 
Symptoms 
Significant 
Burden 
Moderate 
Burden 
Low 
Burden 
No 
Symptoms 
0% 
20% 
40% 
60% 
80% 
100% 
?NT ? 
NT:AS 
 
 AS 
? 
AS:AS 
Dysmenorrhea 
Significant 
Burden 
Moderate 
Burden 
Low 
Burden 
No 
Symptoms  
 
 
66 
 
menstrual cycle (χ2(3) = 17.54, p = 0.04), most participants reporting missing school only 
with some periods (NT = 42%, NT:AS = 11%, AS = 13%, 13%), and only one participant 
in the AS:AS group who missed school with every period. No difference between groups 
was observed for number of school days missed (F(3,9) = 1.70, p = 0.24), with most 
participants missing fewer than two days per cycle. One participant in the AS:AS group 
reported missing up to 5 days of school per cycle because of her period. The rationale 
provided for missing school varied by group (χ2(9) = 18.35, p = 0.03). All participants the 
NT group reported missing school due to pain, whereas the NT:AS group reported pain 
(67%), heavy blood flow (8%) and ‘other’ reasons (25%), the AS group reported pain 
(25%), heavy blood flow (25%) and ‘other’ reasons (50%), and the AS:AS group 
reported nausea or vomiting (50%) and ‘other’ reasons (50%).  
Participants reported little interference of the menstrual cycles with activities of 
daily life and there were no differences between groups on attending school (F(3,71) = 
0.25, p = 0.86), completing school work (F(3,72) = 1.00, p = 0.40), social activities 
(F(3,71) = 1.16, p = 0.33), relationships with family (F(3,72) = 0.26, p = 0.88), or 
relationships with friends (F(3,70) = 1.01, p = 0.39). However, there was a significant 
difference in menstrual cycle interference on sports (F(3,69) = 3.72, p = 0.02), with 
participants in the NT group (M = 5.27, SD = 3.04) reporting significantly more 
interference than NT:AS group (M = 2.77, SD = 2.52; p = 0.03), the AS group (M = 2.3, 
SD = 2.18; p = 0.01). Results compared to the AS:AS group were non-significant (M = 
3.0, SD = 2.0, p = 0.37). Similarly, no differences were observed between groups in 
interference on daily living by symptom. No differences between groups were observed 
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for pain (F(3,67) = 1.92, p = 0.13), heavy blood flow (F(3(,69) = 0.02, p = 1.00), 
tiredness or fatigue (F(3,69) = 1.17, p = 0.33), or moods (F(3,69) = 1.70, p = 0.18). A 
moderate difference between groups was seen for interference of ‘generally feeling 
unwell’ (F(3,69) = 2.43, p = 0.07), with participants in the NT group reported slightly 
greater interference (M = 6.33, SD = 3.14) compared to the other groups (NT:AS: M = 
3.84, SD = 3.11, p = 0.13; AS: M = 4.32, SD = 3.39, p = 0.46; AS:AS: M = 2.86, SD = 
1.86; p = 0.13). Figures 4 and 5 show interference scores by group. 
Figure 3. Lifestyle Interference by Activity.  
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Figure 4. Lifestyle Interference by Symptom. 
 
Knowledge and Family History 
 A series of Chi-square analysis were run on Section 7 questions assessing 
participant’s knowledge and family history of several common gynecologic disorders. 
Few participants from any group reported having knowledge of PCOS, endometriosis and 
pelvic inflammatory disease; knowledge of these conditions was not significantly 
different across groups (See Table 6 for findings). Given their low familiarity, it was not 
surprising that participants reported very low incidence of these conditions in themselves, 
their mother or their sisters (Table 7 for findings).  
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Table 6. Knowledge of Gynecologic Disorders. 
 NT NT:AS AS AS:AS Significance 
PCOS 8% 
1/12 
14% 
5/35 
17% 
4/23 
0% 
0/8 
χ2(6) = 6.41 
p = 0.38 
Endometriosis 8% 
1/12 
6% 
2/35 
13% 
3/23 
25% 
2/8 
χ2(6) = 5.45 
p = 0.49 
Pelvic 
Inflammatory 
Disease 
33% 
4/12 
23% 
8/35 
17% 
4/23 
25% 
2/8 
χ2(6) = 5.80 
p = 0.45 
 
Table 7. Family History of Gynecologic Disorders.  
 NT NT:AS AS AS:AS Significance 
Period 
Problems 
17% 
2/12 
29% 
10/35 
30% 
7/23 
50% 
4/8 
χ2(6) = 5.25 
p = 0.52 
Severe Period 
Pain 
17% 
2/12 
29% 
10/35 
17% 
4/23 
50% 
4/8 
χ2(6) = 8.05 
p = 0.24 
Pelvic 
Inflammatory 
Disease 
8% 
1/12 
0% 
0/35 
0% 
0/23 
0% 
0/8 
 
χ2(6) = 11.12 
p = 0.09 
PCOS 8% 
1/12 
13% 
/35 
17% 
4/23 
13%  
1/8 
χ2(6) = 7.40 
p = 0.29 
Endometriosis 8% 
1/12 
0% 
0/35 
4% 
1/23 
25% 
2/8 
χ2(6) = 12.25 
p = 0.06 
Fibrocystic 
Breasts 
11% 
1/9 
0% 
0/35 
4% 
1/23 
13%  
1/8 
χ2(6) = 6.35 
p = 0.39 
 
Discussion 
This study reveals an association between a diagnosis of ASD, in either 
participants or a sibling, and early age at menarche, with females from multiplex families 
reporting the earliest AAM. This finding supports earlier findings of a decrease in AAM 
in females with ASD (Burke et al., 2010), and stands in contrast to earlier publications 
reporting later AAM in the ASD population and those with high Autism-like traits 
(Hergüner & Hergüner, 2016; Knickmeyer et al., 2006; Whitehouse et al., 2011). Though 
these studies were conducted outside of the United States (England and Turkey), they 
were in countries similar in population structure and economic development to the US 
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and report similar AAM. Of note, neither of these studies took BMI of the participant into 
account. Early age at menarche has been associated with increased BMI (Anderson, 
Dallal, & Must, 2003; Morrison et al., 1994), while decreased BMI has been associated 
with late menarche (Anderson et al., 2003). BMI is crucial to account for, especially 
considering reports of increased BMI in children and adolescents with ASD (Curtin, 
Jojic, & Bandini, 2014; Egan, Dreyer, Odar, Beckwith, & Garrison, 2013; Phillips et al., 
2014). Earlier studies reporting later age at menarche in females with ASD have tied 
findings to the Androgen Theory of ASD, which posits that heightened prenatal exposure 
to testosterone may play a role in the development of ASD. The result of this study 
however suggests the possibility of an underlying developmental mechanism common to 
both ASD and AAM, such that with increased genetic loading the risk for both ASD and 
early AAM increase. As genetics play a clear role in both the development of ASD 
(Geschwind, 2011; Miles, 2011) and AAM (57-82% of the variance in AAM stems from 
genetic factors; Dvornyk & Waqar-ul-Haq, 2012), it is plausible that genes conveying 
increased risk for either or both ASD and AAM may cluster together. 
 This study is the first to characterize in detail the menstrual cycle of females 
diagnosed with ASD compared to NT peers. Participants in this study largely reported 
menstrual cycle characteristics similar to adolescents in the United States at large. 
According to the American College of Obstetricians and Gynecologists (ACOG 
Committee on Adolescent Health Care, 2006) normal cycle length for ranges from 20 to 
45 days in the early menstrual years, settling to 21 to 34 days by the third menstrual year; 
both NT and AS participants reported cycles within this range. Period length is typically 
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3 to 7 days (ACOG Committee on Adolescent Health Care, 2006; Adams Hillard, 2008); 
only the AS group reported experiencing a cycle outside of these bounds (7.2 days), 
which was moderately longer than flow length reported in the other groups. As cycles are 
typically regular by the third menstrual year (ACOG Committee on Adolescent Health 
Care, 2006; Adams Hillard, 2008) and participants were on average 2.3 years post-
menarche, it was unsurprising that the majority of participants across all groups reported 
having regular cycles. This provides an interesting contrast to reports of increased 
irregularity among women with ASD (Ingudomnukul et al., 2007; Pohl et al., 2014). 
Given the lack of a definition for ‘irregular cycle’ in both Ingudomnukul and Pohl’s 
studies and the older age of their participants, it is possible participants perceived their 
cycles as irregular without meeting traditional criteria (less than 21 days or greater than 
45 days between menstruation; ACOG Committee on Adolescent Health Care, 2006) or 
that cycles for females with ASD may shift from a regular pattern in adolescence to an 
irregular pattern in early adulthood. The majority of participants reported having 
moderately heavy periods with the presence of clots, with no significant differences 
observed across groups. In contrast to previous findings, females with ASD in this study 
reported no difference in level of pain related to their menstrual cycle compared to peers. 
As previous studies have observed pain hyper- and hyposensitivity and differential pain 
expression in individuals with ASD (Allely, 2013; Courtemanche, Black, & Reese, 2016; 
Moore, 2015; Yasuda et al., 2016), it may be that females with ASD have more pain 
related to their period, but have difficulties interpreting or reporting the pain as such. 
Despite reporting less pain, multiplex and simplex participants reported elevated rates of 
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OTC pain medication use for menstrual-related pain. This may support the hypothesis 
that these individuals experience as much or possibly more menstrual pain than their 
typical peers but have difficulties in communicating or quantifying the pain, or 
alternatively, that their typical counterparts may select other remedies to menstrual pain, 
such as exercise or heat packs, over medication. Females from simplex and multiplex 
families (NT:AS, AS and AS:AS) were less likely report experiencing pre-menstrual 
symptoms and physical menstrual symptoms than NT peers, and reported symptoms of 
dysmenorrhea, emotional and behavioral menstrual symptoms at similar rates. This may 
be driven by challenges in interpreting and reporting sensory input, unfamiliarity with 
terms used (at least one participant noted at the end of the questionnaires that she did not 
know what ‘Bloating’ meant and had asked her mother at the end of the study), or a true 
difference in menstrual experience.  
 Menstrual symptoms interfered significantly enough for participants from all 
groups to report missing school due to their menstrual cycle with some regularity, 
participants from the AS:AS group reported missing the most days of school due to their 
menstrual cycle. Interestingly, participants from the NT group reported more interference 
of the menstrual cycle across all activities (attending school, completing school work, 
participating in social activities, or relationships with friends and family), and 
significantly greater interference with sports compared to the other groups. Similarly, NT 
participants rated most menstrual symptoms (pain, tiredness, moods and feeling unwell) 
as more interfering with their life than participants from the other groups. Of note, 
participants from simplex families (NT:AS and AS groups) reported very similar 
 
 
73 
 
menstrual symptoms, and interference of the menstrual cycle across activities and 
symptoms. Knowledge of three common gynecologic disorders was low across all 
groups, and unsurprisingly, report of family history of these disorders was similarly low. 
However, significantly more participants in the AS:AS group reported a family history of 
endometriosis (25%) compared to the other groups (0%-8.3%), which is also elevated in 
comparison to general prevalence statistics (2-22% of otherwise asymptomatic women; 
Farquhar, 2000).  
Together, these findings raise concern for the health of women with ASD. Earlier 
AAM is associated with increased BMI and abdominal type obesity, insulin insensitivity 
and Type 2 Diabetes, cardiovascular risk and coronary heart disease, breast cancer, and 
fertility impairment, as well as anxiety and depression in adolescence. Given the 
prevalence of obesity and poor nutrition in individuals with ASD (Curtin et al., 2014; 
Egan et al., 2013; Kral et al., 2015; Phillips et al., 2014), it is critical that practitioners 
serving this population carefully monitor for these negative health outcomes.  
The main strengths of the current study are the use of self-report of AAM and 
menstrual symptoms, control of covariates known to be associated with AAM, as well as 
comparison to a Neurotypical group. In using self-report of both AAM and characteristics 
and symptoms of the menstrual cycle, these data provide a more accurate representation 
of menses as perceived by individuals themselves. While it may be possible that females 
with ASD are less perceptive of pain or menstrual symptoms due to differences in 
sensory perception, the criteria for participation in the study, specifically no diagnoses of 
Intellectual Disability and reading at a 4th grade lever or higher, suggests that these 
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findings accurately reflect the experience of menses for young women with ASD.  
In evaluating the results of this study, it is important to consider some key 
limitations. First, while it the largest sample of females with ASD self-reporting AAM, 
our small sample size reached 77% power for the one-way ANOVA comparing our four 
groups on AAM. Further, our participants were predominately non-Hispanic White, from 
well educated, middle and upper income families. While this does strengthen our findings 
in regards to AAM, as race, ethnicity, and income have all been shown to be associated 
with AAM, this does limit the application of findings beyond these groups. Recruiting 
primarily through autism-focused research centers resulted in an ‘atypical’ control group, 
with the vast majority of participants reporting having a sibling diagnosed with an ASD. 
Though this impacted the ability to compare to a “true” Neurotypical group, it also 
resulted in the parsing of the NT group that led to our primary findings.  
In summary, this study has observed a significant decrease in AAM in study 
participants with ASD and those with a sibling with ASD after adjusting for known 
covariates, including race, ethnicity, BMI, maternal AAM and parental education. These 
findings suggest a common developmental mechanism to ASD and AAM, resulting in 
earlier AAM with increased genetic loading.   
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Abstract 
Study Objective: The objective of the study was to compare self- and parent- report on 
the onset and symptoms of the menstrual cycle in Autism Spectrum and Neurotypical 
populations. Due to the irregular nature of the early menstrual years, we sought to 
determine whether parents were accurate reporters of their daughter’s menstrual cycles, 
and whether parent report may be suitable for use in populations that are unable to self-
report.  
Design: Self- and parent-report on a modified version of the Menstrual Disorders of 
Teenagers (MDOT) Questionnaire and Screen for Childhood Related Anxiety Disorders 
(SCARED).  
Setting: Web-based. 
Participants: Females under the age of 18, with and without a diagnosis of Autism 
Spectrum Disorder (ASD), who had experienced menarche and one menstrual cycle in 
the previous six months, and a parent.  
Main Outcome Measures: Age at menarche (AAM), characteristics and symptoms of the 
menstrual cycle.  
Results and Conclusion: Parents of both Autism Spectrum Disorder and Neurotypical 
participants reported similar AAM and characteristics of the menstrual cycle as their 
daughters. Compared to daughters, Neurotypical parents underreported the severity and 
occurrence of their daughter’s menstrual symptoms across all reported areas, whereas 
parents of ASD adolescents did not follow this trend. ASD parents underreported level of 
menstrual pain, while reporting greater use of over-the-counter pain medication and 
greater efficacy of the medication in treating menstrual pain. ASD parents also reported 
more pre-menstrual, emotional and dysmenorrhea symptoms and fewer physical and 
behavioral menstrual symptoms than their daughters.  
Keywords: Menarche, menstrual symptoms, self-report, parent-report, Autism Spectrum 
Disorder 
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Introduction 
Menarche and menses are key components of every woman’s life, denoting 
reproductive capacity and the transition from child to woman in many cultures (Koff & 
Rierdan, 1993; Posner, 2006). Menarche is often used as the primary measure in research 
on puberty for females (Coleman & Coleman, 2002); although it is the last marker of the 
progression through puberty to adulthood, the sudden onset of menses contrasts to the 
gradual physical changes of puberty, such as breast or pubic hair growth, which are 
considered more difficult to recall or report (Brooks-Gunn, Warren, Rosso, & Gargiulo, 
1987; Carskadon & Acebo, 1993; Coleman & Coleman, 2002). Moreover, self-report of 
age at menarche (AAM) is believed to be moderately reliable across the lifespan (Brooks-
Gunn et al., 1987; Cooper et al., 2006; Dorn, Sontag-Padilla, Pabst, Tissot, & Susman, 
2013; Koo & Rohan, 1997; Must et al., 2002). In the United States, menarche typically 
occurs between 12 and 13 years of age for non-Hispanic White females, with non-
Hispanic Black females and Hispanic-American females typically experiencing menarche 
earlier (Chumlea et al., 2003). Race and ethnicity are two known factors that have been 
associated with AAM; Body mass index (BMI; Lassek & Gaulin, 2007; Morrison et al., 
1994; Rosenfield, Lipton, & Drum, 2009), nutritional imbalances (Berkey et al., 2000), 
mother’s AAM (Graber, Brooks-Gunn, & Warren, 1995), as well as perinatal factors, 
such as preeclampsia (Vatten et al., 2003), maternal tobacco use during pregnancy 
(Windham, Bottomley, Birner, & Fenster, 2004) and small size at birth (Adair, 2001; 
Lazar, Pollak, Kalter-Leibovici, Pertzelan, & Phillip, 2003) have also been associated 
with AAM (Karapanou & Papadimitriou, 2010). In turn, AAM has been associated with 
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many serious health concerns across the lifespan, from breast cancer to obesity 
(Collaborative Group on Hormonal Factors in Breast Cancer, 2012; Freedman et al., 
2003; Petridou et al., 1996), and insulin resistance to osteoporosis (Chevalley et al., 2009; 
Feng et al., 2008; Ho & Kung, 2005). Moreover, the symptoms of the menstrual cycle 
can significantly impact a woman’s quality of life throughout her menstrual years 
(Halbreich, Borenstein, Pearlstein, & Kahn, 2003; Hylan et al., 1999; Robinson & 
Swindle, 2000). Cumulatively, presentation of menses has substantial influence on a 
woman’s health and well-being throughout her life.  
Understanding AAM and the presentation of menses is a critical component of 
every woman’s health, particularly so for women with developmental disabilities, such as 
Autism Spectrum Disorder (ASD). ASD, a pervasive neurodevelopmental disorder, is 
characterized by impairments in language and social communication, restricted interests, 
and repetitive behaviors (American Psychiatric Association, 2013). Accounts that 
females with disabilities do not receive routine gynecologic care are not uncommon 
(Burke et al., 2010; Coyle & Santiago, 2002; Iezzoni, McCarthy, Davis, & Siebens, 
2000), yet the impairments characteristic of ASD, such as rigidity with schedules, 
difficulties with communication, and sensory differences, may pose unique challenges for 
women with the disorder as they navigate puberty. Sensory differences may complicate 
selecting or using feminine hygiene products, irregular menstrual cycles may conflict 
with the desire for routine and sameness, and more significantly impaired individuals 
may have difficulties communicating menstrual symptoms to others in such a way that 
they are accurately and appropriately treated. As we seek to better understand the life 
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course trajectory of this population and serve their needs as practitioners at all points of 
care, acknowledging and addressing gynecologic health as essential to their overall health 
is paramount.  
Only a handful of studies have undertaken this issue to date and have reported 
mixed findings for AAM and menstrual symptom presentation. Reports of AAM have 
ranged from 11.7 years (Hamilton et al., 2011) to 13.3 years (Knickmeyer et al., 2006), 
with two studies observing an increase in AAM in Neurotypical (NT) females with high 
‘autism-like’ traits (Hergüner & Hergüner, 2016; Whitehouse et al., 2011). Elevated rates 
of both precocious puberty (Pohl et al., 2014) and primary amenorrhea or delayed 
puberty (Ingudomnukul et al., 2007; Knickmeyer et al., 2006) have been observed in 
women with diagnoses of an ASD. Regarding menstrual symptoms, there is some 
evidence that they may be more likely to experience irregular cycles (Ingudomnukul et 
al., 2007; Pohl et al., 2014), dysmenorrhea (Ingudomnukul et al., 2007; Pohl et al., 2014), 
menorrhagia (Burke et al., 2010; Ingudomnukul et al., 2007), and premenstrual syndrome 
(Burke et al., 2010; Hamilton et al., 2011; Ingudomnukul et al., 2007; Pohl et al., 2014). 
The majority of these studies relied on parental report (Hamilton et al., 2011), chart 
review (Burke et al., 2010), retrospective report from adults (Ingudomnukul et al., 2007; 
Knickmeyer et al., 2006; Pohl et al., 2014), or proxy populations (Hergüner & Hergüner, 
2016; Whitehouse et al., 2011) to characterize menses for women with ASD, or lacked a 
Neurotypical control group (Burke et al., 2010; Hamilton et al., 2011). While a crucial 
first step towards understanding the presentation of puberty and gynecologic health in 
this population, the data collected omits the voices of the individuals themselves and 
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adolescents in the midst of puberty. The experience of the menstrual cycle is one that is 
extremely subjective and personal, one that females with a diagnosis of ASD may have 
challenges in reporting or conveying the nuisances of to others. Thus, this study sought to 
understand the similarities or differences in self- and parent-report of AAM and the 
menstrual cycle. 
Methods 
Facing Puberty Study Procedure  
This study reports the findings from the parent and daughter dyads participating in 
the cross-sectional, descriptive Quantitative Phase of the Facing Puberty Study. The 
Facing Puberty Study was explanatory sequential mixed-methods study addressing the 
onset, presentation and experience of menses for females with Autism Spectrum Disorder 
compared to Neurotypical (NT) peers through web-based questionnaires and semi-
structure dyad interviews. Eligible for participation were females (1) with and without 
diagnoses of an ASD, (2) under the age of 18 years, (3) who had begun menstruating, 
with (4) at least one menstrual cycle within six months of participating, as well as one of 
their parents. Please refer to Manuscript 1 for complete details of study procedure.  
Area of Exploration  
 The following areas were assessed through the web-based questionnaires for 
analysis.  
Demographics. The demographic questionnaire assessed participants’ age, race 
and ethnicity, height and weight for BMI calculation, primary language and education; 
parents were additionally asked their marital status, family income, daughter’s age at and 
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ASD diagnosis, daughter’s use of prescription and non-prescription medication, diagnosis 
of an ASD in other family members, their own AAM, and weight gain, presence of 
preeclampsia or prematurity during their pregnancy with their daughter.   
Age at Menarche. For both parents and daughter, age at menarche was calculated 
from the midpoint of the reported month and year that daughter began menstruating and 
the daughter’s date of birth (e.g., [Menarche (1/15/16) – DOB (10/8/00)]/365.25 = 15.3 
years at menarche). Menarche was classified as Early Menarche if the reported age was 
less than or equal to 11 years and Late Menarche if the reported age at menarche was 
greater than or equal to 14 years; these ages are commonly used for reporting early and 
late menarche (Freedman et al., 2003; Gaudineau et al., 2010; Ho & Kung, 2005; 
Johansson & Ritzen, 2005; Varraso et al., 2005). In the United States, less than 10% of 
females begin menstruating before age 11 and more than 90% have begun by age 14 
(Chumlea et al., 2003). 
Characteristics and Symptoms of the Menstrual Cycle. The modified 
Menstrual Disorders of Teenagers Questionnaire (MDOT; Parker et al., 2010) assessed 
typical menstrual cycle characteristics such as cycle length, period length, and regularity, 
as well as menstrual symptoms, interference of the menstrual cycle with activities of 
daily life, beliefs about their menstrual cycle, and a brief assessment of knowledge and 
family history with gynecologic disorders. Modifications made from the original version 
included changing wording to that more commonly used in the United States, changing 
pain medication to those more commonly used in the United States, inclusion of more 
menstrual symptoms for a fuller account of symptoms experienced by participants, as 
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well as omission of questions surrounding sexual practice, relationships, and identity, as 
they were not pertinent to the study’s goals. While the MDOT has not yet been validated 
or with the ASD population, it was selected and used with the corresponding author’s 
permission for its depth and breadth of assessment of the menstrual cycle for teenagers 
(Parker, 2014).  
Cycle length, defined as the first day of one period to the first day of the next 
(typically 20 to 45 days in adolescent females; Adams Hillard, 2008), and period length, 
defined as the number of menstrual days (typically 3-7 days; Adams Hillard, 2008), as 
well as regularity of cycle and presence of clots were assessed. Participants rated their 
level of menstrual pain on a scale from 0 to 10, with scores of 1-3 indicating ‘Mild’ pain, 
4-7 ‘Moderate’ pain, and 8-10 ‘Severe’ pain, as well as use of over-the-counter (OTC) 
pain medication and its effectiveness. Participants reported presence of menstrual 
symptoms by ‘No or Never’, ‘Just before a period’, ‘At the time of my period’, ‘Any time 
of the month’, ‘All the time’ or ‘Sometimes’. Count scores for Pre-Menstrual Symptoms, 
Physical Menstrual Symptoms, Behavioral Menstrual Symptoms, Emotional Menstrual 
Symptoms and Dysmenorrhea were created from responses to symptoms experienced in 
relation to the participant’s monthly cycle in Section 3 (see Table 1). Count scores reflect 
the total number of symptoms reported by the participant at the appropriate time (i.e., 
‘Just before a period’ for Pre-Menstrual Symptoms and ‘At the time of my period’ for 
menstrual symptoms). Further, the top six menstrual symptoms reported by daughters are 
explored. The top six menstrual symptoms identified by daughters were: (1) pelvic pain: 
cramping at the time of a period, (2) changes in mood at the time of a period, (3) changes 
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in mood just before a period, (4) bloating at the time of a period, and a tie for (5) with 
feeling irritable at the time of a period and (6) changes in appetite at the time of a period. 
Anxiety. To compare reporting of a subjective experience across parents and 
daughters, the Screen for Childhood Related Anxiety Disorders (SCARED; Birmaher et 
al., 1997; Birmaher et al., 1999) was included to assess presence of anxiety symptoms in 
the participants. This anxiety measure has been used extensively in the ASD population 
and has demonstrated reliable results between self- and parent-report (Stern, Gadgil, 
Blakeley-Smith, Reaven, & Hepburn, 2014).   
Table 1. Symptoms of the Menstrual Cycles 
Pre-Menstrual Symptoms 
Nausea Bloating 
Constipation Diarrhea 
Headaches Indigestion 
Breast Tenderness Acne 
Changes in sleep Changes in appetite 
Lower back pain Feeling down or depressed 
Difficulties concentrating Irritability 
Anxiety related to the period Changes in mood 
Tearfulness 
Physical Menstrual Symptoms 
Nausea Vomiting 
Bloating Diarrhea 
Constipation Indigestion 
Pelvic pain Lower back pain 
Aching outside the vagina or down the legs Thrush 
Headache Dizziness 
Breast pain or tenderness Acne 
Behavioral Menstrual Symptoms 
Changes in sleep Changes in Appetite 
Feeling withdrawn or decreased social interest Difficulties concentrating 
Emotional Menstrual Symptoms 
Feeling down or depressed Irritability 
Anxiety related to the period Changes in mood 
Tearfulness or feeling weepy 
Dysmenorrhea Symptoms 
Aching – outside the vagina Aching – down the legs 
Pelvic pain: aching Pelvic pain: cramping 
Pelvic pain: stabbing Pelvic pain: other 
Lower back pain 
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Analyses 
Participants were divided into four groups for analysis: daughters with ASD 
(ASD) and their parents (ASP), Neurotypical daughters (NTD) and their parents (NTP). 
Demographic characteristics were assessed using independent sample t-tests to compare 
age and BMI for parents and daughters separately. All other demographic variables were 
assessed using chi-square tests across all four groups. Paired t-tests and chi-square tests 
were conducted to compare self- and parent-report of AAM, menstrual cycle 
characteristics, menstrual symptoms and interference. Independent t-tests were used to 
compare the difference in report between parent and daughters across groups. It is 
important to note that no questions in the web-based questionnaires required an answer 
from the participant, and thus the numbers of dyads differ across analyses. There were no 
patterns found between missing values and group. For all tests, a p-value of < 0.05 was 
considered significant and a p-value of 0.05-0.10 was considered moderately significant. 
Following analysis of AAM, only significant findings are reported in text. Please refer to 
tables for other results.  
Results 
Participants 
The majority of parent participants were mothers (ASP = 97%, NTP = 98%). 
Parents were moderately different in age, with ASP participants being slightly older at 
participation (M = 45.17, SD = 6.03 years) than NTP participants (M = 43.01, SD = 5.87; 
p = 0.11). Dyads were predominately non-Hispanic White, however more NTD 
participants described themselves as ‘Other/Two or More’ Races than in the other groups 
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(NTD = 31%, NTP = 19%, ASD = 12%, ASP = 12%; p = 0.08). Significantly more NTD 
participants described themselves as ‘Hispanic’ (15%) or ‘Other’ (17%) than participants 
in the other groups (p = 0.05). BMI was similar for ASD (M = 23.13, SD = 4.55) and 
NTD participants (M = 21.92, SD = 4.73; p = 0.21), and for ASP (M = 29.60, SD = 9.83) 
and NTP participants (M = 27.55, SD = 5.80; p = 0.25). The majority of participants 
spoke English as a first language, parents were well educated (65% of AS parents had a 
Bachelor’s Degree or higher, as did 60% of NT parents) and reported middle to high 
income. Table 2 shows the demographic characteristics of participants. 
Though all participants diagnosed with an ASD are considered as one group for 
the purpose of this study, ASP were asked to report their daughter’s ASD diagnosis and 
age at diagnosis to understand potential variations in key variables by the previous 
diagnostic categories of Autism, Asperger’s Syndrome, Pervasive Developmental 
Disorder-Not Otherwise Specified (PDD-NOS), as well as the new label of ASD. Parents 
reported diagnoses of Autism (35%), PDD-NOS (18%), Asperger’s Syndrome (29%), 
and ASD (18%). ASP reported daughters diagnosed with PDD-NOS receiving the 
diagnoses earliest (M = 41.33, SD = 18.9 months), followed by Autism (M = 60.58, SD = 
56.5 months), Asperger’s Syndrome (M = 69.1, SD = 26.3 months), and ASD (M = 98.0, 
SD = 45.0 months). The increased age at diagnosis for ASD may be due to the change in 
diagnostic criteria away from Autism, PDD-NOS and Asperger’s Syndrome to a unified 
Autism Spectrum Disorder that occurred in 2013 with the publication of the 5th Edition of 
the Diagnostic and Statistical Manual of Mental Disorders. Thus the differences in age at 
diagnosis across these groups should be interpreted with caution (see Table 3).  
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Table 2. Participant Demographics.  
 NTD  
(n = 48) 
NTP 
(n = 48) 
ASD  
(n = 34) 
ASP 
(n = 34) 
Significance  
Age 
(years) 
14.59 ± 1.94 
years 
43.01 ± 5.87 
years 
14.45 ± 1.88 
years 
45.17 ± 6.03 
years 
Daughters:  
t(80) = -0.31 
 p = 0.75 
Parents: 
t(79)= 1.62 
p = 0.11 
Race 
White 
Other / Two + 
 
33 
15 
 
39 
9 
 
30 
4 
 
30 
4 
χ2(3) = 6.83 
p = 0.08 
Ethnicity 
Hispanic 
Non-Hispanic 
Other 
 
7 
33 
8 
 
4 
40 
3 
 
2 
29 
3 
 
1 
33 
0 
 
χ2(6) = 12.43  
p = 0.05 
 
 
BMI 21.92 ± 4.73 27.55 ± 5.80 23.125 ± 4.55 29.60 ± 9.83 Daughters: 
t(78) = 1.26 
p = 0.21 
Parents: 
t(75)= 1.15 
p = 0.25 
Language 
English 
Spanish 
Other 
 
46 
1 
1 
 
44 
3 
1 
 
34 
0 
0 
 
34 
0 
0 
 
χ2(6) = 6.16 
p = 0.41 
Parent Education 
HS/GED - College 
Associate’s 
Bachelor’s 
Master’s 
Professional/Doctoral 
 
12 
6 
13  
12 
4  
 
6 
6 
12 
6 
4  
 
 
χ2(4) = 2.01  
p = 0.74 
Income 
Less than $20,000 
$20-60,000 
$60-100,000 
$100-150,000 
More than $150,000 
Prefer not to say 
 
1 
8 
21 
10 
7 
1 
 
3 
6 
11 
3 
6 
5 
 
χ2(5) = 8.79 
p = 0.12 
 
Table 3. Autism Spectrum Disorder Related Characteristics of AS and NT Groups 
 NT 
(n = 48) 
AS 
(n = 34) 
Significance 
ASD Dx 
None 
Autism 
PDD-NOS 
Asperger’s 
ASD 
 
48 
0 
0 
0 
0 
 
0 
12 
6 
10 
6 
 
----- 
Age at Diagnosis 
Autism 
PDD-NOS 
Asperger’s 
ASD 
---- 
 
 
60.58 ± 56.5 months 
41.33 ± 18.9 months 
69.1 ± 26.3 months 
98.0 ± 45.0 months 
F(3,64) = 4.10 
p = 0.01 
 
PDD-ASD: p = 0.01 
Autism-ASD: p = 0.07 
ASD Sibling 74% 
35/47 
25% 
8/32 
χ2(1) = 18.78 
p = 0.00 
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AAM and Menstrual Cycle Characteristics 
Neurotypical. NT parents and daughters reported overwhelmingly similar AAM 
and characteristics of the menstrual cycle. There was no difference in AAM between 
parent and daughter report (t(43) = -0.01, p = 0.99; Figure 1). Further, there were no 
differences between NTP and NTD in reported AAM that met criteria for Early 
Menarche (χ2(1) = 0.10, p = 0.75) or Late Menarche (χ2(1) = 1.00 p = 1.00; Figure 2). 
NTP reported slightly, non-significantly shorter cycle length and moderately shorter 
period length compared to NTD, underestimating on average by half a day (Table 4). A 
similar proportion of NTP and NTD reported daughters as having regular cycles with 
moderately heavy menstrual flow; fewer parents reported the presence of clots for their 
daughter, though this difference was non-significant (Table 4). 
Autism Spectrum. ASP reported slightly earlier AAM compared to ASD (Figure 
1), though this difference was non-significant (t(32) = 0.84, p = 0.41). A similar 
proportion of ASD and ASP participants reported AAM that met criteria for Early 
Menarche (χ2(1) = 0.04, p = 0.85) and Late Menarche (χ2(1) = 0.13, p = 0.72; Figure 2). 
ASP reported shorter cycle length and significantly shorter period length compared to 
ASD, underestimating period length by an average of 0.65 days (Table 4). A similar 
proportion of ASD and ASP participants reported the daughters’ cycle as being regular 
with moderately heavy flow, though fewer ASP reported presence of clots compared to 
ASD (Table 4).  
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Figure 1. Age at Menarche by Group 
 
*The thick line indicates the median, the box represents the interquartile range, the 
whiskers indicate the range. 
 
Figure 2. Proportion of Reported Age at Menarche Meeting Criteria for Early, Typical, 
and Late Menarche by Group. 
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Table 4. Characteristics of the Menstrual Cycle by Group 
 
 NTD  
(n = 48) 
NTP 
(n = 48) 
Significance ASD  
(n = 34) 
ASP 
(n = 34) 
Significance  
Cycle Length 30.64 ± 8.61 
days 
30.32 ± 8.58 
days 
t(24) = 0.68 
p = 0.50 
29.4 ± 9.15 
days 
27.46 ± 2.79 
days 
t(14) = 0.91 
p = 0.38 
Period Length 6.68 ± 1.99 
days 
6.15 ± 1.62 
days 
t(40) = 1.90 
p = 0.06* 
6.78 ± 1.83 
days 
6.13 ± 1.41 
days 
t(29) = 2.72 
p = 0.01** 
Regular Cycle 79.1% 
34/43 
75.0% 
33/44 
χ2(1) = 0.20 
 p = 0.65 
81.8% 
27/33 
83.3% 
25/30 
χ2(1) = 0.03 
 p = 0.87 
Flow Quality 
(Scale: 1-5) 
2.74 ± 0.57 2.63 ± 0.83 t(40) = 0.82 
p = 0.42 
2.99 ± 0.76 3.02 ± 0.76 t(28) = -0.19 
p = 0.85 
Clots 
(% Yes)  
52% 
25/48 
39% 
15/39 
χ2(1) = 1.61 
 p = 0.21 
52% 
17/33 
46% 
13/28 
χ2(1) = 0.16 
 p = 0.69 
 
Menstrual Symptoms 
Neurotypical. Compared to NTD, NTP followed a pattern of underreporting 
menstrual symptoms, including the level of pain their daughters experienced, the use of 
OTC pain medication to treat menstrual pain, and the level of effectiveness of OTC pain 
medication (Table 5), although none of these differences were significant. NTP also 
underreported the number of symptoms experienced across all symptom categories 
(Table 6), though this trend was only significant for number of behavioral menstrual 
symptoms experienced. For the top menstrual symptoms, the proportion of NTP reporting 
the presence of pelvic pain: cramping was identical to NTD. Fewer NTP reported 
changes in mood at the time of a period, and more NTP reported changes in mood just 
before a period. Also, fewer NTP reported bloating, irritability, and significantly fewer 
NTP reported changes in appetite compared to NTD (NTD = 29%, NTP = 10%; χ2(1) = 
5.32, p = 0.02; Figure 3). 
Autism Spectrum. Compared to ASD, ASP reported that their daughters 
experienced less pain related to their menstrual cycle, reported more use of OTC pain 
medication for treating menstrual pain, and that the OTC pain medication was more 
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effective at treating pain (Table 5). Further, ASP reported that their daughters 
experienced significantly more pre-menstrual symptoms (t(33) = -2.72, p = 0.01), and 
marginally more symptoms of dysmenorrhea and emotional menstrual symptoms (Table 
6). In contrast, ASP reported that their daughters had fewer physical menstrual symptoms 
(t(33) = 1.84, p = 0.07) and behavioral menstrual symptoms (t(33) =1.82, p = 0.08; Table 
6). An identical proportion of ASP reported presence of pelvic pain: cramping as ASD 
and more ASP reported presence of change in mood at the time of a period and just 
before a period, and irritability. In contrast, fewer ASP reported presence of bloating or 
changes in appetite than ASD (Figure 3).  
Table 5. Pain Characteristics of the Menstrual Cycle by Group 
 
 NTD  
(n = 48) 
NTP 
(n = 48) 
Significance ASD  
(n = 34) 
ASP 
(n = 34) 
Significance  
Pain 
(Scale: 0-10) 
4.38 ± 2.63 3.95 ± 2.47 t(38) = 1.51 
p = 0.14 
4.57 ± 2.67 4.21 ± 2.35 t(27) = 0.70 
p = 0.49 
Pain 
Medication Use 
48% 
23/48 
43% 
18/42 
χ2(2) = 3.31 
 p = 0.19 
50% 
16/32 
67% 
22/33 
χ2(2) = 4.10 
p = 0.13 
Effectiveness 
Scale: 0-10 
7.05 ± 2.48 7.0 ± 2.53 t(21) = 0.06 
p = 0.95 
7.59 ± 2.40 7.82 ± 2.13 t(16) = -0.44 
p = 0.66 
 
Table 6. Menstrual Symptom Count Variables by Group 
 
 NTD  
(n = 48) 
NTP 
(n = 48) 
Significance ASD  
(n = 34) 
ASP 
(n = 34) 
Significance 
Pre-Menstrual 
Symptoms 
(0-17) 
2.60 ± 3.29 2.52 ± 2.95 t(47) = 0.13 
p = 0.90 
2.26 ± 3.03 3.74 ± 3.22 t(33) = -2.72 
p = 0.01** 
Dysmenorrhea 
(0-7) 
1.56 ± 1.83 1.15 ± 1.37 4(47) = 1.31 
p = 0.20 
1.38 ± 1.50 1.59 ± 1.69 t(33) = -0.79 
p = 0.43 
Physical Menstrual 
Symptoms 
(0-14) 
2.65 ± 2.47 1.94 ± 2.15 t(47) = 1.40 
p = 0.17 
2.82 ± 2.32 2.15 ± 2.13 t(33) = 1.84 
p = 0.07* 
Behavioral 
Menstrual 
Symptoms 
(0-4)  
0.75 ± 0.93 0.38 ± 0.67 t(47) = 2.28 
p = 0.03** 
0.76 ± 1.16 0.44 ± 0.95 t(33) =1.82 
p = 0.08* 
Emotional Menstrual 
Symptoms 
(0-5) 
1.06 ± 1.33 0.77 ± 1.29 t(47) = 1.04 
p = 0.30 
1.32 ± 1.74 1.44 ± 1.80 t(33) = -0.50 
p = 0.62 
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Figure 3. Most Frequently Reported Menstrual Symptoms by Group 
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Neurotypical. NTP reported similar frequency and duration of missing school 
due to menses as NTD, though most NTD attributed missing school due to menstrual 
pain, whereas NTP attributed it to heavy blood flow and nausea/vomiting (Table 7). 
Parents reported less interference for completing school work, social activities, and 
significantly less interference with sports (t(45) = 2.01, p = 0.05), and more interference 
for attending school, relationships with family and relationships with friends than NTD 
(Figure 4). Further, NTP reported pain and generally feeling unwell as interfering 
significantly less with their daughters activities of daily life than NTD (Pain: NTD M = 
4.96, SD = 3.08, NTP M = 3.93, SD = 2.95; t(40) = 2.44, p = 0.02; Unwell: NTD M = 
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differences were non-significant (Figure 5).  
Autism Spectrum. ASP and ASD reported similar frequency and duration of 
missing school due to menses; while ASD attributed missing school to a variety of 
reasons (Pain, Heavy Blood Flow, Nausea/Vomiting and Other reason near equally), 
most ASP reported Pain or Heavy Blood Flow as the main cause (Table 7). ASP reported 
more interference of the menstrual cycle than ASD across all activities, with significantly 
more interference for completing school work (t(29) = -1.95, p = 0.06), social activities 
(t(29) = -2.11, p = 0.04) and sports (t(28) = -2.34, p = 0.03; Figure 5). Further, ASP 
reported all symptoms except for pain as interfering more with their daughters’ lifestyle 
than ASD, with Mood as significantly more interfering (t(28) = -2.19, p = 0.04; Figure 6).  
Table 7. Menstrual Interference with School by Group 
 NTD 
(n = 48) 
NTP 
(n = 48) 
Significanc
e 
ASD 
(n = 34) 
ASP 
(n = 34) 
Significance 
Missing School 
No 
Yes, every 
Yes, some  
 
38 
1 
9 
 
37 
1 
8 
χ2(1) = 0.03 
p = 0.99 
 
 
27 
1 
4 
 
27 
1 
6 
χ2(1) = 1.39 
p = 0.71 
Days Missed 
(days) 
1.33 ± 
0.52 
1.5 ± 0.45 t(5) = -1.58 
p = 0.17 
 
2.33 ± 
2.31 
1.67 ± 
1.15 
t(2) = 1.00 
p = 0.42 
Rationale 
Pain 
Heavy Blood Flow 
Nausea/Vomiting 
Other 
 
9 
1 
0 
 
6 
2 
1 
 
χ2(2) = 1.89 
p = 0.39 
 
 
1 
1 
1 
2 
 
3 
2 
1 
1 
 
χ2(3) = 1.37 
p = 0.71 
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Figure 4. Menstrual Interference by Group 
 
Figure 5. Interference by Symptom by Group 
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than NTD (t(47) = 3.99, p = 0.00). Across all sub-scales, NTP had significantly lower 
scores than NTD (Table 8).  
Autism Spectrum. In contrast to NT group, there was strong agreement between 
ASD and ASP groups for SCARED scores. There were no differences between AS 
parents and daughters on the summary score or any of the sub-scales (Table 8).  
Table 8. SCARED Scores by Group 
 NTD 
(n = 48) 
NTP 
(n = 48) 
Significance ASD 
(n = 34) 
ASP 
(n = 34) 
Significance 
Summary 
Score 
24.73 ± 
17.20 
 
15.75 ± 
14.60 
t(47) = 3.99 
p = 0.00* 
28.34 ± 
15.19 
 
26.28 ± 
17.78 
t(31) = 0.82 
p = 0.42 
Panic 5.29 ± 5.42 2.52 ± 4.05  t(47) = 3.72 
p = 0.00* 
5.81 ± 4.99 4.91 ± 5.72  t(31) = 1.95 
p = 0.30 
Generalized 
Anxiety 
7.52 ± 5.40 5.19 ± 4.93 t(47) = 3.24 
p = 0.00* 
8.22 ± 5.27 7.91 ± 5.30 t(31) = 0.47 
p = 0.64 
Separation 
Anxiety 
3.33 ± 2.96 1.77 ± 2.37 t(47) = 3.77 
p = 0.00* 
4.49 ± 3.14 4.28 ± 4.30 t(31) = 0.27 
p = 0.79 
Social 
Anxiety 
6.23 ± 4.49 4.63 ± 4.35 t(47) = 2.46 
p = 0.02* 
7.63 ± 4.44 7.09 ± 4.34 t(31) = 0.69 
p = 0.49 
School 
Avoidance 
2.35 ± 2.07 1.65 ± 1.67 t(47) = 2.73 
p = 0.01* 
2.22 ± 1.93 2.09 ± 1.89 t(31) = 0.40 
p = 0.69 
 
Discussion 
 Parents from both Neurotypical and Autism Spectrum populations in our study 
proved to be accurate and reliable reporters of daughters’ AAM when compared to 
daughters’ self-report. While there were no significant differences observed in AAM 
between NT and AS groups, participants with ASD reported slightly earlier AAM, 
experiencing menarche approximately four months earlier than their NT peers. Of note, 
significantly more AS parents and daughters reported AAM that met criteria for Early 
Menarche compared to NT parents and daughters; however there were no differences in 
those meeting criteria for Late Menarche. As menarche is such a significant life event for 
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adolescent females, it is not surprising that they choose to disclose the event to their 
parents and that it is remembered accurately by both parties. This study establishes that 
parents are accurate reporters of their adolescent daughters’ AAM. 
Daughters from both AS and NT groups reported characteristics of the menstrual 
cycle within the normal range for adolescents, with cycle lengths averaging 27.5 to 30.6 
days (normal range for adolescents: 20-45 days; ACOG Committee on Adolescent Health 
Care, 2006; Adams Hillard, 2008), period lengths between 6 and7 days (normal range for 
adolescents: 3-7 days; ACOG Committee on Adolescent Health Care, 2006; Adams 
Hillard, 2008) and moderately heavy menstrual flow with clots for the majority of 
participants. Parents of both AS and NT participants reported shorted cycle lengths for 
their daughters and significantly shorter period length, underestimating period length by 
approximately half a day. Parents of both groups were in agreement with their daughters 
on regularity of cycle and heaviness of flow, but underreported presence of clots. These 
findings may be due to the shared responsibility verses sole responsibility of managing 
menses. For the majority of adolescent females, some activities of managing menses, 
such as changing pads, are the sole responsibility of the daughters, which gives parents 
less opportunity to observe more nuanced details of the menstrual cycle, such as presence 
of clots. However, some activities, such as purchasing sanitary products, are shared 
responsibilities between the daughter and parent. Frequency and use of sanitary products 
is a good estimate not only of the length and regularity of the menstrual cycle (i.e., how 
often the daughter is requesting more sanitary products), but also the heaviness of flow 
(i.e., how many sanitary products the daughter uses per day or per cycle). This shared 
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versus sole responsibility of managing menses may contribute to the differences observed 
in parent- versus self-report of characteristics of the menstrual cycle.  
 In reporting menstrual symptoms, some interesting differences were observed 
between parent- and self-report across the AS and NT groups. While NTP underestimated 
menstrual symptoms in their daughters, from level of pain to number of symptoms across 
all symptom categories, ASP did not follow this same pattern in reporting on their 
daughters’ menstrual symptoms. Notably, ASP reported more OTC pain medication use 
and greater effectiveness in treating menstrual pain than their daughters did. They also 
reported that their daughters experienced more pre-menstrual symptoms, symptoms of 
dysmenorrhea and emotional menstrual symptoms than ASD self-reported. It may be that 
parents of daughters with Autism Spectrum Disorder are more attuned to their child’s use 
of medication, given the use of both OTC and prescription medication in the population 
(Aman, Lam, & Collier-Crespin, 2003). As individuals with ASD have demonstrated 
differences in perceiving and reporting pain (Allely, 2013; Moore, 2015; Yasuda et al., 
2016), it is plausible that females with ASD have difficulties interpreting menstrual 
symptoms, such as cramping or bloating, as pain or discomfort to then report to their 
parents or self-report on a questionnaire. Parents may perceive shifts in mood or 
engagement and, knowing that their daughter is menstruating, attribute that change to 
menstrual pain or menstrual symptoms. This hypothesis may be further supported in 
considering AS to NT report for the top menstrual symptoms; more ASD reported the 
presence of cramping pelvic pain and change in mood just before a period than NTD, 
whereas fewer reported the presence of all other top menstrual symptoms. Cramping is 
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perhaps the most well-known and frequently discussed menstrual symptom among 
adolescents; females with ASD may be reporting presence of cramping in preference over 
other symptoms because it is (1) recognizable, (2) an accepted symptom of menses, and 
(3) because of sensory perception differences, they may have difficulties interpreting or 
translating the physical and sensory experience to lay or clinical terms. 
 In considering the impact of menses on the daughters’ activities of daily life, 
parents from both NT and AS groups broadly reported similar impact as their daughters, 
with a few key differences. NTP were accurate reporters of the frequency, length and 
rationale of missed school due to menses, whereas more ASP reported that their 
daughters missed school more frequently and for fewer days, and for different reasons 
than ASD reported. Parents from both groups reported more interference of menses in 
attending school, relationships with family and relationships with friends. AS parents 
reported more interference of menses across all activities and for all symptoms than their 
daughters, expect for level of interference due to menstrual pain, whereas NT parents 
reported less interference of menses across activities and symptoms. This may simply 
reflect ASP perceptions that their daughters’ menstrual cycle disrupts the normal life of 
daughter and the family, or perhaps that they observe a true increase in disruption 
surrounding the menstrual cycle than their daughters, who may have difficulties 
perceiving these changes due to the impairments of ASD.  
 In sharp contrast to the similarities observed between self- and parent-report on 
menses, NTP reported significantly lower scores on the SCARED than NTD on the 
summary score and across all sub-scales. No differences were observed between ASD 
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and ASP groups on the SCARED. While mean scores for NTP and NTD did not meet the 
cutoff score for presence of an anxiety disorder, NTD fell just shy of this mark, 
demonstrating an atypically high rate of anxiety for a Neurotypical control group. Nearly 
48% of NTD met this cut off, compared to 53% of ASD. The prevalence of anxiety in the 
ASD population is commonly held to be approximately 40% (range 11-84%; White, 
Oswald, Ollendick, & Scahill, 2009), compared to 18% of the Neurotypical population 
(Kessler, Chiu, Demler, & Walters, 2005). Considering that nearly 75% of the NT group 
reported a diagnosis of ASD in a sibling of the daughter, it is likely that this group 
represents an “atypical” control group and may have greater risk of mood disorders.  
 This study is the first to compare self- to parent-report of AAM, characteristics 
and symptoms of the menstrual cycle across Neurotypical and ASD populations and is 
the first to utilize an adolescent sample from the ASD population. However, with the 
prevalence of intellectual disabilities approximately 40% (Christensen, 2016; Werling & 
Geschwind, 2013), adolescent females with a diagnosis of ASD who are able to 
participate in studies such as this one represent a narrow target population and it is 
unsurprising that the study faced difficulties in recruitment that led to the small sample 
size. Congruent findings may have been due to the clear topic of the study; while 
participants were asked to report from their own point of view and parents reminded not 
to confer with their daughter on responses, the study was clearly stated to be on menarche 
and menses, which may have triggered discussions between parent and daughter prior to 
participation that may have improved congruency in report. Further, given the 
discrepancy between parent and daughter report of anxiety symptoms for the NT group, 
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which was not highlighted as a main component of the study, discussion prior to 
participation is probable. Given that the experience of menarche was relatively recent 
(daughters were on average 2.3 years post-menarche), it is possible that parents are more 
familiar with their daughter’s cycle during these early menstrual years as they are more 
active in managing their daughter’s cycle, helping them to assume the responsibility of 
menstrual management, and adapting to their changing bodies. In a free response section 
at the end of the study, some AS parents reported assisting their daughter through the 
questionnaire and discovered that their daughters reported symptoms they had hitherto 
not been aware of, as well as learning that their daughters were unfamiliar with a number 
of common menstrual symptom terms, such as bloating. While this did provide an 
opportunity for the parents and daughters to discuss these points, it may also have 
impacted both the parents and daughters reporting of symptoms.  
This study demonstrates that parents are accurate reporters of AAM, and 
moderately accurate reporters of the characteristics and symptoms of their daughters’ 
menstrual cycle. Further, these findings suggest that parents may be used as reliable 
proxy reporters for issues of gynecologic health of daughters who may be unable to self-
report symptoms. While many of the findings reported here were non-significant, the 
trends observed between parent- and self-report in both NT and AS groups help to 
elucidate the highly individual and personal experience of menses that may not always 
lend itself well to report from one outside the experience. Finally, these results both 
strengthen and clarify previous findings on this subject that have utilized parent-report.  
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Abstract 
Living with an Autism Spectrum Disorder (ASD) presents challenges across the lifespan. 
For young women, puberty is often a period of significant social, physical and emotional 
upheaval. This time can be particularly challenge for young women with ASD. Through 
semi-structured interviews of parent-participant dyads, we sought to understand the 
experiences of these young women as they navigate periods and puberty. Participants 
discussed several themes, including education and preparation for puberty, the physical 
experience of menses, speed bumps on the road through puberty, managing the everyday, 
and looking to the future. This study underscores the unique and varied experiences of 
puberty for females with ASD, and the importance of qualitative research in moving 
towards a holistic understanding of adolescence for these young women. 
Keywords: Autism Spectrum Disorder, Females, Puberty, Menses, Qualitative, Semi-
structured Interviews 
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Introduction 
Background 
Autism Spectrum Disorder (ASD) is a chronic neurodevelopmental disorder 
manifesting in early childhood that is characterized by impairments in social 
communication, restricted interests and repetitive behaviors (American Psychiatric 
Association, 2013). Though a substantial literature base on the disorder has been 
published since it was first described by Leo Kanner in 1943 (Kanner, 1943), the majority 
of research to date has focused on the presentation of the disorder, possible underlying 
etiology, the early childhood experience and interventions (Matson & LoVullo, 2009), 
leaving the life-course trajectory of those with ASD relatively poorly understood. For 
females, who represent approximately one fifth of those with ASD (Christensen, 2016), 
this deficit is compounded by omission and exclusion from research on the disorder due 
to historical belief that autism occurs only in males, their minority status in the autism 
community, and study design limitations (Shefcyk, 2015). This exclusion has had 
significant ramifications, from a poorer understanding of the manifestation of ASD in 
females (Halladay et al., 2015), to delayed diagnoses (Begeer et al., 2013), and lack of 
support and targeted intervention for females as they age (Shefcyk, 2015). 
Research directed towards understanding puberty in females with ASD is in its 
infancy. A handful of studies over the past 10 years have begun to highlight differences 
in timing of menarche and presentation of women’s health issues, reporting increased 
rates of precocious puberty (Pohl et al., 2014), primary amenorrhea (Ingudomnukul et al., 
2007; Knickmeyer et al., 2006), painful and irregular menstrual cycles (Ingudomnukul et 
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al., 2007; Pohl et al., 2014), as well as polycystic ovarian syndrome within this 
population (Ingudomnukul et al., 2007; Pohl et al., 2014). Yet the experience of puberty 
for these young women, what it’s like to live where these two phenomena meet, is 
strikingly absent from the literature. Only Cridland et al’s exploration of the experiences 
of adolescence for females with ASD, notable as the only qualitative study in the field, 
briefly touched upon puberty and related issues (Cridland et al., 2014). Their study, 
drawing only from mothers of females with ASD, reached the conclusion that menarche 
and menses were largely unremarkable. While this study omitted the voices of the 
adolescents themselves on this issue, representations from those at the core of the issue, 
both parents and daughters, are crucial for reaching a more complete understanding of 
puberty in females with ASD.  
Statement of the Problem 
 Puberty represents a significant life event for all human beings. The social, 
physical, and emotional changes of this period impact an individual’s health across the 
life span. In conjunction with the behavioral and interpersonal impairments associated 
with ASD, puberty and adolescence may present challenges to those on the Spectrum that 
are as diverse and challenging as the disorder itself. Little is understood about menses in 
this group and as a result there are few, if any, targeted interventions to support young 
women with ASD through this transition. Many important questions remain unanswered: 
What do they face as they progress through puberty? Who is there to support them? How 
do puberty and ASD interact to shape their experience of adolescence?  
Purpose of the Study 
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A thorough understanding that accounts not only for the presentation of puberty, 
but also the experiences and needs of these women as they perceive them, is currently 
lacking, yet fundamental. In order for practitioners at all levels to provide safe, 
appropriate and accurate education and health care to these women, their voices must first 
be heard. The Autism community has been outspoken in recent years, calling for 
increased attention to the experiences of individuals with ASD across the lifespan (Bölte, 
2014). Accordingly, this study, the Facing Puberty Study, sought to understand the 
phenomenon of puberty for females with ASD through a mixed-methods approach. The 
study team employed descriptive, web-based questionnaires and semi-structured 
qualitative interviews with daughter and parent dyads. The study sought to gain a deeper, 
grounded understanding of puberty and the early adolescent years for these young women 
and their families through their own voices and stories.  
Methods 
Design and Approach 
 This paper represents the Qualitative Phase of the Facing Puberty Study, an 
explanatory sequential mixed-methods study addressing the onset, presentation and 
experience of puberty for females with ASD and their families (see Chapter 1 for more 
detail). Eligible participants for the study were females with a diagnosis of Autism 
Spectrum Disorder (including Autistic Disorder, Pervasive Developmental Disorder- Not 
Otherwise Specified, and Asperger’s Syndrome), under the age of 18 years, who had 
begun menstruating, with at least one menstrual cycle in the previous six months, able to 
read English at a 4th grade level. Additionally, we interviewed one parent of each 
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participant who met the inclusion criteria. In this phase of the study, the principle 
investigator interviewed parents and daughters about the daughters’ experience with 
menses, puberty and adolescence. Parents’ experiences were sought in addition to their 
daughters, as parents have unique perspective and insight into the issues of puberty, and 
may have been able to provide clarification to illuminate their daughters’ experiences 
through triangulation. 
This study is rooted in the constructivist philosophy, which strives to understand 
phenomena through participants and their subjective views (Creswell & Plano Clark, 
2011). The experience of menses and puberty is one that is highly subjective, lending 
itself to exploration through qualitative methods in this philosophy. Following in the 
Constructivist philosophy, the qualitative descriptive approach of thematic analysis was 
used to interpret and organize data from the semi-structured interviews (Braun & Clarke, 
2006; Vaismoradi, Turunen, & Bondas, 2013). Thematic analysis is a flexible qualitative 
tool, which provides a nuanced, thick and detailed account of the data across a set of 
interviews (Braun & Clarke, 2006; Morgan & Zhao, 1993).  
Data Collection 
This study was approved by University of Pennsylvania’s Institutional Review 
Board. Participants were recruited primarily through two Autism research databases, 
autismMatch in Philadelphia, PA and the Interactive Autism Network (IAN) in Baltimore, 
MD. A study summary was available on the autismMatch website with a link to the study 
website. IAN emailed eligible families within their registry with the study summary and 
website to notify them of the opportunity. Interested participants visited the study website 
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to review aims and consent (parent) or assent (daughter) to participate as appropriate. 
While both participants with ASD and Neurotypical control participants completed the 
online questionnaires that comprised the Quantitative Phase of the study, only those with 
ASD and their parents were eligible for selection to participate in the semi-structured 
interviews that comprised this study. After the Quantitative Phase of this study (discussed 
in Manuscripts 1 and 2) had reached 50% target recruitment, 15 parent-participant dyads 
were selected by the researcher and invited by email to schedule the interviews. Emails 
included a review of the interview structure and potential discussion topics. Of these, 
nine of the fifteen dyads responded to the email invitation and participated in the 
interview phase of the study. A second round of participants were selected and invited to 
participate, of these two dyads responded and one dyad participated, resulting in a final 
sample of 10 dyads or 20 participants (10 parents and 10 daughters). All interviews were 
conducted between May 11th and June 13th, 2016. 
Interviews were conducted, in person (one dyad) over the phone (eight dyads) or 
via Skype (one dyad) based on participant preference and geographic access. Participants 
interviewed over phone and Skype were asked to find a quiet location for the interviews 
and to have a clear two hour window of time so they would not be disturbed or feel 
pressed for time during the interviews; the in-person interview was conducted at a quiet 
location of the participants choosing. Parents and daughters were interviewed 
individually, though allowed to be present and participate during one-another’s 
interviews. Some dyads used this alternative arrangement, with the parent present in the 
daughter’s interview to support, facilitate and clarify when necessary (four dyads), or the 
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daughter present in parent’s interview to gain a better understanding of the topics to be 
discussed and structure of the interview (three dyads). Interviews began with a word 
association exercise (“What things come to mind when you think about 
puberty/periods?”) allowing the participants to ‘warm-up’ before the semi-structured 
interview. Semi-structured interviews are designed to promote flexibility, allowing the 
researcher to follow the participant’s response and direction for maximization of valid, 
detailed data (Smith & Osborn, 2008). Prompts were available to stimulate dialogue, with 
clarifying questions asked by the researcher if necessary (Appendices J and K). 
Participants were encouraged to freely discuss their experiences with adolescence and 
puberty; no attempts were made to influence a participant’s answers. On average, 
interviews with dyads lasted for 45 minutes (range 36-70 minutes). Participants were 
given a $25 gift card as compensation. All interviews were recorded for transcription. 
The interview guides were informed by the literature and developed with input from 
mentors and experts in the field. Following guidelines for iterative refinement of the 
interview guide, early interviews were reviewed and the guide was adapted and 
supplemented as topics emerged from the first two completed interviews and the guide 
was reviewed again following the eighth interview, with no additions or modifications 
made at that time (Kvale & Brinkmann, 2009).  
Data Analyses 
All interviews were transcribed verbatim and uploaded to NVivo 11 (QSR 
International Pty Ltd, 2012), a software program used to manage qualitative data and 
facilitate analysis. Data collection and analysis were conducted simultaneously to allow 
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the researcher to determine the point of saturation (that is when no new information was 
being garnered from the interviews) in order to determine the need to recruit additional 
participants. Based on a review of the preliminary data analysis, the team determined that 
no more than ten parental-daughter dyads were needed (Crabtree & Miller, 1992; Glaser 
& Strauss, 2009). Detailed data analysis was subsequent to completion of data collection. 
The author conducted all interviews and transcribed the audio-recordings verbatim, 
furthering familiarization with the data.  
As no studies have previously addressed the interaction of puberty and ASD in 
females through qualitative methods, an inductive approach to code book development 
was employed (MacQueen, McLellan, Kay, & Milstein, 1998). That is, the PI and mentor 
open coded a selection of transcripts (Braun & Clarke, 2006; Hsieh & Shannon, 2005). 
Each code was given an explicit definition to ensure coding accuracy and to improve 
intercoder reliability (Crabtree & Miller, 1992; Glaser & Strauss, 2009). Codes were then 
refined and cross-checked with the author’s expert committee until consensus regarding 
definitions was reached. Themes emerged from codes and were reviewed, defined, and 
named following Braun & Clark (2006) thematic analysis process.  
Preliminary Results 
Participants 
Selected parent-participant dyads were drawn from the Quantitative Phase of the 
Facing Puberty Study. Participants were selected using purposive sampling to achieve a 
heterogeneous group on (1) age at menarche, (2) ASD diagnoses, (3) age, and (4) race 
and ethnicity. All parents participating were mothers, with the majority married (n = 9) 
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with Bachelor’s degrees or higher (n = 8). Daughters participating were between the ages 
of 13 and 16 years old, predominately Non-Hispanic White (n = 7), and in high school 
classroom setting (Typical Classroom = 5, Home Schooled = 2, Special Education = 2, 
Unknown = 1). Dyads were all located in the United States; the majority of parents 
reported an annual income of greater than $60,000. Please refer to Table 1 for more 
detailed information. Participants are referred to by numbered “parent” and “daughter” to 
protect privacy.  
Table 1. Demographic Information of Participants 
Daughter 
(Age) 
Ethnicity 
& Race 
ASD 
Diagnosis 
Age at 
Diagnosis 
Age at 
Menarche 
Co-
Morbidity 
Sibling 
with ASD 
Mother 
(Age) 
Daughter 1 
(14) 
Non-
Hispanic 
White 
PDD-NOS 2.67 years 11.85 years 
 
Allergies, 
Anxiety, 
Asthma 
Migraines 
Unknown Parent 1  
(44) 
Daughter 2 
 (15) 
Hispanic, 
Asian 
ASD 12 years 12.64 years Allergies, 
Asthma 
No Parent 2 
(45) 
Daughter 3 
(14) 
Non-
Hispanic 
Native 
American 
Autistic 
Disorder 
10 years 9.52 years Allergies, 
Asthma, 
Migraines 
Yes Parent 3 
 (45) 
Daughter 4 
(16) 
Non-
Hispanic 
White 
Asperger’s 
Syndrome 
2.5 years 12.41 years Anxiety, 
Depression 
No Parent 4 
(50) 
Daughter 5 
 (15) 
Non-
Hispanic 
White 
Autistic 
Disorder 
15 months 9.94 years None Yes Parent 5  
(51) 
Daughter 6 
 (13) 
Non-
Hispanic 
Native 
American 
& White 
Asperger’s 
Syndrome 
5 years 12.07 years None No Parent 6 
(51) 
Daughter 7 
 (14) 
Non-
Hispanic 
White 
Asperger’s 
Syndrome 
6 years 12.95 years Anxiety No Parent 7 
(43) 
Daughter 8 
 (16) 
Non-
Hispanic 
White 
ASD 8 years 15.04 years Anxiety No Parent 8 
(46) 
Daughter 9 
(14) 
Non-
Hispanic 
White 
PDD-NOS 4.5 years 13.6 years None No Parent 9 
(49) 
Daughter 10 
 (16) 
Non-
Hispanic 
White 
Asperger’s 
Syndrome 
9.25 years 14.1 years Anxiety, 
Depression 
No Parent 10 
(43) 
* ASD = Autism Spectrum Disorder, PDD-NOS = Pervasive Developmental Disorder-
Not Otherwise Specified 
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 Codes were organized into six thematic categories, 1) Preparations for Puberty, 2) 
Physical Experience of Menses, 3) Speed Bumps on the Road through Puberty, 4) 
Managing the Everyday, 5) Looking Forward, and 6) Reflective Advice. While the 
thematic labels do not necessarily correspond to exact phrases used by the participants, 
they were selected by the researchers to conceptualize and summarize the issues reflected 
within each theme. Participants’ thoughts and experiences were diverse across the themes 
identified and many of the themes had bridging elements to one another. This analysis 
seeks to review the highlights and key findings from this phase of the study. Summative 
statements for these themes are followed by supportive quotes. Quotes have been lightly 
edited for clarity and edits are noted by [brackets]. Responses from daughters are 
presented first, followed by parents, to showcase the distinct and at times conflicting 
experiences expressed by the parent and daughter.  
Preparations for Puberty 
Daughters shared a variety of experiences in getting ready for puberty and 
menarche, including learning about the changes that were to take place from their parents 
and at school. 
“We did like a little separation thing [where] boys went with boys, and girls went 
with girls. And, I remember it was like 5th grade, something like that. And, [the 
teacher] was like ‘Oh, you have to use pads!’ and she showed us this video. Then 
in like 8th grade we were supposed to switch, so the boys went to girls and the 
girls went to the boys, but we didn’t do that. I was just a little bit wondering. I 
was wondering if boys had something like periods, or something like that.” 
Daughter 1 (14) 
“I learned it from my parents. I had like ‘The Talk’ when I was about six. We’re 
always very open, so I learned about, like, bodies and how they work normally. Er, 
not normally, but just sorta, when I asked a question, and there’d be no avoiding it. 
There’d be no ‘But uh… uhh… when you’re older’, no it just sorta happened. 
Sometimes during dinner, we’ll bring up like sex or something, there’s always 
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more to learn. Cause just when you think it’s over, there’s more. So that’s pretty 
much when we learn it, it just comes up in conversation.” Daughter 7 (14) 
 
Daughters explained that the onset of menarche was somewhat confusing or anxiety 
provoking and they reported be reassured by parents who provided information and 
support. 
“So I was just in the bathroom and then I saw blood and I was like ‘Mom! Mom!’ 
and she was like ‘Okay, you just started your period’ and then she gave me a pad 
to put on and that was it.” Daughter 2 (15) 
 
“I saw that there was brown stuff in my underwear and I [thought] I had like 
pooped myself, so I showed like my mom my underwear and she told me I got my 
period.” Daughter 4 (16) 
 
“Well [I was] anxious, ‘Oh, what’s gonna happen to my body?’ When I first 
started my period, I felt like ‘Oh, what’s happening?’ and ‘Why is it there?’ And, 
and my mom talked to me about it and I understand what it means.” Daughter 5 
(15) 
 
Parents also shared how they helped their daughter get ready for puberty and menarche, 
drawing from a wide variety of resources and strategies. Some mothers took lead roles in 
opening the conversation with their daughters; others preferred to wait until someone or 
something else introduced the topic, for example a book or their daughter’s physician.  
“When she started to develop, you know, primary sexual characteristics or 
whatever the word is, hair and breast buds and those things, I started talking to her 
about it, you know, so that she understood what was going on with her body. I 
don’t think any child should be in the dark about that stuff. But even more so a 
child on the Spectrum needs to know that.” Parent 1 (44) 
 
“I think the thing that worked out best for us is a lot of education. We got our 
education through our pediatrician, who’s a female pediatrician. Knowing that 
kids with ASD respond differently to people who are not their parents, that was 
really helpful. She responded very well to the pediatrician giving her the ‘What to 
Expect’ [talk] versus an alternative, which is me sitting down with a book and 
pictures and trying to explain it. I think it comes off differently when it’s like 
someone outside that close relationship. Then after she had that discussion, we 
talked about it here and there. I actually let her ask me questions about it, rather 
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than me initiating it, and I think that also helps. I could see how it could be very 
scary though for both the mother and child, but for me I didn’t get that feeling just 
because I had a lot of support and I had a pediatrician that took the time to spend 
time and talk about that.” Parent 2 (45) 
 
Some reported experiencing some resistance from their daughters, who appeared to not 
want to have to go through puberty or deal with menses.  
“Well I just let her know, this is what’s going to happen, this is what you’re going 
to need to do and you know this is about the time frame it happens and I would 
tell her this is a normal thing, it happens to everybody and she was really resistant 
to the idea and she wouldn’t really say much, sometimes she would say ‘Oh that’s 
not going to happen to me’. I did bring it up a lot and talk to her a lot, just so even 
though she wouldn’t talk back to me about it, at least on some level of 
consciousness she did know this is going to happen, so it wasn’t a complete 
surprise to her.” Parent 10 (43) 
 
“We talked about it and when we first started, it was funny, she told me that she 
didn’t want it. But we spent a lot of time with that book [The Care and Keeping of 
Me]. As much as she would. We had to do it in little doses because she would 
totally tune out.” Parent 9 (49) 
 
Physical Experience of Menses 
 Both parents and daughters brought up the physical experience of menses often. 
Daughters expressed experiencing some pre-menstrual symptoms, particularly emotional 
changes and mood swings.  
“[I get] like really emotional [before my period], I think. I think it’s a lot of 
emotions, mostly sad. Yeah, and irritable.” Daughter 4 (16) 
 
“I don’t like always expect [my period’s] coming, but then I’m like oh yeah, that 
makes sense cause I’ll be weirdly emotional or something.” Daughter 10 (16) 
“Just like I have a couple [days] before I get my period I’ll get like mood swings, 
but that’s kinda it.” Daughter 2 (15) 
“A few weeks before, like two weeks before I get a little bit PMS‐y. But during 
my period, I’m fine. [It’s] sadness and anger most of the time.” Daughter 6 (13) 
In contrast, parents expressed more severe pre-menstrual symptoms that had substantial 
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impacts on their daughters.  
“The hormones, the hormonal fluctuations, a week prior to her period were very 
challenging, in terms of anxiety specifically. Anxiety, moodiness, touchiness, all 
of that, seemed to be heightened. And that was, that’s on a very consistent basis. I 
mean like above and beyond typical PMS.” Parent 1 (44) 
 
“When she’s kinda close to her period, and she’ll say ‘I don’t know why I’m 
crying! I don’t know what’s wrong!’ and then I’ll be able to say, ‘Do you think 
it’s because you’re close to your period now?’ and she’ll be ‘Oh, yeah!’ But it’s 
very overwhelming for her to try and deal with those emotions. A couple days 
prior she, she might be a little bit more, sorta snappy. Nothing that, you know, 
having gone through the teenaged stuff with now five [daughters], nothing that 
what her sisters are capable of doing or we’re capable of doing. But, you know, 
for her you can definitely kinda see that she’ll do that usually when she says 
something and she’s not sure that it’s acceptable, she’ll immediately say ‘I’m 
sorry if I was attitudinal’ and ‘I don’t mean to be attitudinal’. And so, that filter 
that she sets up to check and to kind see if she’s socially appropriate or not, kinda 
goes away when she’s getting close to her period and then, usually every month, 
maybe skipping a month here or there she just has an emotional crying break 
down, and just you know, something will just go, you know, she’ll see a yellow 
jacket and that will cause an absolute melt down of crying for 45 minutes. Just 
that irrational, emotional piece.” Parent 6 (51) 
Other parents reported that their daughters experienced relatively minor or insignificant 
symptoms before menstruation.  
“[She doesn’t] have a great deal of PMS symptoms to indicate when [she’s] about 
to have it, [she’s] very regular.” Parent 7 (43) 
When reflecting on the symptoms associated with menses, daughters reported feeling 
more tired, having cramps and being a little bit more ‘on edge’ emotionally.  
 “[I feel] anxious. Sometimes I feel a little sluggish. Um, that’s it, sluggish. Um, 
well sometimes when you’re on your period you feel tired for some reason, and I 
guess when you’re on your period that just happens. Um, sometimes I feel like I 
have stomach cramps. It’s a little hurting, but it’s not like I’m like hurting a lot. 
Sometimes I feel dizzy in my head.” Daughter 5 (15) 
“[The cramping’s] not always mild. It’s actually during the end of the period 
when most of the blood has stopped, and that’s when the cramping just comes. 
It’s weird. Sometimes I can be a little off, just but not really. Uh, I feel a bit more 
tired, although that could just be me. I don’t know. I feel less mobile, cause the 
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underwear I find very restricting and pad very restricting, which is kind of 
annoying. I know that I don’t sleep as well, because you know I, I take melatonin 
to get to bed, I’ve got insomnia issues, I don’t sleep very well, but when I wake 
up, instead of drifting back to sleep, I know that I have to go and I have to change 
my pad and by then I’m so awake I know I’m not going to get back to sleep for 
another hour or so, so that could be why I’m more tired, I don’t know.” Daughter 
7 (14) 
“[…] I’m always tired. I sleep about the same at night and take naps during the 
day as well, and it’s kind of emotions are much higher and [I feel] sore, tired. The 
blood area, things that are tearing themselves apart. Sort of the emotions are much 
higher, like one of those times I just end up crying and I’m like ‘What’s wrong?’ 
and I’m like ‘I don’t know, just like leave me alone for a while, it’ll get better.’ [I] 
just end up crying for no particular reason, not even feeling like upset or anything, 
just couldn’t stop crying. Now [it’s] not as often, it’s more like hey, I’m feeling 
happy, and now I’m not feeling happy. Mood swings, I guess you would call it.” 
Daughter 10 (16) 
“It doesn’t really feel [like] anything, just like on the second day or third day I’ll 
start getting cramps but like, that’s kinda it. I tend to get moody, just like I have a 
couple days like before I get my period I’ll get like mood swings, but that’s kinda 
it.” Daughter 2 (15) 
Parents shared similar thoughts, telling stories of increased emotional sensitivity and 
difficulties in expressing emotions.  
“She can be a little moody. Sometimes it’s just like, you, you try to just tell her, 
‘You need to go do this’ she could just freak out and start crying. And her daddy, 
he could say boo to her and she’ll start crying.” Parent 5 (51) 
 
“She’s definitely moodier. But, I do think, you know, it’s hard for them to explain 
that.” Parent 9 (49) 
“I think what’s the hardest piece for her is the emotional piece. I don’t know that 
she can identify that that’s where it is, but that’s where she seems to be the most 
uncomfortable. And the most unsure, I mean you add the hormones on to 
whatever’s going on and all of us, it kind of [overwhelming]. But I think that’s 
where she has the most trouble coping with her period is the emotional piece, 
because she’s really, really good at keeping her emotions kind of in check, and I 
think she feels kinda overwhelmed by them when she’s on her period. Just from 
my outside view. I think in this area at least of her life, um, I think the biggest 
issue for her is the hormones and the emotions make her uncomfortable. I think 
she can handle the pain, and I think that she feels, that she hates how she feels, 
with not being able to control her emotions the way she wants to. So, you know, 
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grain of salt there.” Parent 6 (51) 
Others didn’t see substantial change in their daughter across the menstrual cycle.  
“It’s just kind of surprising, because I thought she pretty much didn’t have 
symptoms, but then when we were filling out the questionnaires she was saying 
that she would feel symptoms, like she would start feeling, like she didn’t know 
what the word ‘bloated’ was, but she felt kinda yucky and sad, you know. She’s 
mentioned that she’d start feeling a little irritable and cranky and all that. So I 
didn’t see any of that, but she reported that she did. But as far as from a mother’s 
point of view um, I don’t see anything at all, I um, expect just her anxieties that 
it’s coming. She would really like me to be able to tell her it’s gonna start on 
Tuesday at 9am, that would be really, really great for [her]. I said it doesn’t work 
like that.” Parent 8 (46) 
Parents also expressed their impressions of how their daughters experienced and 
communicated menstrual pain. 
“For someone who has sort of extreme sensory issues with any kind of touch, it’s 
interesting her pain threshold is actually really high.” Parent 7 (43) 
“[…] she does have a very high pain threshold. Yeah. I think she experiences less, 
but it’s hard to say how much of that is a communication [thing], you know, not 
telling me about it, versus not feeling the pain. Um, I think that the sensory, the 
pads, the feel of the pad bothers her more than the pain. So in that case, I mean I 
would say that her pain threshold is definitely higher than typical.” Parent 1 (44) 
“As soon as she starts, I get a phone call from her school that she need pain meds. 
And it’ll even be, this last month she had started and I asked her if she wanted to 
take some Motrin or Aleve as we’re leaving and she has access to it and she said 
no, by the time she got in to the school building and I wasn’t even out of the 
parking lot I was getting a call from the school personnel asking to give her 
medication. So it’s really, she has a really hard time, predicting and gaging when 
she’s going to need something, whether it’s um being able to kinda predict her 
periods a little bit so she doesn’t link, or being able to understand that when she 
has a period, she gets cramps and she needs to almost pre-medicate to try to help 
her be as comfortable as possible.” Parent 6 (51) 
Speed Bumps on the Road through Puberty 
 Participants shared experiencing ‘speed bumps’, unexpected or challenging 
incidents, on the road through puberty. One of several ‘bumps’ identified by both 
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daughters and parents were menstrual accidents. Daughters spoke of accidents as a by-
product of irregular or heavy menses. At times accidents could be embarrassing, but 
some identified strategies to prevent their occurrence.  
“I had like really, really heavy flow and I never knew when I was going to get it, 
so my underwear kept getting ruined and it kept happening when I was at school, 
so I was always afraid that I was gonna like, I was gonna leak and people would 
notice.” Daughter 4 (16) 
 
“Like, when I know like it’s gonna come I wear dark pants.” Daughter 2 (15) 
 
Parents described incidents when their daughters had experienced a hygiene product 
malfunction, such as miss use, use avoidance, and inability to predict when a pad needed 
changing, that led to visible spotting on clothes and ultimately left their daughters open to 
teasing or embarrassment. Additionally, this led to work for parents. 
 “I’m worried that there’s gonna be [an accident], you know. She’ll stand up and 
there’s gonna be blood, her pants are gonna be bloody. Which they have been. I 
mean they’ve called me. You know, [I worry] that she’s gonna humiliate herself 
and not really understand it. It’s hard enough as a parent watching your kid be left 
out, ostracized, but especially on that kind of front. And I don’t know that she was 
embarrassed. It was just like really a hassle I think and she just didn’t want to deal 
with it. She didn’t really want to accept that it had come and that she was having 
to deal with it. It’s really [tough] watching it from afar as a parent, like I said, the 
embarrassment of like leaking through your pants. I think I’m more [embarrassed] 
you know, I think it affects me more than it affects her. But, I don’t want people 
to look at her and judge her. ” Parent 9 (49) 
“Even recently, I’ve been dropping her off at school and I’ll see that she has a big 
bloodstain on the back of her pants and I’ll tell her and she’s just more irritated 
with the fact that she has to go home and change, she doesn’t seem to be 
embarrassed that there seems to be a stain there. Surprisingly, they have never 
called me. Quite often she does wear a hoodie, no matter what the temperature is, 
so maybe that kinda covers it up. But, she doesn’t act any differently and it 
doesn’t change her behavior really at all. I mean I just know because I find 
disgusting things in the laundry.” Parent 10 (43) 
Some parents have found that education and practice have decreased the occurrence of 
such hygiene mishaps.  
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“[She had] more [accidents] when she was younger. She hasn’t had that problem 
at all in high school. I finally talked to her. She had an aid in middle school, and I 
told the aid, ‘Can you make sure that she goes to the bathroom?’ And she did. 
And things got better.” Parent 5 (51) 
 
“She’s more worried about leaking, and so she will at times, we’ve discussed, you 
know I’ve found her wearing up to three pads at a time, and so we talked about 
how instead of doing that I could get like overnight pads, you know there was a 
different product, and so that helped. It was more of an anxiety about having an 
accident or leakage, than comfort. I was kind of surprised how she could walk 
around with three pads! Would’ve drove me nuts!” Parent 8 (46) 
“A lot of it for [her] is awareness, and so now that she’s aware that ‘Whoops! You 
can have an accident’, or you could like have it through your clothes, um she’s 
more conscientious of what she wears, what color she wears or sitting on towels 
during like a heavy day. She does that all by herself now, I don’t have to do that. 
And I’ve noticed too, even in her bed, I don’t have to lay a towel out as much as I 
used to, she still likes me to do that underneath her sheets, but I haven’t [been] 
honestly quite as diligent as I used to be because the accidents and just less and 
less. So it was just a matter of getting it on just right.” Parent 2 (45) 
Sensory differences also appeared as another ‘speed bump’. For daughters, sensory 
difference played a strong role in selecting hygiene products.  
“Well, I like the thin pads. I like the pads that don’t feel like nothing, like 
nothing’s there. Those I like. I don’t like the really thick ones and are saying like 
‘Oh! We’re here!’ like the really thick ones. That bugs me.” Daughter 1 (14) 
Parents also spoke about challenges in finding and using the right feminine hygiene 
products, as well as problems with finding the right undergarments for their daughter.  
“The biggest problem we have is trying to find pads that she can tolerate. Cause 
she’s very, she has a lot of sensitivities to materials, so just trying to find the right 
pads that she can tolerate the feel of. Because if [she] doesn’t like the way they 
feel, the material on them irritates her and bugs her, the sensation, you know the 
feel of it. So, she will just keep changing her underwear. And so, that’s the 
biggest struggle we have now is reminding her that she has to use pads.” Parent 3 
(45) 
 
“At first she didn’t want to use feminine products, so that was not good, but I 
convinced her that she had to, that’s just what you have to do. And then initially, 
probably I don’t know the first four or five months, she would hide her used pads 
in a drawer in her room rather than put them in the trash. I mean I would talk to 
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her about that and explain that this isn’t what we do, you know and why are you 
wanting to save them and she never, never would say and she just kept doing it 
and it finally took other people telling her that wasn’t acceptable, I actually asked 
various extended family members to talk to her too.” Parent 10 (43) 
 
“[She] doesn’t like underwear at all, so she doesn’t wear it unless she has a period. 
And that was very concerning for me, that [she] up until her period, how she 
would deal with it, not only having the pad, but also have to wear underwear.” 
Parent 7 (43) 
“She won’t [wear bras]. It’s all the sensory stuff: the shaving, the straps on a bra. 
So, at one point, I’m like ‘You have to wear something. You cannot just wear a t-
shirt.’ And she doesn’t have large breasts or anything like that, but. So, we go to 
look, search for tank tops, you know just like little pull on tank tops that have no 
buttons, no shelf, no nothing. Right now we use just those little cammies, [they] 
don’t even have the built in bra cause she doesn’t like that either.” Parent 9 (49) 
The last ‘speed bump’ identified by parents was their daughters’ resistance or disinterest 
in using tampons. Some parents vocalized feeling that using a tampon would make 
menses easier for their daughter, in terms of reducing accidents and promoting activity, 
but worried about whether their daughter would appropriately use them.  
“I don’t think she’s old enough for tampons and I don’t know if she’d tolerate 
tampons anyway. Or if she’d change them often enough, which would then be a 
health risk.” Parent 3 (45) 
 
“We haven’t even approached the topic of tampons. And I’m not sure when we’ll 
ever be able to reach that, but uh, little baby steps. She does Special Olympics 
here and um, they have swimming and they really wanted [her] to participate in 
swimming, but my concern was that she would not be able to swim during certain, 
you know if she had her period and they have meets and games and her period is 
due during the big game. So, I didn’t feel like she wanted to even really discuss 
tampons, I just kinda broached it and told her about it and she said ‘Uh-uh, no 
way, not gonna do it.’” Parent 8 (46) 
 
“I’m frustrated that she’s so rigid. She won’t. I tried to show her. I mean there are 
a lot of videos and they’re pretty funny on YouTube about using a tampon. And, 
you know. You can use it. If you have a tampon you can actually go swimming in 
the summer. And she picks the pads that she wants. And like she said, she really 
likes the big ones. This, this giant purple wrapped Always thing. It looks like half 
a diaper. Umm, and there were days that, [the pad is] obviously an overnight thing, 
but she would wear that thing to school because it was the only thing that was 
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keeping her from going through her pants. You know like even [with] tampons, it 
would make your life so much easier. But, she just doesn’t care. So, I’ve tried 
different things. Especially with the tampon, that didn’t get me anywhere. I think 
the sensory [thing is an issue]. I think the thought of her sticking something in her 
is just beyond what she can deal with. I think her sensory stuff plays into the 
tampon thing.” Parent 9 (49) 
 
Managing the Everyday 
Parents and daughters reported many different experiences in managing menses, 
possibly reflecting different stages the girls were in post-menarche. Those who were 
further from the onset of menarche, and consequently had more practice, appeared to be 
more appropriately and effectively managing their menses. Several of the daughters 
shared using a calendar or an ‘app’ on a phone or tablet to track their periods. Parents 
explained that the use of a method to track their periods gave the daughters ownership of 
their periods and allowed them to plan more effectively.  
“We have like this special app that helps us know, so we can be prepared. Have 
all the, the stuff ready, like the pads and the stuff that we need for periods. […] I 
like that it tells you like when your periods gonna start.” Daughter 1 (14) 
 
“Well, I put like the first day it starts and the last day it starts and I have like this 
period calendar so that way it can tell you when your next period is gonna come, 
so I use that a lot.” Daughter 2 (15) 
 
Other daughters were able to predict when their periods were going to start on their own 
and used other methods for getting ready.  
“I just put on a back up pad. That’s easy. I always wear dark pants. No matter 
what’s the situation, I just wear dark pants cause dark pants are the only pants that 
I have. Just put a little dot on my calendar when my period starts and that’s it.” 
Daughter 6 (13) 
“I can sort of sense it, I can, like I don’t count every week, but I can sort of be like 
‘Oh, it’s been a while, my period’s probably coming soon’ and I don’t like, and I 
can just sort of sense, I don’t know why, you can just sort of sense, just feel it 
coming. I can just, around the time, cause I ovulate quite a lot, like almost, like 
only a week after my period ends I start ovulating, and I do it for quite a while, so 
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around the time that that ends, I know my period’s about a week away.” Daughter 
7 (14) 
Parents shared playing an active role in helping their daughter manage their menses, with 
some explaining that they transitioned to a more hands-off role as their daughter matured 
and became more comfortable and capable of taking on sole responsibility. 
 “I do [track her period] on like a little calendar on my wall, I’ll track them that 
way, but you know some times I forget to check off the days on the calendar and 
don’t realize, you know, what day it is or that it’s coming. She always carries 
some pads with her, but a lot of times we still end up with some pretty gross 
laundry. She doesn’t act any differently and it doesn’t change her behavior really 
at all. I mean I just know because I find disgusting things in the laundry. I’ll just 
ask her, ‘Do you have any, do you need more [pads]?’ and if there’s an obviously 
stain on her clothing I’ll tell her ‘Hey there’s a stain there, you’re going to need to 
change it’, but she just will easily make kind of a grouchy face at me and not say 
anything, just kind of ‘Ugh, fine!’ is the attitude. And if she’s running low on 
feminine products and I ask her she will tell me she will tell me, but if I don’t ask 
her she will not tell me. […] It seems like sometimes she doesn’t even accept that 
it’s happening at all. Ignores it.” Parent 10 (43) 
“Until like a year ago I would say she was still [needing help]. So she had [her 
first period] when she was like thirteen? Twelve? She was around twelve, and 
even up until a year ago, so two years plus practice, she was still needing 
guidance. It wasn’t until this last year, this last school year, that I haven’t really 
given her that much guidance. So you know, meaning cues, like ‘Have you 
changed it?’ because she was still having [accidents]. You know, she’ll sit on my 
mom’s couch and it’s like ‘Oops! There’s something there.’ That was happening 
up until about a year ago. So [I’m] still having to give her some guidance. I would 
say in terms of other girls, I wouldn’t think it would take that long, I think it does 
take longer with girls that have ASD to get that right.” Parent 2 (45) 
“I suppose because we had so much anxiety about it, that um, it’s easy because 
[she] completely takes responsibility for it, and keeps herself clean and I don’t 
really hear anything about it. Um, so it hasn’t been any drama. Um, yes, very 
independently. She might change pads a little (.) um too frequently, but I’ll take 
that.” Parent 7 (43) 
“She manages, you know even from the very beginning she has managed them a 
lot better than I initially expected. She has taken ownership of it and is very 
vigilant, almost sometimes a little too vigilant with checking her pads. So 
sometimes it’s ‘Um really? You just went to the bathroom 10 minutes ago, you 
don’t need to check again’, but she gets concerned, cause she doesn’t want 
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accidents. So [she’s] very good, very good. But then sometimes forgets like she’ll 
have her period and we’ll be out and she’s like ‘I have to go check’ and I said ‘Do 
you have any extra pads?’ and she’ll be like ‘Oh no, I didn’t bring any!’ So, with 
practice she’s gotten really good with that.” Parent 8 (46) 
Some parents shared the role that medication plays in managing both their menses and 
the accompanying symptoms.  
“I think I might have talked to her pediatrician, who referred me to a gynecologist 
that that works with girls with Asperger’s. So yeah, we went there and then she 
suggested that [oral birth control] would be the best bet because keep trying to 
keep track, I just, I don’t know, [was so] anxiety-ridden. She’s anxiety filled 
anyway, so that was just too much to have to worry about that. It’s hard to tell 
sometimes, but, she’s still irritable, maybe not to the full extent that she was 
before, but definitely still irritable. But the anxiety, about when she is gonna get 
it, you know still a little bit you know probably with weeks, so that a concern, but 
I don’t think it worries [her] like it did before.” Parent 4 (50) 
 
“I took her to the [doctors], we had to talk about it when I took her to the doctor to 
get her on the pill. Kind of explain why, why you’re taking this pill and you 
know, to make [her period] less and there are other options too to make it even 
more less. I wanted to start with this one. But you know it’s, it’s more just you 
know, just maintenance. It’s maintenance.” Parent 9 (49) 
 
“[We] actually just upped her medication of her [anxiolytic] which seems to be 
helping quite a bit, along with her [SSRI] and that has helped tremendously just 
this past month and this period, the week before was not near as difficult as it had 
been. So, when I initially got her put on medication for the anxiety and then went 
back to the psychiatrist at [care network] um, it was specifically, very specifically, 
this PMS is horrible for this child, and so then he put her on the [anxiolytic] and 
so that combination seems to be helping.” Parent 1 (44) 
 
Some parents shared that hygiene could be a challenge for their daughters, noting that 
they struggled helping their daughters understand the need for hygiene and how to 
manage hygiene related issues, while others felt their daughter had assumed the new 
responsibility well. 
“It’s just, you know, it’s kind of the whole personal hygiene thing. You and I 
really care about our hair. That we don’t smell. That’s just kind of a foreign 
concept [to her]. Ok, like taking a shower, she loves taking a shower, but it’s the 
mechanics of the personal hygiene. She will shave her armpits, but she leaves ¾ 
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of it still there. She washes her hair. But it’s like two seconds of three fingers in 
her hair and then that’s considered a wash to her. The reasons behind it, like so 
you have clean hair and you get it all out so that your hair is not greasy. And we 
wash our face so that you know it’s clean and we don’t get zits. That’s beyond the 
comprehension. Like the why we do it. […] It’s not the “this” or “that”. It’s that if 
you have clean hair, you don’t look like a slob. They’re not trying to impress 
anybody.” Parent 9 (49) 
 
“[She] is really very, very clean child and so she doesn’t like germs and messiness 
and that kind of thing, and we’re worried about getting sick and all of that, and so 
she struggles with anxiety in those areas. So how that impacts her period she is 
very quick to change her pad, which is good, but sometimes it’s a little premature 
or she worries, you know, I tell her that if it happens at night it’s no big deal cause 
I showed her, you can put a towel down, cause that’s what I did, still do it, put a 
towel down under your sheet and sleep on top of the towel and then you don’t 
mess up your sheets, and then I’ll just wash the towel and her clothes and no 
biggy, you know, no problem at all.” Parent 8 (46) 
 
Daughters felt that having periods had an impact on their daily lives, limiting their 
activity or keeping them from things they wanted to do, particularly during the summer 
when they wanted to go swimming.  
“Well tonight I was supposed to go to a pool party but I can’t cause I’m on my 
period. It makes me feel left out, but I mean … It was for like girl scouts, so I 
mean, all girls have their period. So it makes me feel left out, but there’ll be other 
times, so I think about all the other times I can go.” Daughter 2 (15) 
“[You] can’t do much with your period, like you can’t do as many activities as 
you do when you don’t have the period. Like, if I do anything like jumping or 
anything that involves more sports or something like that the blood, the period, 
just shoots out sometimes, I don’t know. Yeah. I’m so happy it’s the last day of 
my period, it’s like a ‘Hallelujah’ moment every single month.” Daughter 1 (14) 
“I feel less mobile, cause the underwear I find very restricting and pad very 
restricting which is kind of annoying. But you know, I put up with it because I 
don’t have much of a choice. […] My [sibling and friend] were going swimming 
at a public pool and I couldn’t go, cause I was having a pretty heavy day and I 
was kinda bummed out about that. But swimming is the only thing it really gets in 
the way of. Which is a problem, I mean it’s a problem sometimes, cause I love to 
swim.[…] I mean it might interfere slightly with the movies, cause that requires 
more bathroom breaks, but otherwise, not really. I go to movies a lot, there’s no 
stopping me. I love movies.” Daughter 7 (14) 
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Parents saw that periods sometimes limited their daughters’ activities beyond the play 
activities noted by daughters, but coached them on how to not let their periods 
significantly limit their lives. 
“She’s expressing concerns, like she can’t go to track practice or basketball 
because ‘I have my period’ and we talked about that you can’t stop living when 
you have your period and so you can [still] do those things, and just you know 
make sure that you’re fully prepared. If I let her, she wouldn’t have gone, but we 
made her go and then she realized that she didn’t have to let it stop her. But she’s 
more resistant sometimes when it comes to physical activity or going places, 
she’ll be like ‘Oh well, I can’t go out with you guys because I have my period’ 
and I’m just like ‘Oh well, it’s portable, so let’s go!’ So just walking her through 
that.” Parent 8 (46) 
 
Looking Forward 
Daughters spoke little about the future or what the future might hold for them. 
One participant rejected the idea of having to grow up. 
“I never wanted to grow up. But [with] puberty, I’ve already sort of been there, 
done that and I just think of growing up, and I’m only growing up physically. I 
mean I can at mature, kind of, in public, but I still love fart jokes, I still bathe with 
a thousand rubber animals, I still have my blankey which I need to fall asleep, and 
I still suck my thumb.” Daughter 7 (14) 
Others viewed growing up more objectively, seeing puberty as a process with potential 
benefits.  
“Well, once you get older you start to feel more mature, and your body’s 
changing and you start to notice something different about yourself.” Daughter 5 
(15) 
In response to a direct question included in their interview guide, parents shared diverse 
thoughts on their daughter growing up. For some, seeing their daughters overcome so 
much in the past was a source of pride and hope. 
 “You know, she’s discovered a lot of, a lot of talent with art and animation, and 
it’s become her passion, and she’s really quite good and [it’s] exciting seeing her 
making plans, you know where she wants to go to college and deciding to take 
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summer school classes so she can open up her schedule for more electives. I’m 
excited for her to see who she really is, being able to apply herself in something 
that makes her happy.” Parent 6 (51) 
Some offered conflicting feelings about what the future might hold, expressing that a lack 
of a known future was a cause for both worry and hope.  
“[My feelings are a little] mixed, because I don’t know where she’s going in life, 
but we’ve got lots of hopes. She has come so far and dealing with so much, and I 
don’t know where she’s going yet, so I have some, you know, worry, just not 
knowing what that’s going to look like.” Parent 7 (43) 
 
“[I’m] excited and scared. Excited because she’s exceeded so many expectations 
and done so well. Nervous or scared, because I don’t know. I don’t know where 
she’s gonna go. I think she’s going to do a more non-traditional path, I don’t 
know that she’ll go to college, but I know she’ll do something and so it’s just, the 
scared-ness is not knowing [what] her path is, finding her path for her. With her 
and for her, you know, getting her there.” Parent 8 (46) 
 
“She’s very intelligent for her age, I would say that she’s way above her 
classmates in book knowledge, but she’s very immature and so I worry when she 
gets out in to the world what will happen to her, and if she’ll be able to really take 
care of herself, because she does forget, I have to remind her about all sorts of 
things and, I just hope she’ll be responsible enough to live on her own and take 
care of herself.” Parent 10 (43) 
 
Parents also shared thoughts about potential future romantic relationships for their 
daughters. 
“I guess I’m somewhat relieved that that part of [her] body works too. That, you 
know, eventually she’ll be capable and able [to have children]. I mean, that’s what 
you hope for, eventually have the opportunity to have children herself. I don’t 
find it scary [and] I don’t feel fearful for her getting pregnant for anything. Some 
of that is because, maybe it’s a little naïve on my part, but I think that because of 
her level of maturity I think that’s just so down the line from now. I think that by 
the time she really wants to engage in having sex or whatever, it’s going to be 
later.” Parent 2 (45) 
 
“She told us after [a health class] that she wasn’t going to date until after she 
graduated from college and she had a good job. Well that’s a really good goal, but 
I don’t think that’s going to happen. But okay! I am concerned that the physical 
attraction and the hormones that go with that, of things becoming overwhelming 
to her, and she has impulse control issues and so on, that it could provide for just 
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some very difficult transitions.” Parent 6 (51) 
“I don’t know that she puts together having your period means that you can have 
a baby. Which, [you] need to do. And I have the books, like I said, she just totally 
changes the subject on that. So that’s why I fear things. She could [get pregnant], 
I mean. I worked at a shelter with kids [and] adults with disabilities. They have 
the urges, yet they don’t really manage them appropriately.” Parent 9 (49) 
Reflective Advice 
When asked what advice they might offer a friend going through puberty, many 
of the daughters reinforced the normality of puberty. 
“Don’t be scared, you’ll just be fine, it’s normal.” Daughter 3 (14) 
 
“Puberty happens to everyone, and you’re not alone.” Daughter 4 (16) 
“It happens to all girls. You’re getting older and your body’s gonna change over 
the years, and sometimes you just have to be prepared for the worst and just hope 
for the best.” Daughter 5 (15) 
Others offered advice on what to do once a girl has her period.  
“Don’t be nervous. You’re gonna have cramps so you should have a heating pad 
[or] ask your mom if you can have Advil. Sometimes if it’s really bad, bring extra 
pads where ever you go, if it’s at a friend’s house or at school [or whatever]. Keep 
it like a secret, don’t tell any boys because the boys would have no clue what 
you’re saying.” Daughter 1 (14) 
“Keep feminine products with you, cause you never know when you or someone 
else are going to need it.” Daughter 10 (16) 
“I would say just don’t freak out when you have it. I mean like the first time you 
have it. I’d say always bring like pads with you, cause that’s what I do I bring 
pads with me. So, just always be prepared. Yeah, just always be prepared and 
don’t freak out.” Daughter 2 (15) 
Parents also had words of wisdom to offer other families of girls with ASD. Advice 
frequently focused on the importance of preparing daughters for the upcoming transition 
to womanhood, and the role that parents and others could play in educating daughters for 
the transition.  
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“Well, be honest with them. I know that that’s hard with a lot of parents, and you 
know if it’s hard for you to be honest with them, or to have that talk with them, 
ask someone, either one of their providers or somebody that you trust to start 
having those discussions with them. Because misinformation is bad for a 
Neurotypical kid, it’s really bad for our kids. You know, because that makes them 
a lot more vulnerable.” Parent 3 (45) 
 
“I would say be very open to talking about it and exposing your child to different 
ways of discussing it. I mean, it’s important that mom and dad have conversations 
with their children, but the educators in the public school to give it their try and 
the nurses. When I saw opportunity for [a] video, I thought [since] she’s always 
been such a visual learner, I thought this is really great, because the more we can 
discuss it then she can get more comfortable with it. Everyone presents it in a 
little different way, and I thought she picked up information from each source a 
little bit differently.” Parent 8 (46) 
 
“Make sure you that you talk about it. Frequently. Make sure that you use visuals 
of some sort because they’re typically visual learners.” Parent 1 (44) 
 
“I mean my biggest thing is using the resources that surround you and not being 
afraid or being too overly protective that those resources can’t help you. Meaning, 
you know, your pediatrician, [or] nurses at the school. Having them be involved 
and part of the process, I think it takes a lot off of the mother, the parent, cause 
that’s a lot to bear. So in terms of instruction and really paying attention, I really 
think it’s because it came from someone else and didn’t come from me. It doesn’t 
necessarily always have to be parent driven, conversation can happen outside of 
you.” Parent 2 (45) 
 
Some parents emphasized the normality of puberty for their daughters, letting the 
experience be a way in which they were like all their peers, instead of a way in which 
they were different.  
“We get caught up being parents of kiddos on the Spectrum, especially girls, 
because most of the information is about boys, and we get caught up into all of 
the therapies and all the extra stuff that they need and the IEP meetings and 
everything, when sometimes it’s okay to just sit back and just let things happen. 
And that’s kind of how I’ve approached her period, and for us, it’s worked.” 
Parent 6 (51) 
 
“Just normalize it as much as you can. Because it is what our bodies do and, you 
know, if you can normalize it as much as you can, then that’s not something else 
that’s abnormal about them.” Parent 3 (45) 
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Others offered strategies on how to best meet the needs of those with ASD in 
understanding and coping with the pubertal transition.  
“So it is definitely, especially for our kids on the spectrum, it is not a one shot 
deal, this is something to be discussed several times before, and then obviously 
when it happens. I think she handled it so well because one of the reasons was 
because she was so well prepared.” Parent 8 (46) 
“Be prepared for heightened sensory, you know like try to do things ahead of time. 
Oh that’s another thing I did, I did get panty liners for her before she got her 
period and we would have her try to wear them, didn’t work out too well, she 
didn’t want to, but she tried! She tried them out. And, you know same thing with 
a training bra and things like that. Early!” Parent 1 (44) 
“Keep talking, keep talking even if the person with Autism Spectrum Disorder 
doesn’t answer you, just keep talking to them.” Parent 10 (43) 
Discussion 
This study was the first to investigate puberty for adolescent females with ASD 
through their own and their parent’s perspectives. Codes were organized into the thematic 
categories of (1) preparing for puberty, (2) speed bumps on the road through puberty, (3) 
physical experience of menses, (4) managing the everyday, (5) looking forward, and (6) 
reflective advice. These themes and the experiences shared appear to be unique to 
females with ASD; for example, while Neurotypical females and males with ASD may 
also prepare for puberty, the quality, topics, or extent of education in the preparation 
differs for females with ASD. Overall, the daughters spoke of puberty and periods with a 
matter-of-factness. Some expressed resignation at having to deal with the hassle of 
periods, the monthly management, or the annoyance of growing up, but acknowledged it 
was a reality they had to address. Parents shared a wider variety of experiences and points 
of view on puberty for their daughters, ranging from an easy transition with open 
discussion, to struggles with finding and using feminine hygiene products and challenges 
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in helping their daughter understand and adapt to changes in their bodies. Regardless of 
the difficulties they faced, all mothers shared the importance of talking with their 
daughters about puberty and normalizing the experience.  
Key Findings 
Dynamic Differences. While the stories shared by the parents and daughters in 
the study had overlapping elements, each family experienced their own unique challenges 
in navigating puberty. As no two cases of autism are the same, it appears that the 
interface between ASD and puberty is similarly distinctive. For example, though many of 
the participants shared challenges posed by sensory differences in the daughter, the 
impact of the differences played out in very different ways between girls. Where one 
participant’s tactile hypersensitivity made finding comfortable feminine hygiene products 
extremely difficult, another’s hyposensitivity left her prone to accidents because she was 
unable to sense when her pad needed changing. For another, hypersensitivity meant 
regular struggles with her mother on topics like shaving and yet for a fourth, sensory 
differences resulted in rejection of wearing bras. Understanding that the same underlying 
mechanism can play out in such different ways is important for both families and 
practitioners who work with this population to recognize. It highlights that issues that 
arise in puberty may have an unexpected origin and it’s important to explore what may be 
causing difficulties from a variety of perspectives.  
Role of the Mother. Both daughters and parents repeatedly shared that mothers 
play a central role throughout puberty. Mothers were not only educators, serving as both 
primary and secondary sources of information regarding pubertal changes, but also as 
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sounding boards for their daughters, emphasizing normality of puberty and normality of 
their daughter. Daughters spoke of their mother as a “key-stone” figure, someone who 
they could rely on and check in with should they have questions or concerns. In telling 
the story of their first period, nearly every daughter immediately told their mother, some 
with fears or questions, some with excitement. Parent-participant dyads that shared 
having an open, accessible relationship when it came to discussing puberty and menses 
were more likely to speak of the process in more positive terms. Mothers also played a 
key role in managing menses with their daughter. This role included tracking their 
daughter’s cycle and reminding them when periods were expected, reminders to wear 
pads when anticipating a period, providing a structured schedule for changing feminine 
hygiene products, and ensuring that their daughter had access to specific hygiene 
products and medication to manage symptoms. Some were able to phase out their 
involvement as their daughter’s matured and assumed increasing responsibility, while 
others continued to be active in management over time. The role of the mother was a 
constant throughout all of the themes identified in the study and underscored close 
relationships between mothers and daughters throughout puberty.  
Strengths and Limitations 
This study does have its limitations. While participants were purposefully selected 
to achieve a measure of heterogeneity, the group was predominately Non-Hispanic White 
and the study findings may not speak to experiences of individuals outside this group. 
Meanings and cultural attitudes towards menses vary widely across cultures; all 
participants were located in the United States (nine states from the Pacific Coast, 
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Southwest, Great Plains, New England, Mid-Atlantic and Southeast regions) and findings 
of this study may not be appropriate or accurate outside of a Western cultural setting. All 
parents participating in this phase of the study were mothers and may have shared 
experiences reflecting a distinct role and relationship with their daughters on issues like 
puberty and menses that are key components of womanhood that may or may not be 
shared by fathers. While parent-participant dyads with fathers as parent participant were 
sought, none elected to participate in the interviews. The daughter participants here also 
were from a narrow age range, 14 to 16 years old, and their experiences may be specific 
to the early menstrual years. While the age range was largely due to inclusion criteria, 
future studies would do well to look at the experience of menses and being a woman with 
ASD across the lifespan, from early childhood through late adulthood, to explore how 
understanding and perceptions may shift over time. From anticipation of menses in late 
childhood, to loss of menses in menopause, women across their lives may have strikingly 
different relationships to this central tenant of womanhood, and it is an important next 
step for this area of research to explore how this may present for females with ASD.  
The semi-structured interview format was a challenge for some of the daughters. 
While the researcher made every attempt to promote participant comfort, provide 
clarification and ample time for reflection, the brevity of responses from some 
participants suggests that they may prefer alternative options. Future studies may 
consider piloting several different methods to identify the most productive method for 
data collection. Such methods may include an open-ended questionnaire or essay format 
for participants to write their experiences, providing the topics to participants ahead of 
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the interview for reflection, or group interviews where girls can openly discuss topics. 
Another possibility includes ‘loop-back’ interviewing, where the interviewer engages in 
two or more interviews with the participant so as to build a trusting relationship for 
discussion of sensitive topics and give the participant opportunity to reflect on material 
discussed in earlier interviews.  
Conclusions 
Like the process of puberty itself, the themes identified in this study highlight a 
number of issues that occur over the span of many years and the shifting needs and roles 
that both daughters and parents have throughout the process. The daughters and parents 
interviewed emphasized the importance of preparing for puberty, drawing from a number 
of resources to help daughters understand what to expect as they grow up. Where 
daughters expressed experiencing more menstrual symptoms, parents noted that pre-
menstrual symptoms, particularly emotional changes and anxiety, were also present. The 
transition through puberty is rarely smooth, and participants noted several ‘speed bumps’, 
including menstrual accidents, ASD associated sensory differences and resistance to the 
use of tampons. In working to promote menstrual management, both daughters and 
parents noted the key role that mothers played on a daily basis. Parents also looked to the 
future with hope and trepidation, balancing concerns against progress their daughters 
have made in the past. All participants offered words of wisdom to other girls with ASD 
and their families, offering a glimpse into what practitioners and parents can do to 
provide support. To provide quality care and support to these families, it is vital to 
recognize not only the variations that happen across puberty, but also the unique 
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experience of each family. Practitioners at all levels should dedicate time to explore the 
strengths and struggles of each family and facilitate discussion on alternative strategies 
that can be implemented to meet the needs of these young women.  
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Introduction 
A review of the brief published literature on puberty in females with Autism 
Spectrum Disorder (ASD) shows mixed findings on key issues, including age at 
menarche (AAM), menstrual symptoms, and rates of gynecologic disorders in the 
population. While two studies have reported increased rates of early onset and precocious 
puberty (Hamilton et al., 2011; Pohl et al., 2014), others have demonstrated an increase in 
AAM for females with ASD (Hergüner & Hergüner, 2016; Ingudomnukul et al., 2007; 
Knickmeyer et al., 2006; Whitehouse et al., 2011). Irregular cycles, dysmenorrhea and 
menorrhagia appear to be more common (Burke et al., 2010; Hamilton et al., 2011; 
Ingudomnukul et al., 2007; Pohl et al., 2014), and females with ASD and mothers of 
children with ASD may have higher rates of hirsutism and polycystic ovarian syndrome 
(Ingudomnukul et al., 2007; Pohl et al., 2014). However, the few studies that have 
addressed these issues are limited by study design, including small sample size (Burke et 
al., 2010; Knickmeyer et al., 2006), reliance on proxy populations (Hergüner & 
Hergüner, 2016; Whitehouse et al., 2011), lack of control of variables known to influence 
menses (Burke et al., 2010; Hamilton et al., 2011; Hergüner & Hergüner, 2016; 
Knickmeyer et al., 2006; Whitehouse et al., 2011), and inconsistent definitions of key 
terms. The Facing Puberty Study sought to address the gaps in the literature with an 
explanatory sequential mixed-methods design, combining self and parent-report on web-
based questionnaires with semi-structured dyad interviews on the onset, symptoms and 
experience of menses for this unique population. This study was the first to 
simultaneously assess onset and presentation of menses in adolescent females with ASD, 
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using self and parent report compared to a Neurotypical control group. Further, it was the 
first to use semi-structured interviews with parent and daughter dyads to understand the 
experience of puberty for females with ASD.  
 Four key findings were drawn from this study: (1) earlier age at menarche in 
females with ASD and females of siblings with ASD, (2) differing perception of menses 
and menstrual symptoms between mothers and daughters with ASD, (3) challenges in 
menstrual management, and (4) the unique impact of impairments and differences 
associated with ASD on puberty and menses. While the findings from the study are 
discussed at length in the manuscripts previous to this chapter, a review and summary is 
provided here to link findings across the Quantitative and Qualitative Phases of the study. 
Findings 
Age at Menarche 
 Compared to Neurotypical (NT) peers, females with a diagnosis of ASD in their 
family, either for themselves (AS group) or in a sibling (AS:AS and NT:AS groups), 
reported earlier age at menarche. Females with ASD from multiplex families experienced 
menarche 1.85 years (or 22.2 months) earlier than females with no history of ASD in the 
family. Further, significantly more females from multiplex reported AAM meeting 
criteria for early menarche (≤ 11 years) than those from simplex families and those with 
no family history of ASD. Parents from both AS and NT groups were accurate reporters 
of their daughter’s age at menarche. In the interviews, mothers spoke of preparing 
themselves and their daughters for experiencing early menarche. For Parent 3, drawing 
on family experiences helped guide them, “She had one cousin that started her periods at 
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eight, [so] I didn’t know when she would start hers, anywhere early like that up to, well I 
was 15 when I started mine. So, we started the conversation early.” Parent 5 also 
expressed disappointment and remorse for her daughter having experienced menarche at 
an early age, “Oh man. TEN. Really?! It’s been a very maturing experience for her”. 
Daughters who experienced early menarche spoke of the experience matter-of-factly, 
such as Daughter 3, “I was down at a friend’s house and I was 9 years old and I went, 
and there was blood. Yep. And after that we went to Walgreens and got pads.” Others 
conveyed a more emotional experience, like for Daughter 5 “Well, [I was] anxious. ‘Oh, 
what’s gonna happen to my body?’ When I first started my period, I felt like ‘Oh, what’s 
happening?’ and ‘Why is it there?’ And, and [then] my mom talked to me about it and I 
understood what it means. […] I felt scared. I felt like something was wrong. [But then] I 
showed my mom and she told me I was starting my period and then she told me all about 
it.”  
The trend towards earlier onset of menarche observed in females from multiplex 
and simplex ASD families suggests a potential underlying developmental mechanism 
shared between ASD and AAM. Both AAM and ASD are highly heritable and it is 
plausible that with increased genetic load, the risk for both ASD and early AAM may 
increase. AAM has been associated with a number of genes implicated in or near genes 
implicated in BMI, energy homeostasis, and hormonal regulation (Elks et al., 2010). 
Hormonal regulation genes, such as RORA (Sarachana, Xu, Wu, & Hu, 2011), and 
obesity genes (Persico & Napolioni, 2013) have been linked to occurrence of ASD. 
While elucidating the underlying genes is a fundamental step forwards with this research, 
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ultimately, the mechanisms by which these genes may lead to ASD and early onset AAM 
is essential for understanding the complex effects of ASD on the health and well-being of 
those with the disorder.  
Menstrual Symptoms 
Females from multiplex and simplex ASD families reported experiencing fewer 
premenstrual, dysmenorrheal, or physical menstrual symptoms than NT peers, and 
behavioral and emotional menstrual symptoms at similar rates to NT peers. Within the 
AS groups, multiplex participants reported significantly more physical menstrual 
symptoms than simplex participants. Multiplex participants also had the greatest 
proportion of participants experiencing ‘Significant Burden’ for behavioral and emotional 
menstrual symptoms and report any level of burden for dysmenorrhea. This demonstrates 
a potential shift in presentation for females with ASD towards fewer premenstrual 
symptoms and greater menstrual symptoms, specifically for dysmenorrheal, behavioral 
and emotional symptoms. With parent report of menstrual symptoms, NT parents 
consistently reported fewer menstrual symptoms across all assessed areas, with the 
exception of change in mood before a period, compared to their daughters. In contrast, 
parents of females with ASD reported significantly more pre-menstrual symptoms and 
fewer physical and behavioral menstrual symptoms than their daughters. AS parents 
reported more emotional changes over the menstrual cycle, including changes in mood 
before and during a period and irritability, compared to their daughters, though these 
differences were not significant.  
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It is interesting that within the menstrual symptom sub-groups, only physical 
symptoms show virtually no difference between all four groups. Physical symptoms, 
which include bloating, cramps, constipation, and headaches, may be more challenging 
for females to perceive and report due to differences in bodily perception that have been 
noted for individuals with ASD (Allely, 2013; Courtemanche et al., 2016; Moore, 2015; 
Yasuda et al., 2016). Alternatively, they may experience these symptoms regularly and 
independently of the menstrual cycle and therefore do not perceive them to be associated 
with menses. For example, previous research has reported greater levels of constipation 
for individuals with ASD compared to NT peers (Ibrahim, Voigt, Katusic, Weaver, & 
Barbaresi, 2009); for a female with ASD who is regularly constipated, she may perceive 
no difference when she has her menstrual cycle. Both of these hypotheses were supported 
in interviews with the participants, however they differed by reporter. While parents 
shared experiences that promote the ‘atypical perception and communication’ hypothesis, 
daughters offered experiences in keeping the ‘constant symptom’ hypothesis. Parent 4 
shared that she feels it may be more of a communication deficit, “You know she does 
sometimes have trouble verbalizing what’s she’s feeling, so I don’t know if that [plays a 
role].” Another mother, Parent 1, also shared that communication, as well as atypical 
perception, may be driving the difference, “I think she experiences less, but it’s hard to 
say how much of that is a communication, you know, not telling me about it, versus not 
feeling the pain.” Parent 8 also shared similar thoughts, “I […] think that she experiences 
very little pain, it’s very surprising to me, how little she complains about that.” In 
contrast, Daughter 7 stated, “[I feel] pretty much the same. There’s not really much 
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change. I honestly would have expected more change, if you had asked me when before I 
had my period. I probably would have been quite nervous about it, been like I’ve got, it’s 
probably gonna be bad, but if you ask me now, it’s just sort of an ‘eh?’.” Daughter 2 and 
Daughter 6 had shared similar thoughts: “It doesn’t really.... feel anything, just like on 
the second day or third day I’ll start getting cramps but like... that’s kinda it” (Daughter 
2) and “Except for the cramps, I don’t feel really anything at all” (Daughter 6).  
Pain. Due to the potential differences in sensory perception and reporting of pain 
with individuals with ASD (Allely, 2013; Courtemanche et al., 2016; Moore, 2015; 
Yasuda et al., 2016), it is important to look closely at reports of menstrual pain among the 
groups. Compared to NT peers, AS groups had lower levels of menstrual pain (Scale 0-
10: NT = 5.25 ± 2.49, NT:AS = 3.97 ± 2.64, AS =3.91 ± 2.66, AS:AS = 4.75 ± 2.60), yet 
reported utilizing OTC pain medication at greater rates (NT = 33.3%, NT:AS = 54.3%, 
AS = 45.4%, AS:AS = 62.5%). Parents’ reporting also followed this trend, with lower 
levels of pain in the AS groups, but greater utilization of OTC pain medication. This 
suggests that participants may have differences in the perception and/or expression of 
pain broadly, or perhaps perceive menstrual pain as less severe than other types of pain, 
while still meeting the threshold for treatment. As noted above with perception of 
physical menstrual symptoms, parents frequently reported a surprising lack of 
communication of pain by their daughters and often described their daughters as having 
an atypically high pain threshold. Parent 10 said, “Her pain threshold is a lot higher than 
other people. When she was little would run and fall down and get a scraped knee, she 
would most of the time just like ‘Oh, I’m fine’ [and] get up, where most little kids would 
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be crying, and she runs cross country and track in school and she can just go and go and 
go and go.” Parent 6 shared the memory of when her daughter had broken her leg, “She 
has a really high threshold for pain […] with her femur being broken, and it was 
completely separated from the bottom of the bone. She was trying to walk on it.” 
Impact on Daily Life. Participants from all groups reported generally low levels 
of menstrual interference with activities of daily life, with the exception of sports. 
Though AS participants reported lower levels of menstrual interference with sports than 
NT peers, they expressed dismay and resignation that menses inhibited certain activities, 
like swimming. As shared by Daughter 7, “My brother and his friend were going 
swimming at a public pool and I couldn’t go, cause I was having a pretty heavy day and I 
was kinda bummed out about that. But swimming is the only thing it really gets in the 
way of. Which is a problem, I mean it’s a problem sometimes, cause I love to swim.” In 
contrast, parents of both NT and AS participants perceived more interference of the 
menstrual cycle in attending school and relationships with friends and family, as well as 
completing school work, social activities, and sports for parents of AS participants. 
Parent 8 summarized these differences with her daughter, “She’s expressing concerns, 
like she can’t go to track practice or basketball because ‘I have my period’ and we talked 
about that you can’t stop living when you have your period and so you can [still] do those 
things, and just you know make sure that you’re fully prepared. If I let her, she wouldn’t 
have gone, but we made her go and then she realized that she didn’t have to let it stop 
her. But she’s more resistant sometimes when it comes to physical activity or going 
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places, she’ll be like ‘Oh well, I can’t go out with you guys because I have my period’ 
and I’m just like ‘Oh well, it’s portable, so let’s go!’ So just walking her through that.” 
Though differences between parent and daughter perception of menstrual 
symptoms and their subsequent impact on activities of daily life were apparent, 
considering the impairments in communication and differences in bodily perception for 
females with ASD, they are not entirely surprising. While parents of Neurotypical 
females consistently reported fewer symptoms and less impact of menses, this trend did 
not hold true for parents of females with ASD and highlights areas for future research to 
address. 
Menstrual Management 
 Parents and daughters interviewed in the Qualitative Phase universally spoke of 
challenges in managing menses. While this challenges were varied, from refusing to use 
feminine hygiene products to dramatically increased anxiety prior to menses, they all 
resulted in complicating menstrual cycles. One issue that frequently surfaced for 
interviewed participants was the difficulties in hygiene product use. This was mirrored in 
the Quantitative Phase, in a section within the MDOT where participants responded to a 
series of statements about their menstrual cycle as ‘True’ or ‘False’. This analysis fell 
outside the scope of the quantitative manuscripts and was prompted by the findings in the 
Qualitative Phase, and is presented here. Females with ASD expressed significantly less 
interest in using tampons than NT females (“I am not interested in using a tampon”; ASD 
= 67%, NT = 38%, χ2(2) = 6.77, p = 0.03) and were less likely to report only using 
tampons (“I only use tampons”; ASD = 0%, NT = 21%, χ2(2) = 7.84, p = 0.01). While the 
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majority of females with ASD preferred to only to use pads (“I only use pads”; ASD = 
82%, NT = 60%, χ2(2) = 3.74, p = 0.05), many of them had difficulties in using them (“I 
have difficulties using pads”; ASD = 27%, NT = 4%, χ2(2) = 8.90, p = 0.00). These 
differences may stem from sensory differences and challenges with fine motor skills 
often seen in individuals with ASD (Stevenson; Leekam; Ming; Provost). Daughter 7 
shared having difficulties with pads, noting “I have trouble arranging them in a way so 
there’s no spill over.” Parent 3 noted it was sometimes difficult to get her daughter to use 
pads because of the discomfort they caused, “She doesn’t like the way they feel, the 
material on them irritates her and bugs her, the sensation, you know the feel of it. So, she 
will just keep changing her underwear. That’s the biggest struggle we have now is 
reminding her that she has to use pads.”  
Possibly in response to these challenges, participants reported that mothers played 
a significant role in their daughter’s menstrual management. Mothers played integral 
roles for their daughters in helping them learn about, adapt to, and cope with menses. 
Mothers were often noted to be the first person the daughter shared news of menarche 
with and were typically the primary source of information and education for their 
daughter. After menarche, mothers and daughter noted that the mother played very active 
roles in managing the daughter’s menses, including reminding them when they may start 
their period, suggesting to wear a smaller pad when periods were anticipated, reminding 
daughters to change pads regularly, providing pads and pain medication for symptom 
management, and tracking their daughters cycle. Some of the mothers noted transitioning 
to a less active role as their daughter aged, such as checking in once or twice a month to 
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ensure that their daughter had sufficient supply of hygiene products, while others 
maintained an active and present role across time, often adapting earlier strategies as their 
daughter’s environment changed. One mother developed a system of texting with her 
daughter’s aide and teachers to reminder her to check her pad every two hours. These 
strategies, though at times burdensome for the mothers, helped females with ASD more 
appropriately manage their cycles.  
Different Paths through Puberty 
Just as no two cases of ASD are the same, the impacts of ASD on puberty varied 
across participants in the study. It appears that the individual’s ASD “drives” the 
experience of puberty. The insistence on sameness, highly restricted interests, challenges 
with social-emotional reciprocity and non-verbal communication, hyper and hypo-
reactivity to sensory input all modulate how the individual encounters puberty. For 
example, if the individual is highly resistant to change, has decreased interest in social 
communication, and tactile hypersensitivity, those differences have direct effects in how 
they respond to and cope with puberty: they may require more education and intervention 
prior to starting their period about what periods are, why they will have them and what 
can be done to mitigate accompanying symptoms, they may need education from a 
variety of sources, both verbal and written, and they may struggle with finding bras and 
feminine hygiene products that are comfortable for them to wear. In this way, how their 
ASD presents may, to an extent, inform how they experience puberty and menses. Some 
of the parents verbalized knowing that certain components of puberty would present a 
challenge due to their child’s differences. As Parent 9 noted in trying to work with her 
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daughter on using a tampon, “I’m frustrated that she’s so rigid. She won’t. I tried to show 
her. I mean there are a lot of videos and they’re pretty funny on YouTube about using a 
tampon. But she will not have any part of it. That’s what’s frustrating.” Though she felt 
she had her daughter’s best interests at heart, they couldn’t get around or work with her 
daughter’s rigidity. Other parents however noted that their daughter’s preference for 
sameness and adherence to routine helped them, such as for Parent 7, “She might change 
pads a little too frequently, but I’ll take that.” This highlights how the same hallmark 
symptom from ASD had very different outcomes in different participants.  
Study Strengths and Limitations 
 This study is the first to characterize in substantial detail the onset and 
presentation of the menstrual cycle in females with ASD compared to Neurotypical peers 
using self- and parent-report. Further, the study controlled for variabless known and 
hypothesized to be associated with AAM, strengthening our primary finding of earlier 
onset in females with ASD from multiplex families. Earlier literature on the subject have 
relied on the use of proxy populations, as with Whitehouse’s and Herguner’s use of 
Neurotypical subjects compared across level of ‘autism-like’ traits, or review of medical 
records (Burke et al., 2010). Previous studies have also lacked Neurotypical comparison 
groups (Burke et al., 2010; Hamilton et al., 2011), omitted reporting of AAM 
(Ingudomnukul et al., 2007; Pohl et al., 2014) or menstrual symptoms (Knickmeyer et al., 
2006). Further, this study was the first to explore the experience of puberty through 
qualitative methods, in semi-structured interviews with parent-participant dyads. Through 
this study, a fuller description of the presentation and experience of puberty for females 
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with ASD has been achieved. While participants represented a narrower racial and ethnic 
make-up that initially desired by the researchers, being predominately Non-Hispanic 
White, due to the known association between AAM and race and ethnicity, this helped to 
control for influencing variables and strengthened the findings on AAM and ASD. In 
addition, these results can be generalized broadly to the female ASD population in the 
United States, which is predominately Non-Hispanic White (Christensen, 2016). 
The use of a web-based platform for questionnaires was novel to this population 
and was selected to promote comfort and accessibility for all participants. Openly 
discussing the menstrual cycle remains a taboo topic in the majority of Western cultures 
(Houppert, 1999). Through the web-based platform, participants could take part in a 
private setting and would not feel pressured to respond according to cultural norms. 
However, the web-based platform and the anonymity that accompanies it unfortunately 
resulted in the study being vulnerable to fraudulent participants. Several checkpoints 
were built in to the study, including a brief 5-question screener and consent/assent forms 
that required the participant’s email address. Participants were sent individualized links to 
the password-protected website and a separate password-protected page to claim the $10 
compensation for participation, ensuring only those completing the study could claim 
compensation. It appears that an individual or group of individuals located within a small 
geographic location learned the responses necessary to move through the screening 
questionnaire to consent/assent and were subsequently given access to the study website. 
After completing the questionnaires, they accessed the gift card page and claimed 
compensation. In reviewing their completed questionnaires however, it was apparent that 
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they did not meet criteria for participating in the study, such as reporting birthdates 
outside of the 18 years of age maximum, or reporting that the participant was male where 
only females met inclusion criteria. Further, data from these individuals for the study 
questionnaires appeared to be filled in at random, the built-in repetition of key themes 
showing conflicting answers between questions on the same topic. Ultimately, four 
parent-participant dyads, all from the AS group, were dropped from the study as they 
were deemed to be fraudulent. After these cases were identified, potential participants 
raising red flags drawn from these individuals (i.e., from the same geographic location as 
noted through Qualtrics IP tracking or blocked IPs, reporting different last names for 
parent and participant, reporting suspicious email addresses) were screened more closely 
and barred from participation if deemed to be fraudulent.  
Beyond this, the web-based platform may have led to sampling bias, drop out and 
non-response. While some individuals may have been excluded from this study due to 
lack of Internet access, we believe this number to be negligible within our population of 
interest. We affirm that the use of web-based questionnaires for the ASD population may 
actually promote participation, as it may be less stressful and socially taxing to the 
individual with ASD compared to a site-based study. However, the study did experience 
significant decreases in participation between ‘Step 1’ of the study, completion of the 
consent/assent form, and ‘Step 2’, completing the questionnaires. All participants were 
emailed individualized links to the password-protected page of the study questionnaires 
and sent up to five reminder emails. Reminder emails occurred a minimum of 4 days 
apart and were varied time of day (morning, afternoon and evening). The researcher did 
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not observe any trends in day or time of day of reminder emails that elicited more 
participants to complete the questionnaires. Non-response was uncommon, though 
present. The researcher elected to not force responses to any question throughout the 
study to allow participants to engage and respond as freely as possible. No efforts were 
made to correct for non-response in analysis, as it was not substantial enough to warrant 
for any given analysis.  
As a result of slow recruitment and time constraints, the initial goal of 50 
participants per group (AS versus NT) was not met. Ultimately, the study was able to 
recruit 48 Neurotypical and 34 ASD parent-participant dyads. Subsequent power analysis 
for the oneway ANOVA comparing AAM by group in Manuscript 1, which targeted the 
primary aim of the study, revealed that the analysis was just shy of the 80% standard, at 
77% power. As the overarching goal for the Facing Puberty Study was primarily to 
describe menses for females with ASD, the researchers feel that this does not impact the 
strength or importance of the findings observed in the study.  
Summary 
 The Facing Puberty Study observed earlier age at menarche for females from 
multiplex ASD families compared to Neurotypical peers. Parents and daughters from 
both ASD and NT groups were highly congruent in their reports of age at menarche. 
Earlier age at menarche may increase risk for a myriad of health concerns across the 
lifespan, including obesity (Freedman et al., 2003; Okasha et al., 2001), social anxiety 
and depression in adolescence (Joinson et al., 2011; Kaltiala-Heino et al., 2003; Mendle 
et al., 2007; Stice et al., 2001), breast cancer (Collaborative Group on Hormonal Factors 
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in Breast Cancer., 2012; Petridou et al., 1996; Stoll et al., 1994), Type 2 diabetes (He et 
al., 2010), and cardiovascular disease (Feng et al., 2008; Lakshman et al., 2009). Given 
the increased prevalence of several of these health concerns already observed for 
individuals with ASD, notably obesity (Curtin et al., 2014; Egan et al., 2013), anxiety and 
depression (Buck et al., 2014; Stacy et al., 2014), providers working with these young 
women should include assessment of age at menarche in their care. No significant 
differences in menstrual presentation or menstrual symptoms were observed between 
groups. More females with ASD reported experiencing symptoms at the time of menses, 
whereas NT females reported experiencing both pre-menstrual and menstrual symptoms. 
For females with ASD, behavioral, emotional, and dysmenorrheal symptoms posed 
greater burden compared to physical symptoms. Parents of Neurotypical daughters 
followed a trend of reporting fewer menstrual symptoms, whereas parents of daughters 
with ASD reported more pre-menstrual, dysmenorrheal and emotional menstrual 
symptoms than their daughters. The experience of puberty varied substantially, however 
several key themes were identified that were unique to families with a daughter on the 
Autism Spectrum: preparations for puberty, physical experience of menses, speed bumps 
on the road through puberty, managing the everyday, and looking to the future, as well as 
reflective advice.  
Future Directions 
The complex needs of females with ASD calls for a multi- and inter-disciplinary 
approach, combining bench, descriptive, clinical and intervention research to maximize 
the health and well-being of these women and their families. Their health status, 
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including women’s health issues, across the lifespan has yet to be fully documented and 
would add considerably to the literature. For puberty specifically, following a large group 
of females with ASD across the pubertal years would elucidate a richer understanding of 
how this population progresses through this key phase of life and their unique needs at 
different stages of puberty. Future research should also look to female siblings and 
mothers of individuals with ASD in addition to a Neurotypical comparison group, as 
these populations represent the ‘Broader Autism Phenotype’ and may shed light on ASD 
as a spectrum disorder, as well as women’s health concerns for females with ASD. 
Additionally, measures of sex steroids across puberty and the menstrual cycle may help 
to establish the cause of increased rates of gynecologic disorders like polycystic ovarian 
syndrome and hirsutism in females with ASD. There is much yet to uncover within this 
growing field and research stands to impart substantial benefits to the care and health of 
females with Autism Spectrum Disorder.  
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Appendix A. Instruments for Data Collection. 
Instrument Time Description Use in Study 
Demographic 
Questionnaire for 
Parents 
5 min A 23-item questionnaire to 
address the socio-
demographics of the parent, 
as well as relevant diagnosis 
of the daughter. 
Assess relevant socio-
demographic and 
diagnostic variables. 
Demographic 
Questionnaire for 
Participants 
5 min An 8-item questionnaire on 
the socio-demographic 
variables of the participant. 
Assess relevant socio-
demographic and 
diagnostic variables. 
Menstrual 
Disorders of 
Teenagers 
(MDOT) 
Questionnaire, 
Modified 
20 
min 
This 7-section questionnaire 
assesses onset, regularity, 
duration, symptoms of 
menses and impact on daily 
activities. The questionnaire 
will be modified to remove 
questions on sexuality, as 
well as add additional 
questions on menstrual 
symptoms.  
Assess characteristics of 
menses, and presence 
and severity of 
menstrual symptoms. 
Dietary Screener 
Questionnaire 
(DSQ) 
10 
min 
A 26-item parent-report 
assessing consumption of 
major food types over the 
past month. 
Evaluate level of 
nutrition. 
Physical Activity 
Questionnaire, 
Adolescent 
Version 
10 
min 
This questionnaire, tailored 
to children 14-19 years, 
assesses general levels of 
activity by parent-report of 
various activities in the past 
7 days.  
Evaluate level of 
physical activity.  
Screen for Child 
Anxiety Related 
Disorders 
15 
min 
This 41 item questionnaires 
assess anxiety symptoms in 
children 8 to 18 years 
through self- or parent-
report.  
Evaluate presence of 
symptoms related to 
anxiety disorder.   
Interview Guide 30-60 
min 
A semi-structured interview 
question bank, comprised of 
14 questions, to initiate 
conversation with 
individuals and their 
families regarding the 
experience of puberty for 
females with ASD.  
Explore the experience 
of puberty for daughters 
with ASD and their 
parents. 
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Appendix B.  Summary of Variables. (Primary variables of interest highlighted) 
Concept Associated 
Variable 
Type of 
Variable 
Operational Definition 
Demographic 
Variables 
Age Continuous Age in years and months 
Gender Dichotomous Participant or parents reported 
gender.  
Race Categorical Participant or parents reported 
race. 
Ethnicity Categorical Participant or parents reported 
ethnicity. 
Marital_Status Categorical Parents reported marital status 
Level_Schooling Ordinal Parents reported highest 
completed level of education. 
Language Categorical Participant or parents primary 
language. 
Income Ordinal Family income.  
Diagnoses ASD_Dx Dichotomous Presence of ASD diagnosis. 
Age_ASD_Dx Continuous Age in months at ASD 
diagnosis. 
Co_Morbidities Categorical Presence of other medical 
conditions. 
Medications Prescription Categorical Use of prescription medications 
in participant. 
Non-Prescription Categorical Use of non-prescription 
medications in participant. 
Birth Control Dichotomous Use of birth control in 
participant. 
Age at 
Menarche 
AAM Continuous Age in years and months at 
which a female has her first 
menstrual bleeding. 
Period 
Characteristics 
Regularity Dichotomous Self-report of regularity of 
cycle.  
Cycle_Length Continuous Number of days from the first 
day of bleeding at one period, to 
the first day of bleeding at the 
next.   
Clotting Dichotomous Presence of blood clots during a 
period. 
Spotting Dichotomous Presence of blood on underpants 
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between periods (after bleeding 
from one period has ended, 
before the next period has 
begun). 
Miss_School Dichotomous Any number of school days 
missed due to issues 
surrounding a period.  
Period_Pain Ordinal Level of pain associated with a 
period in the past 6 months. (0-
10) 
Pain_Medication Dichotomous Use of any pain relieving 
medication associated with a 
period.  
Medication_ 
Effectiveness 
Ordinal Effectiveness of pain relieving 
medication at relieving pain 
associated with a period. (0-10) 
Pre-Menstrual 
Symptoms 
PMS_Summary Ordinal Summary score of pre-
menstrual symptoms: nausea, 
bloating, diarrhea, constipation, 
heartburn, headache, breast 
tenderness, acne, changes in 
sleep, changes in appetite, lower 
back pain, depression, 
irritability, anxiety, changes in 
mood, and tearfulness.  
0 = No Symptom Burden 
0.01- 0.33 = Low Symptom 
Burden 
0.34 – 0.66 = Medium 
Symptom Burden 
0.67 – 1.00 = High Symptom 
Burden 
Dysmenorrhea Dys_Summary Ordinal Summary score of menstrual 
pain symptoms: aching- down 
legs, aching- outside vagina, 
pelvic pain-cramping, pelvic 
pain-stabbing, pelvic pain-
aching, pelvic-other, and lower 
back pain. 
0 = No Symptom Burden 
0.01- 0.33 = Low Symptom 
Burden 
0.34 – 0.66 = Medium 
Symptom Burden 
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0.67 – 1.00 = High Symptom 
Burden 
Physical 
Menstrual 
Symptoms 
Nausea Dichotomous Presence of nausea symptoms 
associated with a period. 
Vomiting Dichotomous Presence of vomiting associated 
with a period 
Bloating Dichotomous Presence of bloating associated 
with a period. 
Diarrhea Dichotomous Presence of diarrhea associated 
with a period. 
Constipation Dichotomous Presence of constipation 
associated with a period 
Reflux_Heartburn Dichotomous  Presence of reflux or heartburn 
associated with a period. 
Aching Dichotomous Presence of aching outside the 
vagina or down the legs 
associated with a period. 
Pain_Pelvic Dichotomous Presence of aching, cramping or 
stabbing pelvic pain associated 
with a period. 
Pain_Lower.Back Dichotomous Presence of lower back pain 
associated with a period. 
Thrush Dichotomous Presence of thrush associated 
with a period. 
Tired_Faint Dichotomous Feeling tired or faint associated 
with a period. 
Headaches Dichotomous Headaches associated with a 
period. 
Breast_ 
Tenderness 
Dichotomous Breast pain or tenderness 
associated with a period. 
Cyclical_Acne Dichotomous Acne associated with a period.  
PhysMS_Sympto
m_Count 
Continuous Count of reported physical 
menstrual symptoms. 
PhysMS_Summar
y_ Score 
Ordinal Summary score calculated by 
averaging all physical menstrual 
symptom scores  
0 = No Symptom Burden 
0.01- 0.33 = Low Symptom 
Burden 
0.34 – 0.66 = Medium 
Symptom Burden 
0.67 – 1.00 = High Symptom 
Burden 
Behavioral Sleep_Changes Dichotomous Changes in sleeping patterns, 
 
 
176 
 
Menstrual 
Symptoms 
either hypersomnia or insomnia, 
associated with a period. 
Appitite_Changes Dichotomous Changes in eating patterns, 
including increased or 
decreased appetite and presence 
of cravings, associated with a 
period. 
Social_Withdraw
al 
Dichotomous Withdrawing from social 
engagements and opportunities 
associated with a period. 
Concentration_ 
Problems 
Dichotomous Difficulties concentration on 
work or school related tasks 
associated with a period.  
BMS_Symptom_
Count 
Continuous Count of reported behavioral 
menstrual symptoms. 
BMS_Summary_ 
Score 
Ordinal Summary score calculated by 
averaging all behavioral 
menstrual symptom scores. 
0 = No Symptom Burden 
0.01- 0.33 = Low Symptom 
Burden 
0.34 – 0.66 = Medium 
Symptom Burden 
0.67 – 1.00 = High Symptom 
Burden 
Emotional 
Menstrual 
Symptoms 
Irritability Dichotomous Presence of irritability 
associated with a period.  
Anxiety Dichotomous Presence of anxiety associated 
with a period. 
Mood Dichotomous Mood changes or mood swings 
associated with a period. 
Depression Dichotomous Feeling blue, down or depressed 
associated with a period. 
Tearfulness Dichotomous Feeling tearful associated with a 
period. 
EMS_Symptom_
Count 
Continuous Count of reported emotional 
menstrual symptoms. 
EMS_Summary_ 
Score 
Ordinal Summary score calculated by 
averaging all emotional 
menstrual symptom scores. 
0 = No Symptom Burden 
0.01- 0.33 = Low Symptom 
Burden 
0.34 – 0.66 = Medium 
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Symptom Burden 
0.67 – 1.00 = High Symptom 
Burden  
Impact on 
Lifestyle 
Attending_School Ordinal How much one’s period 
interferes with attending school. 
(0-10; no interference to major 
interference) 
Completing_ 
School.Work 
Ordinal How much one’s period 
interferes with completing 
school work. 
Casual_Work Ordinal How much one’s period 
interferes with casual paid 
work. 
Social_Activities Ordinal How much one’s period 
interferes with social activities. 
Relationships_ 
Family 
Ordinal How much one’s period 
interferes with relationships 
with family members.  
Relationships_ 
Friends 
Ordinal How much one’s period 
interferes with relationships 
with friends. 
Relationships_ 
Partner 
Ordinal How much one’s period 
interferes with relationships 
with a romantic partner. 
Relationships Ordinal Summary score (average) of 
how much ones’ period 
interferes with all relationships. 
Exercise Ordinal How much one’s period 
interferes with sports and 
exercise.  
Lifestyle 
Interference 
Pain Ordinal How much pain from one’s 
period interferes with one’s 
lifestyle. (0-10; no interference 
to major interference) 
Heavy_Flow Ordinal How much heavy blood flow 
from one’s period interferes 
with one’s lifestyle. 
Tired_Fatigue Ordinal How much feeling tired or 
fatigued from one’s period 
interferes with one’s lifestyle. 
Moods Ordinal How much mood changes or 
mood swings from one’s period 
interferes with one’s lifestyle. 
Unwell Ordinal How much generally feeling 
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unwell from one’s period 
interferes with one’s lifestyle. 
Knowledge K_PCOS Dichotomous Knowledge of polycycstic 
ovarian syndrome. 
K_Endometriosis Dichotomous Knowledge of endometriosis. 
K_PID Dichotomous Knowledge of pelvic 
inflammatory disease.  
Family History Hx_PCOS Dichotomous Presence of polycystic ovarian 
syndrome in any first (self, 
mother or sister) degree relative 
Hx_Endometriosi
s 
Dichotomous Presence of endometriosis in 
any first degree family member. 
Hx_PID Dichotomous Presence of pelvic inflammatory 
disease in any first degree 
family member. 
Hx_FibrocysticBr
easts 
Dichotomous Presence of fibrocystic breasts 
in any first degree family 
member. 
Nutrition Pred_Fiber Continuous Predicted fiber (gm) per day 
Pred_Calc Continuous Predicted calcium (mg) per day 
Pred_Sug Continuous Predicted added sugars (tsp) per 
day 
Pred_Whgr Continuous Predicted ounce equivalents of 
whole grains per day 
Pred_Dairy Continuous Predicted cup equivalents of 
dairy per day 
Pred_FVL Continuous Predicted cup equivalents of 
fruits and vegetables (including 
legumes) per day 
Physical 
Activity 
Summary_Score_
PAQ 
Ordinal Level of activity. A score of 1 
indicates low physical activity, 
a score of 5 indicates high 
physical activity. 
Anxiety Anx_TotalScore Ordinal Indicated the overall extend of 
anxiety symptoms.  
Range = 0-82 
Score ≥ 25 indicates presence of 
anxiety 
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Appendix C. Demographic Questionnaire for Parents 
Please answer the following questions to the best of your ability. You will be asked some 
questions about yourself, and some questions about your daughter with ASD (who will be 
referred to as the 'daughter', regardless of your relationship to her).  
1. How are you related to the young woman with ASD?  
a. Mother 
b. Father 
c. Sibling- Sister 
d. Sibling – Brother 
e. Caretaker/Legal Guardian  
f. Grandparent 
2. What is your date of birth? 
3. Please specify your race (Select all that apply).  
a. American Indian/Alaska Native 
b. Asian  
c. Native Hawaiian or Other Pacific Islander  
d. Black or African American  
e. White  
f. Other 
4. Please specify your ethnicity.  
a. Hispanic or Latino 
b. NOT Hispanic or Latino  
c. Other 
5. What is your gender?  
a. Female  
b. Male  
c. Other  
6. What is your height (in feet and inches)?  
7. What is your weight (in lbs)?  
8. What is your primary language?  
a. English  
b. Spanish  
c. German  
d. French  
e. Other  
9. What is your marital status?  
a. Single, never married  
b. Married  
c. Widowed  
d. Divorced  
e. Separated 
f. Long term partner  
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10. What is the highest level of schooling you have completed? 
a. None  
b. Kindergarten through 8th grade  
c. Some high school  
d. High school graduate or GED  
e. Some college courses, no degree  
f. Associate's degree  
g. Bachelor's degree  
h. Master's degree  
i. Professional degree (MD, JD)  
j. Doctoral degree  
11. What is your family's annual income? 
a. Less than $20,000  
b. $20,000 - $40,000  
c. $40,000 - $60,000  
d. $60,000 - $80,000  
e. $80,000 - $100,000  
f. $100,000- $150,000  
g. More than $150,000  
h. Prefer not to say  
Please answer the following questions about your daughter to the best of your ability.  
12. What diagnosis of Autism Spectrum Disorder was your daughter given?  
a. No diagnosis 
b. Autism 
c.  PDD-NOS  
d. Asperger's Syndrome  
e. Autism Spectrum Disorder  
f. I don't know  
13. At what age (in months) was your daughter diagnosed with an ASD?  
14. What type of classroom is she in at school? 
a. She is home schooled 
b. Special Education classroom  
c. Inclusion classroom  
d. Typical classroom 
e. I don't know  
f. Other 
15. Does your daughter take any of the following non-prescription medications?  
a. Advil / ibuprofen  
b. Aleve / naproxen  
c. Bayer / aspirin 
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d.  Benadryl / diphenhydramine  
e. Orudis / ketoprofen  
f. Pepcid / famotidine  
g. Prilosec / omeprazole  
h. Tagamet /cimetidine  
i. Tylenol / acetaminophen  
j. Zantac / ranitidine  
16. Does your daughter take any prescription medication for the following conditions 
or reasons?  
a. ADHD 
b. Allergies  
c. Asthma  
d. Bladder control problems  
e. Birth control  
f. Crohn's disease 
g. Constipation 
h. Depression  
i. Gastric reflux or heartburn  
j. Glaucoma  
k. Hemophilia  
l. High blood pressure  
m. Diabetes (Type I or Type II)  
n. High cholesterol  
o. Inflammatory bowel disease  
p. Migraine headache  
q. Hyperthyroidism or Hypothyroidism  
r. Other 
If you are the biological mother of the daughter with ASD, please answer the questions 
below to the best of your ability.  
If you are not your daughter's biological mother, or do not recall your pregnancy with 
your daughter with ASD, please skip the following questions and move on to the next 
section.  
17. At what age (in years, months if you recall) did you start your period?  
18. How much weight (in lbs) did you gain while pregnant with your daughter?  
19. Did you have preeclampsia while pregnant with your daughter?  
20. Was your daughter born prematurely?  If so, how many weeks was she born at?  
21. Has anyone in your family been diagnosed with an Autism Spectrum Disorder 
(Autism, Asperger’s Syndrome, PDD-NOS)? 
a. No 
b. Yes, my daughter (not participating) 
c. Yes, my son 
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d. Yes, myself 
e. Yes, my partner 
f. Yes, a parent or sibling 
g. Yes, a cousin, aunt/uncle, or niece/nephew 
h. Yes, Other 
i. I don’t know 
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Appendix D. Demographic Questionnaire for Daughter Participants 
 
You will be asked some questions about yourself, please answer to the best of your 
ability. 
1. What is your date of birth?  
2. What is your age (in years)?  
3. What is your race?  
a. American Indian/Alaska Native 
b. Asian  
c. Native Hawaiian or Other Pacific Islander  
d. Black or African American  
e. White  
f. Other 
4. What is your ethnicity?  
a. Hispanic or Latino 
b.  NOT Hispanic or Latino  
c. Other 
5. What is your gender?  
a. Female 
b. Male 
c. Other 
6. What is your height (in feet and inches)?  
7. What is your weight (in lbs)?  
8. What is your primary language? 
a. English 
b. Spanish 
c. German 
d. French 
e. Other 
9. What grade are you in school?  
a. Kindergarten through 4th grade 
b. 5th through 8th grade 
c. 9th through 12th grade 
d. I am home schooled 
e. College 
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Appendix E. Modified Parker-Sneddon Menstrual Disorders of Teenagers Questionnaire  
 
Example below is the parent version, participation version is identical with modifications 
for first person language. 
 
Section 1. General Information.  
1. What is your daughter's date of birth (MM/DD/YY)?  
2. When did your daughter start menstruating (MM/DD/YY)?  
Section 2. About her usual periods. Please answer these statements about your daughter's 
periods to the best of your ability.  
3. Does your daughter have periods?  
a. Yes 
b. No 
c. If not, please explain.  
4. Over the past 12 months, her periods have been:  
a. Regular  
b. Irregular  
c. I don't know  
5. What is the usual number of days from the first day of bleeding at one period to 
the first day of bleeding at the next?  
6. How many days does she bleed?  
7. (Questions 8-17 Modifiable to Length of Flow) 
8. On the first day of her period, how heavy is her bleeding? 
a. Light  
b. Medium 
c. Heavy 
9. On the second day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
10. On the third day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
11. On the fourth day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
12. On the fifth day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
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13. On the sixth day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
14. On the seventh day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
15. On the eighth day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
16. On the ninth day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
17. On the tenth day of her period, how heavy is her bleeding?  
a. Light  
b. Medium 
c. Heavy 
18. Does her bleeding contain clots? 
a. Yes 
b. No 
19. If yes, how often does it contain clots? 
a. Sometimes 
b. Most of the time 
c. All the time 
20.  Do you ever notice spots of blood on her underpants?  
a. Just before a period 
b. In between periods 
c. During periods 
d. Never 
21. Does she ever miss school because of her periods?  
a. No 
b. Yes, every period 
c. Yes, some periods 
d. I don’t know 
22. If yes, how many days of her period does she usually stay home for?  
23. What is it about her period that causes her to miss school?  
a. Too painful  
b. Blood flow too heavy  
c. Nausea or vomiting  
d. Other: ____________ 
24. Have her period symptoms worsened over the past 12 months?  
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a. Yes 
b. No 
c. I don’t know 
d. Not applicable 
25. Please rate her period pain over the past 12 months? (0 being no pain, 10 being 
the worst pain)  
26. Does she take medication for her period pain?  
a. No 
b. Yes 
c. I don't know 
d. Not applicable  
27. If so, what type of medication does she usually take?  
a. Naproxen  
b. Advil 
c. Aspirin  
d. Ibuprofen  
e. Other: ___________ 
28. How effective is it at relieving her pain? (0 being not effective, 10 being highly 
effective) 
29. Does she use hormonal birth control? 
a. Yes 
b. No 
30. If ‘yes’, what type of birth control does she use?  
a. Oral birth control (‘The Pill’) 
b. Intrauterine device (IUD) 
c. Vaginal ring (NuvaRing) 
d. Hormonal patch (OrthoEvra) 
e. Hormonal implant (Implanon, Norplant) 
f. Hormonal injection (Depo-Provera) 
31. Why does she use hormonal birth control? 
a. To regulate her periods 
b. To decrease her menstrual symptoms 
c. To cause her periods to happen less frequently 
d. Other: _____ 
Section 3. Over the past 12 months, has your daughter experienced any of the following 
in relation to her monthly period?  
Please answer these questions to the best of your ability. If you do not know the answer, 
please select ' I don't know'. Please do not ask your daughter.  
Answers: Doesn't apply to her, No/Never, Just before a period , At the time of the period, 
Any time of the month, All the time , Sometimes,  I don't know 
1. Nausea  
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2. Vomiting  
3. Bloating  
4. Diarrhea  
5. Constipation  
6. Indigestion, reflux, or heartburn  
7. Changes in appetite  
8. Changes in sleep 
9. Aching outside her vagina  
10. Aching down her legs  
11. Pelvic pain - aching  
12. Pelvic pain - cramping  
13. Pelvic pain - stabbing  
14. Pelvic pain - other  
15. Lower back pain  
16. Pain when urinating 
17. Pain when empting bowel 
18. Headaches  
19. Thrush (itchy and sore around and outside the vagina)  
20. Dizziness, fainting or passing out  
21. Feeling down or depressed  
22. Breast tenderness 
23. Cyclical acne 
24. Social withdrawal 
25. Decreased interest 
26. Concentration problems 
27. Anxiety 
28. Moodiness 
29. Tearfulness or increased sensitivity to rejection 
Section 4. Does her period affect her lifestyle? Please rate from 0 to 10, with 0 meaning 
no interference, and 10 meaning major interference, N/A = not applicable (to her).  
Please answer these questions to the best of your ability. If you do not know the answer, 
please select ' I don't know'. Please do not ask your daughter.  
1. Attending school  
2. Completing school work 
3. Casual paid work  
4. Social activities  
5. Relationships with family 
6. Relationships with friends 
7. Relationship with a partner  
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8. Sports or exercise  
9. Does the above interference with lifestyle occur with: 
a. Some periods 
b.  Most periods  
c. All periods  
d. Not applicable to her  
What is it about her period that interferes with her life? 0 = no interference, 10 = major 
interference, N/A = not applicable (to her).  
Please answer these questions to the best of your ability. If you do not know the answer, 
please select ' I don't know'. Please do not ask your daughter.  
1. Pain  
2. Heavy blood flow 
3. Tiredness / fatigue 
4. Moods  
5. Generally feeling unwell  
6. Other: ___________ 
7. Does the above interference with lifestyle occur with: 
a. Some periods 
b.  Most periods  
c. All periods  
d. Not applicable to her  
e. I don't know  
Section 5. The following is a list of statements related to periods. Please select the answer 
that best represents your beliefs of your daughter’s period for each statement. N/A = not 
applicable (to her).  
Please answer these questions to the best of your ability. If you do not know the answer, 
please select ' I don't know'. Please do not ask your daughter.  
Answers: True, False, I don’t know, Not applicable to her 
1. She usually has a period every month.  
2. She has never missed a period.  
3. She has problems with her periods.  
4. She has had tests because things weren't right with her period. 
5. She has a period problem that has a name.  
6. She is on the pill.  
7. She is on the pill to help period pain.  
8. She has never taken the pill.  
9. Her periods don't worry me too much.  
10. Her periods worry me a lot.  
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11. Her periods are 'normal' most of the time.  
12. Sometimes I think there is something 'wrong' with her periods.  
13. I am sure there is something 'wrong' with her periods.  
14. She has never used a tampon.  
15. She has tried to use a tampon but couldn't get it in.  
16. She is not interested in using a tampon.  
17. She can insert a tampon but it is too uncomfortable.  
18. She only uses tampons.  
19. She only uses pads (sanitary napkins).  
20. She has difficulties using pads. 
21. She is not interest in using pas. 
22. She can use a pad, but it is too uncomfortable.  
23. She uses pads and tampons.  
24. She often gets lots of pimples on her face.  
25. She often gets lots of pimples on her back.  
26. She often gets lots of pimples on her chest.  
27. She has more hair than usual growing on her body.  
28. She has had a blood test for her period pain.  
29. She has had an ultrasound to look for causes of her period pain. 
30. She has had an operation to look for causes of her period pain.  
31. She talks to her friends about her period.  
32. She talks to me about her period.  
33. She talks to her doctor about her period.  
34. She talks to a specialist doctor about her period.  
35. She talks to a naturopath/herbalist/acupuncturist about her period.  
36. She is grumpy before or during her periods.  
37. She is grumpy all the time.  
38. She gets teary before or during a period.  
39. She feels overwhelmed and not able to cope before or during a period.  
40. She often wants to withdraw or hide when she has her period. 
41. Her periods don't affect her moods.  
Section 6. Please list any allergies or intolerances your daughter has.  
1. Medications: ______________ 
2. Foods: _________________ 
3. Other (bee stings, seasonal allergies): _________________ 
Section 7. Have you ever heard of the following? Please answer these questions about 
yourself, not your daughter.  
1. Polycystic ovarian syndrome / polycystic ovaries.  
a. No  
b. Yes 
c. I don’t know 
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2. Endometriosis  
a. No 
b. Yes 
c. I don’t know 
3. Pelvic inflammatory disease (PID).  
a. No  
b. Yes 
c. I don’t knw 
Do you, your mother or sister have any of the following?  
1. Period problems  
a. Yes  
b. No  
c. I don't know  
2. Severe period pain  
a. Yes  
b. No  
c. I don't know  
3. Polycystic ovarian syndrome / polycystic ovaries 
a. Yes  
b. No  
c. I don't know  
4. Endometriosis  
a. Yes  
b. No  
c. I don't know  
5. Pelvic inflammatory disease (PID) 
a. Yes  
b. No  
c. I don't know  
6. Fibrocystic Breasts 
a. Yes 
b. No 
c. I don’t know 
7. Is there anything else that you would like to tell us about you or your daughter's 
periods, or something that has changed in either of your periods?  
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Appendix F. Dietary Screening Questionnaire 
 
These questions are about foods your daughter ate or drank during the past month, that is, 
the past 30 days. When answering, please include meals and snacks at home, at work or 
school, in restaurants, and anyplace else.  
1. During the past month, how often did your daughter eat hot or cold cereals?  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
2. During the past month, what kind of cereal did she usually eat? _________ 
3. During the past month, how often did your daughter have any milk (either to 
drink or on cereal)? Include regular milks, chocolate or flavored milks, lactose-
free milk, buttermilk. Please DO NOT include soy milk or small amounts of milk 
in coffee or tea. 
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2-3 times per day  
j. 4-5 times per day 
k. 6 or more times per day 
4. During the past month, what kind of milk did she usually drink?  If other, please 
list.  
a. Whole or regular milk 
b. 2% fat or reduced-fat milk  
c. 1%, 1/2% or low-fat milk  
d. Fat-free, skim or nonfat milk  
e. Soy milk  
f. Other:___________ 
5. During the past month, how often did your daughter drink regular soda or pop that 
contains sugar? Do NOT include diet soda.  
a. Never 
b. 1 time last month  
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c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2-3 times per day  
j. 4-5 times per day 
k. 6 or more times per day 
6. During the past month, how often did your daughter drink 100% pure fruit juices, 
such as orange, mango, apple, grape and pineapple juices? Do NOT include fruit-
flavored drinks with added sugar or fruit juice you made at home and added sugar 
to.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2-3 times per day  
j. 4-5 times per day 
k. 6 or more times per day 
7. During the past month, how often did your daughter drink coffee or tea that had 
sugar or honey added to it? Include coffee and tea you sweetened yourself and 
presweetened tea and coffee drink such as Arizona Iced Tea and Frappuccino. Do 
NOT include artificially sweetened coffee or diet tea.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2-3 times per day  
j. 4-5 times per day 
k. 6 or more times per day 
8. During the past month, how often did your daughter drink sweetened fruit drinks, 
sport or energy drinks, such as Kool-Aid, lemonade, Hi-C, cranberry drink, 
Gatorade, Red Bull or Vitamin Water? Include fruit juices you made at home and 
added sugar to. Do NOT include diet drinks or artificially sweetened drinks.  
a. Never 
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b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2-3 times per day  
j. 4-5 times per day 
k. 6 or more times per day 
9. During the past month, how often did your daughter eat fruit? Include fresh, 
frozen or canned fruits. Do NOT include juices.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
10. During the past month, how often did your daughter eat a green leafy or lettuce 
salad, with or without other vegetables?  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
11. During the past month, how often did your daughter eat any kind of fried potatoes, 
including french fries, home fries, or has brown potatoes. 
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
12. During the past month, how often did your daughter eat any other kind of potatoes, 
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such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad?  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
13. During the past month, how often did your daughter eat refried beans, baked 
beans, beans in soup, pork and beans or any other type of cooked dried beans? Do 
NOT include green beans.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
14. During the past month, how often did your daughter eat brown rice or other 
cooked whole grains, such as bulgur, cracked wheat, or millet? Do NOT include 
white rice.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
15. During the past month, not including what you just told us about green salads, 
potatoes, and cooked beans, how often did your daughter eat other vegetables?  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
 
 
195 
 
i. 2 or more times per day  
16. During the past month, how often did your daughter have Mexican-style salsa 
made with tomato?  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
17. During the past month, how often did your daughter eat pizza? Include frozen 
pizza, fast food pizza and homemade pizza. 
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
18. During the past month, how often did your daughter eat any kind of cheese? 
Include cheese as a snack, cheese on burgers, sandwiches, and cheese in foods 
such as lasagna, quesadillas, or casseroles. Do NOT include cheese on pizza.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
19. During the past month, how often did your daughter eat red meat, such as beef, 
pork, ham or sausage? Do NOT include chicken, turkey or seafood. Include red 
meat she had in sandwiches, lasagna, stew, and other mixtures. Red meats may 
also include veal, lamb, and any lunch meats made with these meats.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
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f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
20. During the past month, how often did your daughter eat any processed meat, such 
as bacon, lunch meats, or hot dogs? Include processed meats you had in 
sandwiches, soups, pizza, casseroles, and other mixtures. Processed meat are 
those preserved by smoking, curing, or salting, or by the addition of preservative. 
Examples are: ham, bacon, pastrami, salami, sausages, bratwursts, frankfurters, 
hot dogs and spam.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
21. During the past month, how often did your daughter eat whole grain bread, 
including toast, rolls and in sandwiches? Whole grain includes whole wheat, rye, 
oatmeal, and pumpernickel. Do NOT include white bread.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
22. During the past month, how often did your daughter eat chocolate or any other 
types of candy? Do NOT include sugar-free candy.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
23. During the past month, how often did your daughter eat doughnuts, sweet rolls, 
Danish, muffins, pan dulce, or pop-tarts? Do NOT include sugar-free items.  
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a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
24. During the past month, how often did your daughter eat cookies, cake, pie, or 
brownies? Do NOT include sugar-free kinds.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
25. During the past month, how often did your daughter eat ice cream or other frozen 
desserts? Do NOT include sugar-free kinds.  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
26. During the past month, how often did your daughter eat popcorn?  
a. Never 
b. 1 time last month  
c. 2-3 times last month  
d. 1 time per week  
e. 2 times per week  
f. 3-4 times per week 
g. 5-6 times per week 
h. 1 time per day 
i. 2 or more times per day  
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Appendix G. Physical Activity Questionnaire – Adolescent Version 
We are trying to find out about your level of physical activity from the last 7 days (in the 
last week). This includes sports or dance that make you sweat or make your legs feel tired, 
or games that make you breathe hard, like tag, skipping, running, climbing, and others.  
Remember:  
There are no right and wrong answers — this is not a test. Please answer all the questions 
as honestly and accurately as you can — this is very important.  
1. Physical activity in your spare time: Have you done any of the following activities in 
the past 7 days (last week)? If yes, how many times? (Mark only one circle per row.) 
Answers: No, 1-2, 3-4, 5-6, 7 times or more 
a. Skipping 
b. Rowing/canoeing 
c. In-line skating 
d. Tag 
e. Walking for exercise  
f. Bicycling  
g. Jogging or running  
h. Aerobics  
i. Swimming  
j. Baseball, softball 
k. Dance  
l. Football  
m. Badminton  
n. Skateboarding  
o. Soccer  
p. Street hockey  
q. Volleyball  
r. Floor hockey  
s. Basketball  
t. Ice skating  
u. Cross-country skiing  
v. Ice hockey/ringette  
w. Other: __________________ 
2. In the last 7 days, during your physical education (PE) classes, how often were 
you very active (playing hard, running, jumping, throwing)? (Check one only.)  
a. I don’t do PE  
b. Hardly ever  
c. Sometimes  
d. Quite often  
e. Always  
3. In the last 7 days, what did you normally do at lunch (besides eating lunch)? 
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(Check one only.)  
a. Sat down (talking, reading, doing schoolwork) 
b. Stood around or walked around  
c. Ran or played a little bit  
d. Ran around and played quite a bit  
e. Ran and played hard most of the time  
4. In the last 7 days, on how many days right after school, did you do sports, dance, 
or play games in which you were very active? (Check one only.)  
a. None  
b. 1 time last week  
c. 2 or 3 times last week  
d. 4 times last week  
e. 5 times last week  
5. In the last 7 days, on how many evenings did you do sports, dance, or play games 
in which you were very active? (Check one only.)  
a. None  
b. 1 time last week  
c. 2 or 3 times last week  
d. 4 or 5 last week  
e. 6 or 7 times last week  
6. On the last weekend, how many times did you do sports, dance, or play games in 
which you were very active? (Check one only.)  
a. None  
b. 1 time  
c. 2 — 3 times  
d. 4 — 5 times  
e. 6 or more times  
7. Which one of the following describes you best for the last 7 days? Read all five 
statements before deciding on the one answer that describes you.  
a. All or most of my free time was spent doing things that involve 
little physical effort  
b. I sometimes (1 — 2 times last week) did physical things in my free 
time (e.g. played sports, went running, swimming, bike riding, did 
aerobics)  
c. I often (3 — 4 times last week) did physical things in my free time  
d. I quite often (5 — 6 times last week) did physical things in my free time  
e. I very often (7 or more times last week) did physical things in my free 
time 
8. Mark how often you did physical activity (like playing sports, games, doing dance, 
or any other physical activity) for each day last week. Answers: None, Little bit, 
Medium, Often, Very often 
a. Monday 
b. Tuesday 
c. Wednesday 
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d. Thursday 
e. Friday 
f. Saturday 
g. Sunday 
9. Were you sick last week, or did anything prevent you from doing your normal 
physical activities? (Check one.)  
a. Yes  
b. No 
c. If Yes, what prevented you? ________________  
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Appendix H. Screen for Child Anxiety Related Disorders (SCARED) 
Example below is the parent version, participation version is identical with modifications 
for first person language.  
 
Below is a list of sentences that describe how people feel. Read each phrase and decide if 
it is "Not True or Hardly Ever True" or "Somewhat True or Sometimes True" or "Very 
True or Often True" for your child. Then, for each statement, fill in the circle that 
corresponds to the response that seems to describe your child for the last 3 months. Please 
respond to all statements as well as you can, even if some do not seem to concern your 
child. 
 
1. When my child feels frightened, it is hard for him/her to breathe. 
2. My child gets headaches when he/she am at school.  
3. My child doesn’t like to be with people he/she doesn’t know well.  
4. My child gets scared if he/she sleeps away from home.  
5. My child worries about other people liking him/her.  
6. When my child gets frightened, he/she feels like passing out.  
7. My child is nervous.  
8. My child follows me wherever I go.  
9. People tell me that my child looks nervous.  
10. My child feels nervous with people he/she doesn’t know well.  
11. My child gets stomachaches at school.  
12. When my child gets frightened, he/she feels like he/she is going crazy.  
13. My child worries about sleeping alone.  
14. My child worries about being as good as other kids.  
15. When my child gets frightened, he/she feels like things are not real.  
16. My child has nightmares about something bad happening to his/her parents.  
17. My child worries about going to school.  
18. When my child gets frightened, his/her heart beats fast.  
19. He/she child gets shaky.  
20. My child has nightmares about something bad happening to him/her. 
21. My child worries about things working out for him/her.  
22. When my child gets frightened, he/she sweats a lot.  
23. My child is a worrier.  
24. My child gets really frightened for no reason at all.  
25. My child is afraid to be alone in the house.  
26. It is hard for my child to talk with people he/she doesn’t know well.  
27. When my child gets frightened, he/she feels like he/she is choking.  
28. People tell me that my child worries too much.  
29. My child doesn’t like to be away from his/her family.  
30. My child is afraid of having anxiety (or panic) attacks.  
31. My child worries that something bad might happen to his/her parents.  
32. My child feels shy with people he/she doesn’t know well.  
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33. My child worries about what is going to happen in the future.  
34. When my child gets frightened, he/she feels like throwing up.  
35. My child worries about how well he/she does things.  
36. My child is scared to go to school.  
37. My child worries about things that have already happened.  
38. When my child gets frightened, he/she feels dizzy.  
39. My child feels nervous when he/she is with other children or adults and he/she has to 
do something while they watch him/her (for example: read aloud, speak, play a game, 
play a sport.)  
40. My child feels nervous when he/she is going to parties, dances, or any place where 
there will be people that he/she doesn’t know well.  
41. My child is shy. 
  
 
 
203 
 
Appendix I. Semi-Structured Interview Guide for Parent 
 
Word Association: What comes to mind when you think of.. 
-­‐ Puberty for your daughter 
-­‐ Your daughter’s periods 
 
Thinking back to the day your daughter got her first period, how did she react to getting 
her period?  
 
How does (your daughter) manage her periods now? 
 
Did you and (your daughter) talk about puberty and periods before she got her period? 
How do you talk about them now?  
 
What resources have you used to prepare yourself and/or your daughter for puberty? 
 
How did you think about puberty or periods before she entered? How about now? 
 
Does she talk to friends/siblings about ‘growing up’? 
 
Some of the girls in the study reported feeling a lot or very little pain in relation to their 
periods. Do you feel your daughter experiences an atypical amount of pain related to her 
periods compared to her peers? What does you daughter do (or what does your family do) 
to help her cope with her period pain? 
 
Does your daughter have any sensory issues? Has it influenced how she manages her 
periods? 
 
How do you feel when you think about your daughter growing up? 
 
What would you like to tell other mothers whose daughters with ASD who are entering 
puberty/will start their periods soon? 
 
What would you have done the same or differently in helping your daughter prepare for 
getting her period?  
 
Anything you’d like to tell other families with girls with Autism who are going through 
puberty? 
 
Wrap: Thank you so much for your time. Is there anything else that you’d like to share? 
Is there anything want us to know?  
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Appendix J. Semi-Structured Interview Guide for Participant 
 
Word Association: I’d like you to tell me what words that come to mind when you think 
about… 
-­‐ Puberty 
-­‐ Your period 
 
Okay. You shared the word ___________I’d like to talk more about that. Why do you 
say ______ when we talk about ________? Does it have meaning for you? 
 
How does your body feel when you have your period? 
 
How do you feel emotionally when you have your period? 
 
What do you do to get ready for your period? Does it work? 
 
Do you always know when your period is coming? Does it ever surprise you? 
 
Do you remember the first time you got your period? Can you tell me about it? 
 
Have you learned about bodies or periods at school? Do you talk about bodies or periods 
with your friends? Your sisters? What do you talk about? 
 
Are you taking any medication that affects your period? 
 
Do you track your period? How? 
 
If you have a friend about to get her period for the first time, what would you tell her to 
help her get ready? 
 
Is there anything you’d like to tell other girls with Autism who are going through 
puberty? 
 
Have you ever missed out on anything you wanted to do because you had your period? 
 
Wrap: Thank you so much for your time. Is there anything else that you’d like to share? 
Is there anything want us to know?  
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